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The origins of adult disease have been a prime topic for research, as deciphering causes can lead to strategies for preventions 
and cures . There has been recent intrigue focused on the environment in the womb . Records from England and Wales in 1911 
show that those who suffered from cardiovascular disease were geographically correlated with regions high in infant mortality in 
the past, seventy years before the study . When looking into the cause of the neonatal death rates, low birth weight, poor maternal 
health, and high maternal death rates during childbirth were clearly associated . Barker inferred that there is much happening in 
the intrauterine environment that ultimately affects our quality of life . This research helps support the concept that rather than 
looking at childhood adversity and socioeconomic circumstances to help explain adult disease, we might need to reach further 
back (Barker,1990) .
Through epigenetic mechanisms, alterations to the physical expression of our DNA can take place without changing the sequenc-
es of the actual DNA. Epigenetics is what is responsible during fetal development for the differentiation of stem cells to specific 
cells by adding or subtracting methyl groups to silence or activate particular genes . When an egg and sperm unite all previous 
methylation patterns are stripped from the newly formed diploid . However, by the time it becomes a blastocyst, new patterns have 
already formed . It is during this crucial stage of development that new patterns and changes to our epigenome our founded and 
passed down (Powledge, 2009) .
 The purpose of this paper is to determine if chronic health issues in adulthood have their roots in the environment and changes 
experienced by the fetus in the womb . Environmental exposures like nutrition, stress, and toxicants are evaluated and tested for 
their potential hand in setting the course for adult disease . Many studies show correlation between malnutrition and the develop-
ment of metabolic diseases like obesity, type II diabetes, and even hypertension . Likewise, stress during gestation has been linked 
to anxiety, depression, and posttraumatic stress disorder (PTSD) in offspring . Toxicants like bisphenol-A are the likely culprit for 
genetically expressed abnormalities that range from cancers of the reproductive system to attention/deficit hyperactive disorder 
(ADHD) in exposed offspring . The “how” and the “why” are explored in this paper . If we can better understand the origins of adult 
disease then we are better equipped to defend our future generations against it . Furthermore, the notion that our DNA is not at 
fault for these outcomes, but rather epigenetic adjustments written on top of our DNA, provides hope that just as easily as it can 
be added on, we can take it off (Powledge, 2009) .
Are Health Problems in Adulthood linked to our 
Experiences in the Womb? An Epigenetic Approach
Simone Tendler
Simone Tendler graduated in January 2020 with a B.S. degree in Biology.
Introduction: What is Epigenetics?
The concept that the in utero environment causes adult dis-
eases later in life was first proposed by DJ Barker in the fa-
mous, “Barker Hypothesis,” some twenty years ago, but the 
term, “epigenetics,” was originally coined by developmental 
biologist Conrad Waddington in the early 1940s. Waddington 
labelled it as, “the interactions of genes with their environment, 
which brings the phenotype into being.” He was referring to 
the phenomenon that all cells share the same DNA, yet they 
express complete differences in their phenotype and function. 
Moreover, skin cells, liver cells, and brain cells are only capable 
of producing more of their type within their same phenotypic 
expression, so whatever mechanism is accounting for the dif-
ferentiation is clearly able to be inherited. These modifications 
usually take place on certain regions of DNA, cytosine-phos-
phate-guanine dinucleotides, at the carbon-5’ position of cyto-
sine. The most common mechanism seen in the fetal environ-
ment includes methylation, the adding or removing of a methyl 
group to and from the carbon-5’ position. The usual methyl 
donor is S-adenosylmethionine (SAM), which the methyl trans-
ferase uses as a source of methyl to the DNA molecule. During 
methylation, methyl-transferase adds on the methyl group, pre-
venting binding of transcription elements, thereby silencing gene 
expression (figure 1) (Odom, Taylor, 2010).
The silencing of genes via methylation occurs by obstruction 
of the binding of transcriptional machinery that needs contact 
with the cytosine, in the major groove of the double helix. 
Methylation can also function by methylating the promoter re-
gion of DNA. Methylation can sometimes lead to activation of 
a gene by obstructing the binding of transcription repressors, 
ultimately activating certain genes. Another common mecha-




addition or subtraction of different compounds like methyl, ac-
etate, or phosphate groups to histone proteins, causing changes 
in chromatin packaging. The adding on of these compounds to 
the four pairs of proteins that make up the “octameric histone 
core…restricts physical access of nuclear factors to the DNA 
and alters gene expression” (Odom, Taylor, 2010).
Methylation happens at very critical times in development. 
During gametogenesis, haploid cells demethylate from the 
development of primordial germ cells until the period before 
preimplantation, to return the cell to its pluripotent state. The 
pluripotency refers to the cells ability to take the shape and re-
sponsibility of any cell type in the body. After implantation of the 
embryo, remethylation begins to differentiate each cell, forming 
cell specific DNA methylation patterns (Odom, Taylor, 2010). 
Methylation and histone modification are seen as adaptive 
responses. In other words, it is a mechanism to protect the 
fetus from the volatile environment in which it is developing. 
For example, in a situation of food shortage, metabolic adap-
tations are made to increase the energy storage. Problems 
arise, however, when the adult environment does not match 
the environment in the womb. When the fetus is subsequently 
born into a nutrient-rich environment, suddenly its metabolic 
adaptations can lead it on a path of obesity and all its associated 
medical complications. (Odom, Taylor, 2010) It is with this idea 
that we construct a hypothesis that links adult chronic disease 
to in utero environmental exposures. 
Methods
This comprehensive review is based on critical analysis of litera-
ture on epigenetics obtained using the Touro College Online li-
brary and PubMed publishing, analyzing the information and opin-
ions that were expressed in various experiments. Review articles 
were useful in providing additional references to source material.
Discussion: Nutrition
Malnutrition
Nutrition is extremely significant when looking at studies to link 
fetal environment to adult disease. The majority that is known 
on the epidemiology of epigenetics comes from animal studies, 
yet the Dutch Famine of 1944-1945 affords a unique opportu-
nity to study the effects of malnutrition on a human population. 
The period of the famine was clearly defined, the food rations 
were documented, and registries and health care documenta-
tion remained intact. (Heijmans et al., 2008)
Insulin-like growth factor II (IGF-2) is one of the most epige-
netically controlled loci. IGF-2 is integral for human growth and 
development, is known to play a significant role in “metabolic 
regulation of glucose homeostasis, cardiovascular functions, and 
lipid metabolism,”(Rijlaarsdam et al., 2016), and is maternally 
imprinted. This means that while both alleles are inherited, the 
maternal allele is silenced via methylation. If hypomethylation, 
the decrease of methylation via subtracting of methyl groups, 
takes place in these regions, bi-allelic expression of IGF-2 oc-
curs, leading to detrimental outcomes in adult health. (Heijmans 
et al., 2008)
A previous study involving 372 twins shows that the meth-
ylation of IGF-2 largely depends on genetic factors and has 
methylation marks that are stable at least up until middle age 
(Heijmans et al., 2008). Therefore, any alterations from the ge-
netic disposition in the methylation patterns done during ges-
tation would be able to be detected many years later. The many 
different diseases that have been linked to the Dutch Famine 
are thought to be mediated by abnormal methylation of IGF-2.
A study was done to test methylation patterns of children 
conceived during The Dutch Famine in comparison to their 
same sex siblings. The study was careful to segregate those that 
experienced famine in the periconceptional period and those 
that experienced famine during late gestation. Blood was drawn 
from the 122 subjects and their same sex siblings, treated with 
bisulfite to segregate methylated regions of IGF-2, and then 
amplified using polymerase chain reaction (PCR). The region 
contained five CpG islands, areas that are rich in cytosine-phos-
phate-guanine dinucleotides. In the 60 adults whose mothers 
experience the famine in early gestation, all but one island 
showed hypomethylation of between 5-6%. Interestingly, those 
that were exposed to the famine during late gestation did not 
have differing methylation patterns than their siblings, suggesting 
that methylation pattern of the IGF-2 allele are susceptible to 
environmental influences at a critical window in early develop-
ment (figure 2).Those exposed during late gestation did exhibit 
lower birth weight than the other groups, a birth feature that 
was previously associated with adult disease. This study shows 
that while low birth weight might be indicative of malnutrition, it 
is epigenetic modifications that are thought to hold responsibili-
ty for deteriorating adult health. (Heijmans et al., 2008)
Coronary artery disease (CAD) is strongly linked to fetuses 
exposed to the Dutch Famine. Developing organ systems re-
spond negatively to a lack of nutrients available, especially during 
periods of critical development. Using a registrar of 2,414 in-
fants from the Dutch Famine Birth Cohort born between the 
dates of November 1, 1943 and February 28,1947, Painter et al. 
extracted a group of 975 participants that experienced a caloric 
intake under 1,000 calories for at least 13 weeks of gestation 
during the famine. Various medical information was collected 
from participants at age 50 and 58, including blood pressure, 
glucose tolerance test results, total cholesterol levels, and elec-
trocardiogram information. (Painter et al., 2006)
By the end of this study, 83 candidates developed coronary 
artery disease, with the highest cumulative incidence of coro-
nary artery disease at 13% seen in those exposed during early 
gestation. Interestingly, it was those born in mid and late gesta-
tion that were born with the lowest birth weights with mothers 
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that weighed the least. Yet, those that developed coronary 
artery disease after exposure in mid to late gestation did not 
show a significant difference in cumulative incidence compared 
to those that were unexposed. On average, coronary artery 
disease manifested three years earlier in adults exposed in 
early gestation than in persons unexposed. (Painter et al., 2006) 
These results support the previous study that hypomethylation 
affects fetuses exposed to lack of nutrition in early gestation, 
thus linking hypomethylation of IGF-2 to adult disease as op-
posed to small birth weight. (Heijmans et al., 2007) That being 
said, any exposure to famine correlated with elevated glucose 
concentrations at 120 minutes and elevated ratios of LDL (low 
density lipoproteins) to HDL (high density lipoproteins). Most 
of the subjects were also being treated for type II diabetes and 
hypocholesterolemia (Painter et al 2006).
Schizophrenia is also linked to this critical window. A cohort 
of persons born in cities in western Netherlands during 1944-
1946 were compared for their risk of schizophrenia. The study 
included those exposed in early gestation compared with those 
exposed at other points of pregnancy. A national psychiatric 
registry of the region was referenced to see the frequency of 
patients hospitalized at age 24 to 48 years in the two groups of 
subjects. The results attested to the fact the those conceived at 
the height of the famine (i.e., that were exposed in early gesta-
tion) had a statistically significant twofold increase in the risk for 
schizophrenia (Susser et al., 1996). 
High-Sugar-High Fat Diet
High fat high sugar diets are associated with development of 
ADHD, conduct problems (CP), and their co-occurrence. IGF-2 
may also be linked to ADHD, as it is a major modulator of pla-
cental and fetal growth, as well as brain development after birth. 
Previous animal studies have linked IGF-2 to developmental ab-
normalities in structure and/or function of the cerebellum and 
hippocampus, two regions that play significant roles in ADHD. 
As previously noted, IGF-2 is easily influenced by diet during 
critical periods of development (Heijmans et al., 2008). Studying 
a sample of cohorts of mothers and 164 children with early 
onset conduct problems (EOP) or low conduct problems (CP), 
researchers considered the link between prenatal diet, IGF-2 
methylation status, current conduct problems, and risk symp-
toms for ADHD (Rijlaarsdam et al., 2016).
DNA methylation information was extracted from cord blood 
of the children from birth and peripheral blood at age seven. It 
was then bisulfite converted using the EZ-DNA methylation kit. 
A large number of probes,139, were extracted that are mapped 
to IGF-2 or overlapping regions, with methylation at factor 1 the 
most relevant to the study. Researchers assessed the mothers’ 
diets during pregnancy via The Food Frequency Questionnaire 
(FFQ), recording the maternal dietary patterns at 32 weeks of 
gestation and child’s diet at age 3, 4.5, and 7 years of age. The FFQ 
recorded the frequency of consumption of particular foods with 
higher frequency indicated by higher scores. High scores in pro-
cessed foods (chips, fried foods, pasties) and confectionery foods 
(chocolate bars, cakes, biscuits) indicated a prenatal and postnatal 
high-fat and sugar diet. At three different occasions (age 7, 10, and 
13), ADHD symptoms were assessed with the Development and 
Well-Being Assessment (DAWBA), a semi-structured interview 
with open and closed questions directed toward parents about a 
range of symptoms seen in their children relevant to ADHD, op-
positional defiant disorder (ODD), generalized anxiety disorder 
(GAD), conduct disorder (CD), and major depressive disorder 
(MDD) (Rijlaarsdam et al., 2016).
Results from this study indicate that youth with early onset 
persistent conduct problems (n= 83) exhibited higher levels 
of ADHD symptoms than youth with low conduct problems 
(n=81). The study also found that early onset persistent conduct 
problems youth showed high factor 1 methylation at birth of 
IGF-2 with symptoms of ADHD, but at age 7, methylation levels 
were negatively correlated with postnatal cumulative risk, with 
risk domains including life events such as relative’s death, con-
textual risk like financial problems, or direct victimization like 
Figure 2, showing different methylation patterns between those exposed periconceptionally and those exposed in late gestation (Heijmans et al . 2007)
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bullying. This can be seen as further proof that the prenatal envi-
ronment is the true origin for postnatal disease development, as 
opposed to what the child experiences after birth. IGF-2 meth-
ylation did not correlate with ODD, GAD, or MDD symptoms 
(Rijlaarsdam et al., 2016).
Cross-lagged associations showed that prenatal diet was asso-
ciated with IGF-2 methylation at birth for both early onset per-
sistent conduct problems and low conduct problems. However, 
associations between methylation at birth and ADHD symptoms 
at ages 7-13 was significantly higher in early onset problem youth 
than in low conduct problem youth, even though the maternal 
diet was significant in both domains (figure 3). In early onset 
persistent conduct problems youth, high methylation did predict 
ADHD symptoms, linked through the epigenetic modifications 
that were caused from unhealthy eating habits. It is possible that 
this vulnerable developmental pathway presents a specific risk 
factor for EOP children only (Rijlaarsdam, et al., 2016).
Methyl-Supplements
Methylation, the addition of methyl groups to cytosine-phos-
phate-guanine dinucleotides or to histone proteins, is what 
causes much of the gene silencing that takes place during 
fetal programming and early development. For methylation to 
happen, methyl donors like the B vitamins are vital in our diets. 
Methylation frequently occurs at transposable elements, DNA 
sequences that are unique in their ability to “jump” positions 
on the genome. At first glance, they seem rather parasitic, the 
source of genetic diseases and mutations by a series of rear-
rangements and recombination. However, mobile DNA has 
recently been discovered to have an important role in biodi-
versity and evolution. A concept known as “molecular domes-
tication” claims that open reading frames, complete RNA, and 
coding exons are thought to have originated from transposed 
DNA (Bohne et al., 2008). When methylation patterns differ on 
transposable elements, they account for epigenetic “mosaicism” 
and varying phenotypes. They are likely the cause of differential 
gene expression in identical twins. These regions are also meta-
stable and therefore, very susceptible to nutritional influences 
(Waterland and Jirtle, 2013).
To analyze the effect methyl donors might have on the de-
veloping epigenome, yellow agouti mice were used. The murine 
agouti gene encodes for a paracrine signaling molecule that in-
structs follicular melanocytes to switch from black eumelanin 
production to yellow phaeomelanin, resulting in yellow fur. This 
is known as the agouti A allele with the pseudoexon 1A pointing 
away from the agouti allele. The agouti “a” allele is caused from 
Figure 3, “Prospective interrelationships between unhealthy diet, IGF2 methylation and ADHD for youth with early‐onset persistent (n = 83) versus 
low (n = 81) conduct problems. Multiple group path analysis. Solid arrowed lines indicate standardized path coefficients that survived bootstrap‐
corrected confidence intervals (i.e. significant paths) for EOP versus low CP youth or averaged across all youth” (Rijlaarsdam et al., 2016).
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a loss-of function mutation in A, causing homozygotic “a” allele 
mice to be black. In contrast, the Avy allele is caused by the in-
sertion of an intracisternal A particle (IAP) retrotransposon to 
the 5’ end of the A allele, within the agouti exon 1A. This ectopic 
gene is transcribed from a cryptic promoter in the proximal end 
of the intracisternal A particle (figure 4). The CpG methylation 
of this region varies largely among different mice, inversely cor-
related with ectopic agouti expression. This variability is also 
responsible for a wide variation of hair color, adiposity, glucose 
tolerance, and tumor susceptibility in Avy/a mice that are other-
wise isogenic (Waterland and Jirtle, 2003).
If a/a dams are given specific dietary supplementation before 
mating with Avy mice, their Avy/a offspring exhibit a shift in coat 
color from yellow to pseudoagouti brown. Because the coat 
color correlates with Avy methylation status, it is inferred that 
supplementation influences this phenotypic shift via methylation 
of the Avy  gene. To test this hypothesis, a population of congenic 
Avy mice that had been sibling mated for forced heterozygosity 
for 200 generations were prepared. In another group, a/a female 
mice that were 8 weeks old were randomly assigned to either 
NIH-31 diets or NIH-31 diets supplemented with methyl do-
nors and cofactors like folic acid, vitamin B12, choline chloride, 
and anhydrous betaine. The diet was issued for two weeks be-
fore mating with the Avy mice, as well as throughout pregnancy 
and lactation. At age 21 days, the Avy/a offspring were weighed, 
tail tipped, photographed, and evaluated for coat color of yellow, 
slightly mottled (a bit of brown mixed in with yellow), mottled 
(half yellow, half brown), heavily mottled (greater than half is 
brown), or pseudoagouti. Pseudoagouti refers to the silencing of 
ectopic agouti expression, causing the brown agouti phenotype 
of an A/- mouse (Waterland and Jirtle, 2003). 
The supplemented dams did in fact express the brown color 
of pseudoagouti phenotype. Using tail tip DNA, researcher 
quantified the result from seven different  CpG sites of the re-
gion, showing methylation at each site, whereas the non-supple-
mented dams seemed to have methylation distributed bimodally 
with the epigenetic switch in one of two different states. This 
observation further proves the notion that methylation of Avy 
is the mediator of the affects of nutrition on coat color (figure 
5). Furthermore, methylation patterns in the tail correlated with 
methylation patterns in the liver, kidney, and brain, representing 
the early embryo layers of endoderm, mesoderm, and ecto-
derm, respectively. This continued to show that such methyl-
ation patterns were created at the earliest stages of embryo 
development and were maintained throughout development 
(Waterland and Jirtle, 2003).
Forty percent of the human genome is made of transposable 
elements, with copying number exceeding double the magni-
tude of classical genes. Much variation can be made by simple 
recombination and transposition of the elements in different 
areas. Epigenetic modification is likely in these areas (Bohne et 
al., 2008). Furthermore, many human genes are also transcribed 
from a cryptic promoter, similar to how the ectopic agouti 
transcription originates from the Avy intracisternal A particle. 
This study provides compelling evidence that much of our own 
phenotypic variability and “epigenetic mosaic” can be influenced 
by early nutrition  (Waterland and Jirtle, et al., 2003).
The restriction of methyl donors has previously been linked 
to neural tube defects in infants. Pregnant women are careful 
to take folic acid to avoid this fatal outcome. However, the fe-
tus’s epigenome is so sensitive, that even exposure like slightly 
improper methyl donor levels can bring about its own set of 
variations. Sinclair et al. experimented by restricting specif-
ic B vitamins and methionine within the normal physiological 
range to explore its effect on adult offspring. He administered 
a specific diet to adult female sheep from six days before con-
ception until eight weeks after conception. Diets were formed 
containing all nutrient requirements with decreased vitamin B 
and sulfur amino acids, yet within the physiological range in both 
Figure 4, “IAP insertion site in Avy allele . (A) Exon 1A of the murine 
agouti gene lies within an interrupted 4 .1-kb inverted duplication 
(shaded block arrows) . The duplication gave rise to pseudoexon 1A 
(PS1A) . “(Waterland and Jirtle et al ., 2003)
Figure 5 shows that once adding methylation to the model, no 
correlation was significant between supplement and color alone. 
Methylation was the clear mediator .
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sheep and human to be considered non-toxic. Because gametes 
and preimplantation embryos go through extensive methylation 
reprogramming, this experiment was used to test, “the extent 
to which periconceptional availability of methyl groups altered 
DNA methylation of gene-associated CpG islands and affected 
adult health status” (Sinclair, et al., 2007).
Twenty five ewes that were placed on the ‘methyl deficient’ 
(MD) diet showed homocysteine levels in follicular fluid, plasma, 
and in granulosa cell lysates higher than the 25 ewes that were 
in the control diet with no methyl deficiency. Most importantly, 
the incorporation of methionine into S-adenosyl methionine 
(SAM), as well as S-adenosyl methionine into adenosyl-homo-
cysteine (SAH) were both reduced in ewes on the MD diet. At 
day 6, the blastocysts were transferred to 203 normal eating 
ewes. Those that became pregnant gave birth to typical weight 
babies on both diets, yet the growth weight to weaning for the 
MD babies were higher, persisting at 22 months of age, resulting 
in heavier MD offspring. Male offspring of the MD diet experi-
enced an increase immune response to a single intramuscular 
bolus of ovalbumin both at 1 year of age and in the weeks fol-
lowing the vaccination. The MD males were also proportionate-
ly fatter with less muscle mass than control males. MD males 
also showed the greatest response to an i.v glucose infusion, 
showing signs of glucose resistance independent of body fat. 
In terms of cardiovascular function, MD males showed 11 mm 
Hg higher blood pressure than the controls, as well as a higher 
systolic, diastolic, and mean arterial pressure response to angio-
tensin II infusions given in increments.
To test whether these results were linked to epigenetic mod-
ification, DNA was processed to look at 1,400 CpG sites using 
restriction landmark genome scanning (RLGS). Methylation sen-
sitive restriction enzyme, NotI, was used to digest the unmeth-
ylated CpG sites, resulting in spots on the autoradiograph. Fifty 
seven loci were found to be altered in two or more MD animals, 
which is more than was expected if it were to be distributed 
randomly between the MD group and control group. Eighty 
eight percent of these loci were found to be unmethylated or 
hypomethylated compared to the control group. The other loci 
appeared to be hypermethylated. Again, a majority of these al-
terations occurred in males (Sinclair, et al., 2007). These stud-
ies continue to support the notion that the etiology of human 
disease can stem from epigenetic gene regulatory mechanisms 
that originate early in development from simple aspects of our 
daily nutrition. This knowledge can be utilized as a cautionary 
tale for intending mothers to start preventing the conception of 
unhealthy adults (Waterland and Jirtle, et al., 2003).
Toxicants
Bisphenol A
Bisphenol A (BPA) is an endocrine disruptor used in the man-
ufacturing of polycarbonate plastics found in food and drink 
containers, baby bottles, and dental composites. Endocrine dis-
ruptors are chemicals that mimic endocrine hormones, inter-
fering with the homeostasis of our various organ systems. The 
endocrine disruptor known as BPA has previously been linked 
to heavier body weight, increased risk of breast or prostate can-
cer, and abnormal reproductive function. BPA has been detect-
ed in 95% of human urine samples, attesting to the widespread 
exposure of BPA in the general public (Dolinoy, et al., 2007).
BPA is most known for its effect on genetic expression of 
homeobox gene Hoxa10, a gene that controls uterine organ-
ogenesis. Because BPA is an endocrine disrupting chemical, it 
has the ability to mimic the actions of these hormones in vitro, 
disrupting normal development. Hoxa10 gene expression alter-
ations have previously been linked to human cancers, as well 
as endometriosis in females. BPA seems to work through an 
epigenetic mechanism to disrupt Hoxa10. In a study by Bromer 
et al., pregnant mice were treated with an intraperitoneal in-
jection of BPA in sesame oil on days 9-16 of gestation, at a 
dose of 5mg/kg of maternal body weight. In comparison, mice 
in a control group were injected with just sesame oil. Offspring 
were then euthanized at two or six weeks after birth. Genomic 
DNA was treated with sodium bisulfite with unmethylated re-
gions converted to uracil, while methylated regions remained 
unchanged. Via quantitative real time PCR, it was concluded 
the Hoxa10 expression increased by 25% after BPA exposure, 
as per the mRNA expression seen in comparison to controls. 
Immunohistochemistry, staining using antibodies specific for a 
target protein, showed consistent results, as Hoxa10 protein 
was seen throughout the uterus of female offspring. To de-
termine if these changes were epigenetic in nature, bisulfite 
conversion, PCR amplicon cloning, and sequencing were done 
to determine DNA methylation levels. 100% of control mice 
showed methylation in the promoter region while only 38% 
of BPA-treated mice showed any sort of methylation. CpG 
islands in the intronic region showed methylation in 100% of 
control mice and only 57% of BPA-exposed mice. In summary, 
demethylation or hypomethylation was observed in all regions 
in all BPA-treated mice. However, no methylation changes were 
found in the pregnant mice that were treated with the intraper-
itoneal dose (Bromer, et al., 2010).
Hoxa10 gene is also known to be a weakly estrogenic com-
pound, with the ability to bind to estrogen receptor α and β. 
With decreased methylation, Hoxa10 has an increased ability 
to bind to estrogen receptors (ER) . Therefore, the estrogen re-
ceptor element (ERE) of Hoxa10 becomes more occupied by 
estrogen receptor α and β, causing a heightened reactivity to 
estrogen levels. The health implications of this were examined 
by testing estradiol sensitivity in MCF-7 cells. MCF-7 cells are 
estrogen receptor expressing breast carcinoma cells, with a 
well characterized estrogen response. In this study, MCF-7 cells 
were transfected with either methylated or unmethylated ERE 
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containing Hoxa10-promoter sequence. The cells with unmet-
hylated containing sequences had significantly increased activity 
with the addition of estradiol, while the methylated cells showed 
no change in activity (figure 6).  These results can explain dis-
ease risks in later life due to increased estrogen responsiveness, 
perhaps explaining some reproduction system abnormalities or 
cancers of the reproductive system. In summary, these epigenetic 
changes that are spurred by uterine BPA exposure can be one of 
the suspects of health problems in adult life (Bromer, et al., 2010).
As mentioned previously, although most tissue-specific DNA 
methylation levels don’t vary much across the mammalian ge-
nome, methylation is randomly determined at transposable el-
ement insertion sites. This can potentially affect the expression 
of neighboring genes, creating a site of metastable expression. 
As noted before, this site is particularly susceptible to environ-
mental exposures early in development. The agouti mouse is 
a frequently studied case because it features the insertion of 
the intracisternal A particle, causing ectopic Avy transcription 
via a cryptic promoter at its proximal end, potentially leading 
to yellow fur, obesity, diabetes, and tumorigenesis (figure 6). 
Furthermore, methylation of the cytosines near the intracister-
nal A particle is inversely correlated to ectopic Avy expression 
and varies tremendously amongst isogenic individuals, causing a 
wide range of fur colors. BPA was hypothesized to demethylate 
this area, causing transcription and its phenotypic outcomes 
(Dolinoy, et al., 2007).
In this study, two groups of female a/a mice were prepared. 
The control received with one a phytoestrogen-free AIN-93G 
diet.. The experimental group received the diet with 50 mg of 
BPA/kg. Both diets were administered two weeks before mat-
ing with a Avy/a male until after gestation and lactation. There 
were 120 resulting offspring in the control group and 124 re-
sulting offspring in the experimental group, with 60 and 73 Avy/a 
offspring, respectively. Maternal BPA exposure was shown to 
dramatically shift the coat color of genetically identical Avy/a 
offspring toward yellow, showing demethylation. 21% of off-
spring from the group exposed to BPA were labelled as yellow 
in comparison to 10% of the control group. To assess methyl-
ation levels, nine CpG sites in the cryptic promoter regions 
of the intracisternal A particle were measured using bisulfite 
treatment and sequencing. The BPA exposed offspring exhibited 
significantly lower levels in the nine CpG sites, with around 27% 
methylation compared to around 39% methylation in the off-
spring control group. After entering BPA dietary exposure, in-
tracisternal A particle methylation, and offspring coat color into 
a mediational regression analysis model, it was determined that 
there was little relationship between BPA exposure and coat 
color directly, but rather methylation was the real mediator 
of effects. Methylation levels found in the tail corresponded to 
methylation levels found in the brain, kidney, and liver, revealing 
that these methylation patterns were established before germ 
layer differentiation in the embryo.  BPA was also seen to affect 
other metastable epialleles, causing hypomethylation in multiple 
loci across the genome (Dolinoy, et al., 2007).
In an effort to test BPA levels in human subjects, 244 mothers 
and their 3-year-old children were recruited for a longitudinal 
study to measure BPA concentrations in maternal and child 
urine samples. Maternal urine samples were taken at week 16 
and 26 of pregnancy and within 24 hours after delivery. Child 
urine samples were taken at ages 1, 2, and 3 years old. Behavior 
and executive functions of the children were also measured 
using the Behavior Assessment System for Children 2 (BASC-
2), a 134-item test of a parent’s assessment of a child’s behavior 
in a home and public setting. Parents were also administered 
the Behavior Rating Inventory of Executive Function-Preschool 
(BRIEF-P), a 63 question, parental report test that analyzes the 
child’s ability to modulate emotion, control behavioral respons-
es (inhibition), plan for future events, set goals, grasp main ideas, 
transition from event to event, and hold information to com-
plete a task. For both tests, higher scores indicated more severe 
impairment. It is intriguing that of the mothers who completed 
all the assessments, the majority were white, married, between 
25 to 34 years old, wealthier, and more educated. Interestingly, 
these mothers had lower gestational BPA urine concentration 
than mothers who did not complete the assessment. Children 
from families of lower maternal education and income also had 
higher scores on BASC-2 and BRIEF-P.(Braun, et al., 2011)
Gestational urinary BPA concentrations were found to posi-
tively correlate with BASC-2 anxiety, hyperactivity, and depres-
sion scale scores at three years old, with the magnitude seen 
greater in females (almost double the association of the whole 
sample). Lack of emotional control and behavior inhibition sug-
gest that BPA exposure may affect a neurobehavioral domain 
that is associated with behavioral regulation. Gestational urinary 
BPA concentrations were also positively correlated with emo-
tional and inhibition scores on the BRIEF-P, with higher scores 
Figure 6 shows the reactivity of unmethylated Hoxa10-promoter 
to the addition of estradiol, while the methylated Hoxa10-promter 
shows a loss of response (Broner et al ., 2010)
12
Simone Tendler
attributed to girls again. In general, the effects of gestational 
BPA concentration were larger among girls than boys and had 
varying effects (boys had less hyperactivity). Neurobehavior and 
test scores were not predicted at all by childhood urinary BPA 
concentration. Only gestational BPA exposure can be implicated 
in altered neurobehavior, and specifically in females, as well.
The findings of these studies are consistent with previous 
animal studies that assess the effect of BPA exposure on neu-
rodevelopment. BPA exposure might be responsible for the dis-
ruption of sexual differentiation in the brain, altering behavior in 
a “gender dependent manner,” by disrupting endocrine or other 
neurotransmitter pathways. It is interesting to observe that all 
of the outcomes of BPA are traced to the exposures inside the 
womb, with no correlation at all to the postnatal environment 
(Braun, et al., 2011).
Remarkably, when the formerly mentioned agouti mice of the 
study done by Dolinoy et al. were supplemented with methyl 
donors or genistein in the experimental BPA diet, coat color dis-
tribution was observed as closer to what was seen in the control 
group (Dolinoy et al., 2007). Ten to thirteen percent of BPA- ex-
posed -methyl/genistein supplemented offspring exhibited yellow 
fur color as opposed to the 21% seen in the non-supplemented 
BPA group, showing that maternal nutrition clearly modified the 
effects of BPA exposure on methylation patterns. Genistein at 
high levels had the same effect, even though it is not a methyl 
donor. Interventions as subtle as maternal nutrition is enough to 
counteract the effects of an estrogenic endocrine disruptor. This 
information implies that we are able to reduce disease suscepti-
bility by making small changes in maternal nutrition, giving us the 
ability to affect generations to come (Dolinoy, et al., 2007).
Nicotine
The in utero effects of maternal smoking are infamous in their 
detrimental ways. Offspring exposed to smoking after birth 
do not experience the same adverse affects as those that are 
exposed as fetuses, hinting to a mechanism that is biologically 
mediated. It has previously been proven that rodents exposed 
to nicotine prenatally experienced a direct impact on brain 
development, reporting “abnormal dendritic morphology, and 
reduced synapse density in the cerebral cortex and nucleus ac-
cumbens” (Chatterton, et al., 2017). Nicotine exposure during 
gestation is also known to upregulate nicotinic acetylcholine 
receptors, causing cell death, altered cell size, and increased risk 
for behavioral impairment. A study done by Chatterton et al. 
examines the possible epigenetic modifications that are respon-
sible for these developmental differences that have been found 
to persist even until adolescence. Fetuses aborted during the 
second trimester were studied and classified based on whether 
they were exposed to maternal smoking or not. In total, 24 
fetuses were tested. The brains of the fetuses were removed 
to examine the dorsolateral prefrontal cortex, an area known 
to be involved in decision-making, memory, and neurodevelop-
ment. It is also known to be compromised in function in differ-
ent psychiatric conditions, including autism spectrum disorder. 
Methylation microarray analysis was performed to determine 
differentially methylated regions between the exposed and un-
exposed groups. Although differences did not remain significant 
after multiple testing correction (likely due to the small sample 
size), hypomethylation was found on two genes in the exposed 
fetuses; SDHAP3 and GNA15. The hypomethylation during sec-
ond trimester of these two genes is indicative of developmental 
delays. This resulted in up-regulation of this gene as evident by 
the increase of mRNA in the samples, an effect mediated by 
maternal smoking (Chatterton et al., 2017).
Between early and late second trimester, many methylation 
changes are meant to occur to proceed with development. 
However, in fetuses exposed to maternal smoking, less change 
was observed. There was a delay in the upregulation of the 
SYCE3 gene, a gene that is responsible for synaptic initiation 
that results in meiotic arrest. As previously stated, SDHAP3 and 
GNA15 also displayed developmental delays. SDHAP3 is a sub-
unit of the succinate dehydrogenase complex that functions in 
the electron transport chain. A mutation in this subunit can ac-
tually increase levels of oxidative stress. This same differentially 
methylated region was shown to be hypermethylated in patients 
with autism spectrum disorder and differentially methylated in 
the dorsolateral prefrontal cortex of patients with schizophre-
nia. GNA15 was also found to be differentially methylated in 
the prefrontal cortex of patients with autism spectrum disorder 
(Chatterton et al., 2017).
These results show a potential risk that smoking introduc-
es to the fetus in the development of neural abnormalities. All 
in all, this study supports the concept that smoking exposure 
during gestation leads to changes in developmental patterns of 
DNA methylation and gene expression, causing reduced mature 
neuronal content via nicotine. Unfortunately, the damage can be 
everlasting (Chatterton et al., 2017).
Smoking during pregnancy has also been linked to obesity 
because of the shared presence of chemerin, an inflammatory 
adipokine that is responsible for adipocyte differentiation. It acts 
as a ligand for chemokine-like receptor 1 (CMLKR1), which is 
highly expressed in adipocytes. It is found to be elevated in both 
individuals who smoke and obese individuals. 
Obesity has become a national epidemic with 35% of 
American adults and 20% of children obese, with a total of $200 
million is spent each year in obesity-related healthcare costs. 
Finding the roots to this epidemic can help prevent and treat 
future cases. The hypothesis that the perinatal environment is 
responsible for the programming of adult disease is in question 
as it has been previously shown that fetal exposure to nicotine 
increases the risk of developing obesity and type II diabetes. 
The mechanism behind the correlation has yet to be confirmed, 
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as 15-18% of pregnant mothers continue to smoke throughout 
pregnancy and lactation (Reynolds et al., 2018).
In this study, two separate cohorts (2012-2013 and 2015-2016) 
of  postpartum women were recruited from the University of 
Kentucky Chandler Hospital, Labor and Delivery Unit. Subjects 
were then identified as either smokers or non-smokers. All had 
full term pregnancies, singletons, and birthed male infants with 
circumcision performed less than 72 hours after birth.  In the first 
cohort, foreskin tissue was then taken and dissected, snap frozen, 
and analyzed for chemerin mRNA expression. Of the 46 samples, 
31 belonged to offspring of non- smokers with 15 belonging to 
offspring of smokers. Chemerin mRNA was analyzed in all sam-
ples while DNA methylation levels were analyzed in a subset of 
the samples (12 non-smokers, 7 smokers) (Reynolds et al., 2018).
In the second cohort, foreskin samples were collected from 
24 newborns with 13 of them born to smoking mothers. Of 
these samples, only eight were able to be used due to cell con-
tamination or lack of cell growth. These samples were dissected 
for the dermal/epidermal layer and incubated. The epidermis 
was separated from the dermal layer, and the dermal cells were 
processed and plated. RNA was then collected and isolated 
from the samples, and chemerin gene expression was analyzed 
from each sample using qPCR. Maternal and infant character-
istics such as weight, height, and body mass index (BMI) were 
collected for both cohorts (Reynolds et al., 2018). 
The results demonstrated that the weight and lengths of in-
fants born to smokers were significantly reduced compared to 
those whose mothers did not smoke. The foreskin  
Figure 7a and 7b compares chemerin mRNA expression and 
chemerin methylation in non-smoking exposed and smoking ex-
posed infant foreskin samples. (Reynolds et al.,2018)
tissue of babies exposed in utero showed increased chemerin 
gene expression (figure 7a). Methylation percentages of chem-
erin CpG sites showed reduced levels of methylation. CpG site 
3 of chemerin showed the most significant reduction of methyl-
ation with chemerin gene expression inversely correlated with 
methylation at site 3 (figure 7b).
The dermal fibroblasts that grew in cultures for the second 
cohort were then stimulated with an adipogenic cocktail. Babies 
of smokers produced cell plates that showed elevated chemerin 
gene expression, compared to the cells isolated from babies of 
non-smokers (figure 8). These results correspond with another 
study that demonstrates that although babies exposed to ciga-
rette smoke in utero tend to be smaller, they have a greater rate 
of obesity as they get older, suggesting an altered developmental 
programming. This phenomenon known as, ‘catch up growth,’ 
puts babies at risk of developing cardiovascular disease, type II 
diabetes, or obesity later in life (Power, Jeffries, 2002).
This study involving the two cohorts supports the findings 
of Power and Jeffries et al., further linking cigarette smoking 
and obesity to methylation and chemerin gene expression. Of 
course, official causation cannot be completely determined 
without more research. The study has other limitations, as well: 
only testing male babies, testing dermal tissue and not adipose 
tissue, small sample size of the smoking group, and not taking 
into account second hand smoking are just to name a few. That 
being said, the overall conclusion is in agreement with other 
studies on this subject: Smoking alters chemerin gene expres-
sion in neonatal tissue of babies exposed to smoking, possibly 
causing obesity later in life. And perhaps the mediator in this 
change is epigenetic in nature (Reynolds, et al., 2018).
Trauma
Many people can be exposed to 
the same trauma, but only some 
will develop post-traumatic 
stress disorder (PTSD). So, it 
begs the question: Is there a bi-
ological basis or risk factor for 
the development of PTSD? 
A cohort of 40 Holocaust 
survivors and their 31 offspring 
were studied in comparison 
to individuals of the same age 
that were not living in Europe 
in the time of the Holocaust. 
Figure 7a and 7b compares chemerin mRNA expression and chemerin methylation in non-smoking 
exposed and smoking exposed infant foreskin samples . (Reynolds et al .,2018)
Figure 8, (Reynolds et al . 2017)
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Epigenetic changes in the FKBP5 allele, a glucocorticoid binding 
sequence at intron 7, were measured. Psychiatric analysis was also 
obtained from the subjects, showing that Holocaust survivors and 
their offspring suffered more from PTSD and anxiety and/or de-
pression, respectively. After a whole blood examination, bisulfite 
treatment, and pyrosequencing were performed on the DNA 
isolates, both Holocaust survivors and their offspring showed 
differences in methylation on intron 7 of the allele at the bin3/
site 6 region, in comparison to the control group. This highlights 
that Holocaust exposure in the parent was the sole predictor of 
methylation levels in the offspring. However, survivors showed 
10% higher methylation, while their offspring showed significantly 
lower methylation (Yehuda, et al., 2016).
Offspring methylation levels were inversely related to their 
wake-up salivary cortisol levels, as well. This might be due to 
a “intergenerational biological accommodation” (Yehuda et 
al., 2016). A similar notion is seen with the 11β-HSD-2 allele, 
another moderator of glucocorticoid action. Increased activity 
of this allele in offspring was seen as a counteraction to the 
decreased levels of activity seen in mothers. In mothers, this de-
crease in activity was an accommodation due to high circulating 
glucocorticoids. However, in children, upregulation was needed 
to optimize glucocorticoid levels again. Similarly, because hyper-
methylation is occurring at the maternal FKBP5 allele to lessen 
the effects of circulating glucocorticoid, offspring exhibited de-
methylation to optimize glucocorticoid levels, as well. Although 
10% less methylation seems relatively small, differential gene 
expression has previously been observed with methylation dif-
ferences between 1%-2%. This lack of glucocorticoid sensitivity 
can lead to increased risk of psychopathology in the offspring 
generation, something that the offspring exhibited according to 
psychiatric evaluation (Yehuda et al., 2016).
A recent study that included Holocaust survivors, as well, 
discovered that parental PTSD is an important risk factor for 
the development of PTSD in offspring. Physically, children of 
survivors had lower 24 hour mean urinary cortisol excretion, 
an important symptom as lower cortisol levels are also linked 
to people who have suffered previous traumas. Previous trau-
ma is another risk for the development of PTSD. If cortisol is 
associated with the risk of developing PTSD, prenatal influences 
must be investigated as the hypothalamic-pituitary-adrenal axis 
is programmed during early development. Maternal exposure to 
glucocorticoids while pregnant can lead to higher levels in the 
offspring and lower birth weight, a condition linked to various 
adult diseases including hypertension, insulin resistance, and de-
pression, as well (Yehuda et al., 2005).
To test this correlation, 38 women from a larger cohort of 
187 women directly exposed to the World Trade Center col-
lapse on September 11, 2001 while pregnant, agreed to partake 
in a longitudinal study along with their children. At the ninth 
month checkup, mothers and infants were asked for their 
salivary samples at wake up and bedtime to assess cortisol lev-
els. Probable maternal PTSD and severity were assessed with 
a PTSD checklist, and depression was assessed with the Beck 
Depression Index. Mothers with PTSD reported more depres-
sion than mothers without. Salivary cortisol levels in children 
of mothers with PTSD were significantly lower than those of 
mothers without PTSD, a trend that continued throughout the 
first year of infancy (Yehuda et al., 2005).
It is interesting to note that while the trimester of gestation 
did not affect maternal PTSD, the effect glucocorticoids had on 
the baby did differ slightly depending on the trimester of expo-
sure. The babies born to mothers exposed in their third trimester 
showed even lower cortisol levels. That being said, the severity of 
PTSD symptoms in the mother correlated with cortisol levels in 
infants regardless of trimester (figure 9). The results highlight the 
critical windows of development that are available for reprogram-
ming at each point of gestation, a principle that is important in 
most epigenetic modifications (Yehuda et al., 2005).
Many people are mistaken in assuming that children of 
Holocaust survivors or of parents with PTSD suffer mentally 
because of their postnatal upbringing by a traumatized and emo-
tionally incapable parent. However, in Yehuda et al., 2016, the sole 
predictor for methylation levels in the offspring was parental ex-
posure to trauma. According to the study, emotional abuse and 
childhood adversity actually did not show any significant correla-
tion to methylation levels and glucocorticoid abnormality. This 
latter experiment is another testament to the effects the in utero 
environment can have on the future of the child, as opposed to 
postnatal “..vicarious traumatization of the offspring by the par-
ents’ communication of their trauma to the child or other con-
sequences of parental symptoms (e.g. poor parenting)” (Yehuda, 
page 4). Babies in Yehuda et al., 2005 were only nine months 
old at the time of their endocrine testing, so glucocorticoid 
Figure 9, (Yehuda et al ., 2005)
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programming in utero and/or underlying genetic susceptibility is 
more relevant then the postnatal environment. Yes, there is always 
the argument that postnatal care by mothers suffering from PTSD 
can show inconsistent behavior towards their offspring, affecting 
their glucocorticoid regulation. However, the stronger correlation 
to PTSD shown in offspring of the third trimester does implicate 
prenatal factors (Yehuda et al., 2005).
Stress
The hypothalamic-pituitary-adrenal axis controls growth, repro-
duction, metabolism, and behavior. It is also extremely active in 
a human’s ability to ‘defend’ itself during stressful situations via 
the glucocorticoid receptor (GR). Transgenerational epigenetic 
modifications can affect the programming of the hypothalam-
ic-pituitary-adrenal axis during early development, affecting 
glucocorticoid function, as stated previously. In a study that ex-
amined intimated partner violence during pregnancy, it was de-
termined that the glucocorticoid promoter gene’s methylation 
status can originate in the womb while a mother’s remains un-
changed, and sustain itself throughout adolescence. In this study, 
25 mother and children pairs were evaluated to determine if 
gestational maternal adverse experience can cause methylation 
in offspring that persists for years after pregnancy. Children 
were between ten and nineteen years old at the time of the 
study (Radtke et al., 2011).
Mothers were given the Composite Abuse Scale (CAS) test 
three different times to evaluate intimate partner violence be-
fore, during, and after pregnancy (see Table 1). Blood was taken 
from the mother and child with which she was pregnant with at 
the time of abuse. The methylation status was evaluated at ten 
CpG sites found in a transcription factor binding site that are 
known to have their methylation statuses influenced by early 
life circumstances. Methylation was detected in 7 of the 10 CpG 
sites of the glucocorticoid promoter region, with methylation 
levels ranging from zero to 20%.  There was significant correla-
tion of methylation to maternal exposure to intimate partner 
violence that was experienced during pregnancy only, but no 
significant correlation was found between offspring methyla-
tion and intimate partner violence before or after pregnancy. 
There was also no correlation between maternal methylation 
and offspring methylation (figure10).  This attests to the prenatal 
transgenerational influence that stress can have on the hypo-
thalamic-pituitary-adrenal axis. This is consistent with previous 
studies that have shown that prenatal anxiety has caused sus-
tained elevation of basal hypothalamic-pituitary-adrenal activity, 
causing behavioral and emotional problems that can continue 
throughout the lifetime of an individual. Methylation of the 
glucocorticoid promoter is the potential mechanism in which 
prenatal stress can influence psychological function. It is inter-
esting that although this is transgenerational in nature, meth-
ylation was not inherited along the germ line, as there was no 
correlation between maternal methylation and offspring meth-
ylation (Radtke et al., 2011).
While direct stressors, like the aforementioned intimate part-
ner violence on the mother, have been tested, indirect stress can 
also prove to be dangerous to a developing fetus. The perinatal 
environment is extremely impactful on the future of an offspring, 
with the malleable fetal brain susceptible to even the most sub-
tle of experiences. Mychasiuk et al. studied the phenomenon 
known as “bystander stress” to demonstrate the effects it might 
have on the brain, behavior, and development of the epigenome. 
In this study, eight pregnant dams were separately caged with 
eight non-pregnant dams. On day 12 and 16 of gestation, the 
non-pregnant dams were placed on elevated Plexiglass plat-
forms and exposed to bright light for thirty minutes, twice a 
day. In the control study, the cage mates were moved to another 
room twice a day for thirty minutes and returned unstressed. 
To examine data, researchers recorded ultrasonic vocalizations 
from the rats after the thirty minutes of stress were adminis-
tered. After the birth of the 120 pups, the pups were also ex-
amined in various behavioral procedures to assess their brain 
development. Afterward their frontal cortex and hippocampus 
were examined for DNA methylation (Mychasiuk et al., 2011).
At baseline, all ultrasonic vocalizations were the same. 
However, after the stress procedure, the stressed dams had 
an increased number of low frequency calls while the bystand-
er dams showed an increased number of high frequency calls. 
Previous research has demonstrated that low frequency calls 
are emitted during particular distressing situations, while high 
frequency calls are emitted in positive situations, such as in 
times of reward. The researchers suggest that it was the preg-
nant dam’s attempt to soothe the distressed dam by emitting 
the high frequency call. The stressed dam had a loss of fur on fe-
male rats and were more aggressive toward their handlers than 
the pregnant dams. Once the 120 pups were born to the sixteen 
mothers, further analysis was done. Brain weight was not affect-
ed, but female pups exposed to “bystander stress” showed a 
decrease in body weight, confirming that the experience proved 




Pups were then tested on their negative geotaxis to assess 
brain development. Negative geotaxis depends on “vestibular 
and proprioceptive detection, processing of the vestibular and 
proprioceptive inputs by the central nervous system, and motor 
competence to change orientation” (Mychasiuk et al., 2011). This 
is generally used to detect milestones in the sensorimotor de-
velopment of rats.  After being placed downward at a 40 degree 
angle, pups were tested on their ability to stay upward on the 
Plexiglass for the longest amount of time. Pups exposed to “by-
stander stress” spent less time facing upward on the Plexiglass 
platform with stressed females specifically receiving the lowest 
scores in the exercise. The pups were then tested in open field 
to assess their activity levels. The pups were placed in the center 
of a transparent Plexiglass box divided into 130 squares. Pups 
were scored based on how many novel squares they touched 
with their paw. The “bystander stressed” pups scored less than 
the control group, with females scores significantly lower than 
the males. This seems to show the hesitance and unwillingness 
to explore novel environments exhibited by these young pups. 
However, as they age, they will lose this inhibition, as seen in 
previous research (Mychasiuk et al., 2011).
In terms of global DNA methylation, all animals in the “by-
stander stress” cages showed increase in methylation in the 
frontal cortex and hippocampus with a total of 558 genes dif-
ferentially expressed between stressed male and female pups 
combined. There was minimal overlap of differentially expressed 
genes in brain regions between the sexes (figure 11). This sug-
gests a preexisting difference in brain structure and genetic 
influence exhibited by males versus females, allowing them to 
respond differently to “bystander stress.” This was clearly seen 
in their behavioral assessment after birth, as the females did 
significantly poorer than the males on both negative geotaxis, 
open field, and lower birth weight. That being said, while the 
genes did not overlap much, the biological processes that these 
genes control are very similar between the sexes, with most 
of genes controlling processes that are important for plasticity 
of the brain (i.e. cell communication, motion, and transport). 
Interestingly, a gene that was identical between the sexes in 
its abnormal expression was the SLC6A1 gene. This gene was 
downregulated in the frontal cortex. It encodes for a GABA 
transporter, removing GABA from the synaptic cleft. With its 
downregulation, GABA would be elevated in the frontal cor-
tex, influencing processes like attention, response inhibition, and 
working memory. This study is groundbreaking in suggesting that 
indirect social stressors are just as harmful to the development 
of offspring as direct stressors, hinting to the intense sensitiv-
ity of the fetus. That being said, because blood was not drawn 
from the mother or “bystander” dam, the mechanism behind 
this stressed induced methylation cannot be understood com-
pletely and is in need of further experimentation (Mychasiuk et 
al., 2011).
It is vital to realize that while there is much evidence to sup-
port the concept that overactivation of the hypothalamic-pitu-
itary-adrenal axis via heightened maternal glucocorticoids puts 
the infant at a great disadvantage that persists until adolescence, 
most experiments have been done with animals or small sample 
sizes. To properly test these results on humans, a cohort of 481 
mother-infant pairs were taken from the Barwon Infant Study 
of Barwon, Australia. Maternal mental well-being was assessed 
using the Perceived Stress Scale (PSS) questionnaire, a well val-
idated scale that assesses the biological impact of psychologi-
cal distress. Maternal mental health was also tested using the 
Edinburgh Postnatal Depression Scale (EPDS) questionnaire at 
28 weeks of pregnancy, a 10 item questionnaire used to assess 
symptoms of depression with a subscale of questions used to 
assess anxiety. A survey was also distributed to determine infor-
mation on the physical and mental health of the mother, fam-
ily medical history, lifestyle, demographic, education, maternal 
drinking, and other confounding factors. Many exposures were 
considered to eliminate narrow results that only reflected a 
specific measure of mental well-being (Table 1). Umbilical cord 
blood from infants were also collected from participants, as 
well as blood from the placenta before placental delivery, when 
possible. DNA was then extracted from the sample of blood 
and bisulfite converted using MethylEasy DNA conversion kits. 
Primers were used to amplify a 403 base pair region of the 
NR3C1 glucocorticoid promoter, spanning 47 CpG sites. After 
PCR amplification of the region, in vitro transcription and cleav-
age, DNA methylation was then quantified (Mansell et al., 2016).
The results revealed a strong correlation between the three 
tests. 65% of depressed mothers were also anxious, while 74% 
of anxious mothers were also depressed. Methylation levels of 
NR3C1 in three CpG units were shown to be higher in moth-
ers with increased adverse maternal mental well-being; CpG 1.2, 



















Figure 11 shows the differentially expressed genes found in stressed 
male and female pups .(Mychasiuk et al ., 2011)
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to different mental well-being exposures. CpG 1.2 and CpG 
3.4.5 were both correlated with perceived maternal distress. 
Maternal anxiety was correlated with CpG 47. Yet another re-
gion, CpG 12.13 was weakly correlated with maternal depres-
sion. The covariates like hypertension, preeclampsia, maternal 
age, antidepressant use, and smoking were correlated with 
hypo/hypermethylation at different CpG sites, independent of 
the three that were correlated to mental well-being. That being 
said, although this was the largest study of its kind performed 
on the association of methylation and mental-well being, after 
taking into account the multiple tests and numerous CpG is-
lands affected by the three exposures and the covariates, none 
of the associations remained significant. This experiment essen-
tially questions all previous experiments that were done with 
smaller sample sizes and lack of multiple testing. While there is 
consistency amongst the studies to suggest that it is more than 
just chance that links maternal depression, anxiety, and adverse 
well-being to methylation and offspring behavior abnormalities, 
this study highlights the caution needed in interpreting results 
and evaluating the studies without bias. The results do support 
previous findings, like the role of cortisol on fetal “program-
ming,” yet it also reveals how the proof is not yet strong enough 
to withstand a bigger sample size and multiple exposures. In 
conclusion, more studies, including longitudinal observations, 
are needed to fully link maternal mental well-being to meth-
ylation, as well as to determine the phenotypic implications 
(Mansell, et al., 2016).
Limitations
Although there has been much speculation and experimentation 
in the field of epigenetics, no study has yet to link the interplay 
between genes and epigenetics. When dealing with the cohorts 
in human studies, genetic dispositions might play a larger role in 
phenotypic outcome than is given credit. For example, in stud-
ies of trauma effect of Holocaust survivors, all subjects were 
of Eastern European Jewry (Yehuda et al., 2016). It is possible 
that the effects of methylation on the FKBP5 allele is specific 
to individuals within the gene pool of Ashkenazic Jewry, while 
other genetic population would not experience this specific 
outcome between genes and epigenetics. The fact that there 
are some Holocaust survivors that have PTSD and not others, 
also was not explored and hints to a genetic disposition, as well. 
Furthermore, many human studies relied on questionnaires that 
were geared toward the mothers or children that were being 
studied. It is hard to believe that every subject answered with 
only factual information as opposed to biased and emotional 
responses. These studies already create a bias from the start, 
as all subjects consented to the study, thereby aware of what 
the study was about. Perhaps they agreed because of their feel-
ings of relevance, removing randomness from the population. 
Another limitation as discussed in Mansell et al. concerns the 
sample sizes and multiple testing of the experiments. Most of 
the sample sizes, especially in the human experiments, are not 
big enough to be relied on completely. Even many of the an-
imal experiments involved less than 100 samples, something 
that definitely takes away from the credibility of the results. 
Furthermore, as Mansell et al. clearly stated, multiple testing 
procedures usually eliminate any significant correlation found. 
While there is definitely integral information for epidemiology 
within the field of epigenetics, future experiments and reports 
should focus on expanding the sample size and designing exper-
iments to survive multiple testing (Mansell et al., 2016).
Conclusion
Epigenetics refers to covalent bond changes that happen above 
the level of DNA that affects gene expression. Many researchers 
have speculated about a link between the prenatal environment 
and adult health. This link is thought to exist because of epigenetic 
alterations that happen to the fetus because of different environ-
mental exposures. Epigenetic programming takes place during 
early development in the fetus, thereby presenting a vulnerable 
and malleable setting for modification. 
The purpose of this paper was to investigate the possible link 
between the in utero environment and adult health, along with 
the biological mechanism behind it. While there were many lim-
itations to the studies as previously mentioned, there is over-
whelming proof that environmental exposures like nutrition, 
vitamin B, smoking, BPA, stress, and trauma have negative effects 
on the health and quality of life of offspring. Studies have linked 
prenatal exposures to obesity, hypertension, coronary artery 
disease, cancers, and mental illness. According to the aforemen-
tioned studies, the events a mother experiences and the decisions 
that she makes during gestation can seriously deter the path of 
health for her future adult child. More research and samples are 
definitely needed to further back this hypothesis, but there is un-
questionably enough evidence to support the correlation. It is 
also important to note that it is possible to avoid some of the 
detrimental effects of these exposures. As seen in Dolinoy et al., 
a simple methyl supplement was enough to modify the effects of 
BPA on an exposed mouse (Dolinoy et al., 2007).
There is no shortage of adult disease victims in America. 
The Heart Disease and Stroke Statistics of the American Heart 
Association stated that as of 2019, 46% of Americans suffer from 
hypertension. The National Institute of Mental Illness stated that 
1 in 6 Americans suffer from mental illness. By educating ex-
pectant mothers, maybe we can prevent the development of 
adult disease in at least a percentage of patients. Furthermore, 
as Powledge mentioned in her article, epigenetics is not per-
manent like our DNA. More research in this area can help us 
learn how to rid ourselves of the modifications, or use these 
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Type 2 diabetes mellites has become an increasingly prevalent worldwide epidemic . The tremendous economic burden, coupled 
with the numerous secondary risks associated with the disease, have encouraged researchers to search for causes as well as 
treatment methods . This research paper focuses on the effect of physical activity as a preventative measure for those at risk for 
diabetes and as a treatment method for those already diagnosed with the disease . The articles collected included meta-analysis, 
randomized controlled trials, cohort studies, surveys, etc . The studies that were analyzed have indicated an inverse relationship 
between physical activity and type 2 diabetes. Since there are multiple variables involved, it is challenging to pinpoint the specific 
level of effect that physical activity has . However, the majority of the research has shown some level of correlation .
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Introduction 
The drastic increase in type 2 diabetes mellitus has caused many 
to research the risk factors associated with this disease. Type 2 
diabetes is characterized by the body resisting the effect of in-
sulin or insufficient insulin production. Insulin is a hormone that 
regulates blood glucose levels. High blood glucose levels over a 
prolonged period can cause damage to the eyes, heart, nerves, 
and kidneys. More than 1.6 million new cases of type 2 diabetes 
arise in the US each year, and millions more are at high risk. 
(ADA, 2018) It is rated as the seventh deadliest disease in the 
world by the World Health Organization (WHO). Furthermore, 
individuals diagnosed with this disease are 2-4 times more likely 
to develop secondary complications such as stroke, peripheral 
vascular, and cardiovascular disease. 
The various complications caused by type 2 diabetes have 
created a severe physical and economic burden on our society. 
Those suffering from this disease have medical costs around 
2.3 times higher than those who do not have diabetes. (ADA, 
2015). An estimated $21.6 billion is spent in New York each 
year for the treatment of diabetes and prediabetes.  It has thus 
become a priority to identify those who are at a higher risk and 
provide preventative measures to help decrease the likelihood 
of acquiring the disease. 
The vast research conducted regarding the numerous risk 
factors contributing to this disease has concluded that type 2 
diabetes results from the interaction between a genetic pre-
disposition and behavioral and environmental risk factors 
(Tuomilehto et al., 2001). Can lifestyle modification, specifically 
physical activity, prevent or decrease associated diseases/symp-
toms of type 2 diabetes mellites. 
Methods
The research articles used throughout this paper have been col-
lected through various databases, including Google Scholar as 
well as the databases available through Touro College Libraries 
such as PubMed and ProQuest.
Lifestyle Intervention Reducing Incidence of Diabetes
Lifestyle is one of the factors that may impact the presence of 
type 2 diabetes (Ahmad, Crandall, 2010). Examples of lifestyle 
characteristics include dietary intake, sleeping patterns, and 
physical activity. Recent clinical trials, as well as several large 
cohort studies, have shown that physical activity can reduce the 
incidence of type 2 diabetes (Sigal et al., 2004). 
Exercise and insulin promote the transfer of GLUT4, a glu-
cose carrier protein, which aids in glucose uptake into the mus-
cles. (Colberg et al., 2010).  When we exercise, intramuscular 
glycogenolysis and glucose uptake are increased to meet meta-
bolic demands for energy. There is often an issue with GLUT4 
transport for type II diabetic patients. However, exercise allows 
for an increase in GLUT4 levels and the movement of GLUT4 
to the plasma membrane. Therefore, this becomes a non-insulin 
dependent pathway for glucose to be transported into the skel-
etal muscle. This glucose uptake has the potential to be equal to 
normal glucose uptake in non-diabetics. 
The Da Qing IGT and Diabetes Study were one of the ear-
liest randomized trials. It analyzed lifestyle interventions which 
can prevent type 2 diabetes. Individuals with impaired glucose 
tolerance (IGT) have a high risk of developing NIDDM (non-in-
sulin dependent diabetes mellitus/type 2 diabetes). The study 
recruited 577 men and women in a Chinese community who 
had impaired glucose tolerance. They were randomized into 
four groups, exercise only, diet only, diet plus exercise and con-
trol. The 6-year follow up found that the three intervention 
groups had a risk reduction of 31-46% versus the control group. 
The long term-follow up had shown that a majority had pro-
gressed to the disease, with a lower risk in intervention groups. 
Although this study may have shown a significant short term 
(6 years) risk reduction in diabetes, the long-term follow up 
showed a minor difference between the groups thus indicating 
that physical activity may not have such a significant long-term 
effect (Xiao et al., 1997). 
The Finnish Diabetes Prevention Study, a more recent study, 
analyzed the influence of intensive lifestyle changes in the reduc-
tion of diabetes). The study randomly assigned 522 overweight 
(350 women and 172 men), middle-aged (mean age of 55 years 
individuals who had impaired glucose tolerance to a control or 
intervention group. The subjects in the intervention group re-
ceived specific exercise guidelines and dietary recommendations. 
The 3-year follow-up showed a clinically significant impact of the 
interventions in the reduction of diabetes. The group had a 58% 
reduced risk compared to the control group. The study also found 
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that at least 2.5 hours of moderate to vigorous activity per week 
caused a 63-69% reduction of diabetes. Furthermore, an extend-
ed follow- up revealed that the intervention group maintained 
a 36% reduction of diabetes incidence. This percentage suggests 
that benefits can be maintained even after the active interven-
tion was completed. The results of this study clearly show that 
intensive lifestyle changes (diet and exercise) have the potential 
to reduce the risk of diabetes in individuals with impaired glucose 
tolerance (Tuomilehto et al., 2001). 
The Diabetes Prevention Program, an additional study of the 
effect of intensive lifestyle changes, is an even larger random-
ized controlled trial, recruiting over three thousand overweight, 
nondiabetic participants with impaired glucose tolerance. The 
participants were separated into three intervention groups; 
placebo, metformin (an oral diabetes medicine that helps con-
trol blood glucose levels) and intensive lifestyle changes (ILS). 
The subjects presented with a mean BMI of 34.0 and a mean 
age of 51 years. Forty-five percent of the subjects were from 
minority groups, who often display a higher risk for diabetes. 
The ILS group was given a specific regimen to follow including a 
low calorie and fat diet and 150 minutes of exercise per week. 
Furthermore, they joined a 16-week class to learn about diet, 
exercise, and behavioral modification. Results from a 2.8 year 
follow up displayed a 58% decrease in diabetes development in 
the ILS group and 31% reduction in the metformin group com-
pared to the placebo. Results also indicated that weight loss was 
the main predictor of diabetes reduction (16% reduction per 1 
Kg./2.2 Ib weight lost). The participants who did not lose the tar-
geted amount of weight but participated in the physical activity 
still displayed a 44% reduction in diabetes incidence compared 
to the placebo group. The results support the hypothesis that 
type 2 diabetes can be prevented or delayed in persons at high 
risk for the disease. This study shows that specific guidelines, 
coupled with a wealth of information about health and well-
ness, can have the potential to impact the incidence of diabetes. 
The subjects were provided with a lot of knowledge which lasts 
even after the conclusion of the study.  Furthermore, although 
this thesis does not focus on other forms of diabetes preven-
tion, it is significant to note that physical activity could have 
a greater effect when combined with additional risk reduction 
methods such as metformin (Knowler et al., 2002). 
A large-scale observational study examined how physical 
activity impacted the development of type 2 diabetes. The 
study included 5,990 males from the alumni of the University 
of Pennsylvania, aged 39–68 years. The subjects were followed 
for an average of 14 years. A follow-up showed that the disease 
had developed in 202 of the men. Leisure-time physical activi-
ties were measured in kilocalories, and examples included stair 
climbing, walking, and sports.  The study showed that the more 
the subject participated in leisure-time physical activity, the less 
likely they were to develop type 2 diabetes. The researchers 
observed that for each 500 kcal/wk of activity, there was an av-
erage of 6% lower risk of type 2 diabetes. It is important to note 
that since this study is an observational study, it is less conclusive 
than the previous randomized controlled trials. Furthermore, 
the study focused on leisure-time physical activities as opposed 
to more intensive, regimented exercise. This may have been the 
reason why there was only a 6% risk reduction. On the other 
hand, it is nice to see that simply engaging in leisure-time phys-
ical activity can have a positive impact on one’s physical health 
(Helmrich et al., 1991). 
A study was conducted by the use of a questionnaire and a 
12-year incidence report to determine if physical activity reduc-
es the incidence of type 2 diabetes in postmenopausal women 
(age 55-69). During a follow up 1,997 out of the original 350,000 
women had reported a new onset of diabetes. There was a 
negative association with both moderate and vigorous physical 
activity and diabetes incidence. Furthermore, the most active 
women had half the risk of diabetes compared to the least fre-
quently active women. The results of this study also showed that 
reducing adiposity through participating in physical activity can 
partially prevent diabetes (Folsom et al., 2000). 
Lifestyle Intervention Preventing Secondary Risks
Results of these multiple studies have displayed the role of life-
style modification, specifically physical activity, in the positive 
reduction in diabetes incidence. The question remains whether 
physical activity can also benefit those who are already diag-
nosed with type 2 diabetes in preventing secondary risks. 
Recently diagnosed diabetics were grouped to measure the ef-
fect of flexibility, aerobic, and resistive exercises on cardiovascu-
lar disease risk factors. These risk factors included lipid profile, 
exercise capacity, flexibility, glycemic control, and body compo-
sition. The outcomes displayed that, body fat triglyceride levels 
and postprandial glucose levels decreased, while aerobic ability 
and flexibility increased after exercise. These results led to a 
decrease in the cardiovascular risk profiles in diabetic patients, 
thus reducing their intrinsic complications. This study showed 
that even those already diagnosed with the disease can decrease 
their risk for secondary diseases that are often associated with 
type 2 diabetes (Acar et al., 2014). 
A similar study also focusing on the secondary risk of cardio-
vascular disease on type 2 diabetic women showed that physical 
activity allows for a considerable decrease in high sensitivity 
C reactive protein levels, fasting glucose and total cholesterol 
(Alizadeh et al., 2012). On the other hand, it causes high-density 
lipoproteins to increase. Additionally, the study showed that an 
eight-week exercise schedule could help lower glycemic and 
lipid profile, thus reduce the risks of cardiovascular disease in 
type 2 diabetic women. 
A thorough 2005 literature review concluded that regular 
physical activity provides health benefits in individuals who have 
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already expressed clinical diabetes. Indeed, several prospective 
observational studies have shown that among individuals with 
impaired fasting glucose or diabetes, higher levels of activity and 
fitness are associated with a lower incidence of cardiovascular 
events and mortality from all causes and cardiovascular disease 
(LaMonet et al., 2015).
A prospective cohort of 1,263 men, who all had type 2 dia-
betes, was analyzed. The purpose of the study was to evaluate 
the relationship of mortality in men with type 2 diabetes, with 
low fitness and physical inactivity. These men were given a thor-
ough medical examination, which included their fitness level and 
participation in physical activity. A self-reported baseline was 
used to document their physical activity while fitness was mea-
sured by an exercise test.  One hundred and eighty subjects 
died during a 12-year follow up. Diabetic men in the low-fitness 
group and physically inactive had a two times greater risk for 
mortality than fit men and active men (Wei et al., 2000). 
Various Forms of Physical Activity
One study meta-analyzed how different modes of exercise train-
ing affects glucose control as well as other complications associ-
ated with type 2 diabetes. The study included 27 controlled trials 
involving the estimates for the effect of aerobic training, resistive 
training, and combined training. There was a total of 1,003 patients 
with type 2 diabetes that were followed for a 5-104-week period. 
Results of the meta-analysis indicated that all forms of exercise 
allow for small-moderate benefits in A1C, the main measure of 
glucose control. The effects of exercise training seemed to be 
similar to those of drug, dietary, and insulin treatment. Additional 
research is imperative to conclude about factors that could affect 
the outcomes of an exercise program, such as the patient’s sex. 
However, this study indicates that prescribing an exercise pro-
gram to patients with type 2 diabetes can provide small positive 
results (Snowling, Hopkins, 2006). 
Another study examined the benefits of vigorous activity vs. 
walking and the incidence of type 2 diabetes in women. The 
design was a cohort study completed in 1986 (updated in 1988 
and 1992). It included surveys of over 70,000 female nurses be-
tween the ages 40 to 65 years from the original Nurses’ Health 
Study cohort, which began in 1976. These women did not have a 
diagnosis of diabetes, cardiovascular disease, or cancer. Although 
earlier analysis of the original cohort study showed an inverse 
relationship between vigorous activity and the risk of type 2 
diabetes occurrence, there was a lack of evidence regarding the 
possible role of walking which is a more common form of phys-
ical activity in women. In this study, vigorous activity is defined 
as something which requires 6 METs (metabolic equivalent 
task-hours) or greater such as jogging, lap swimming, bicycling, 
etc., as opposed to walking which requires only 2-4.5 METs. The 
study concluded that both walking and vigorous activity are re-
lated to a significant reduction in type 2 diabetes risk in women. 
These findings support the current guidelines from the National 
Institute of Health and the Centers for Disease Control and 
Prevention that recommend a minimum of 30 minutes of mod-
erate intensity physical activity daily (Webster, 2018).  
A randomized control trial was conducted comparing the im-
pact of aerobic training (AT) and progressive resistive training 
(PRT) on the health status of a multi-ethnic Asian population. 
Progressive resistive training is a program that builds physical 
strength by lifting progressively heavier weights and is based 
on the individual’s maximum strength. Both programs were 
completed over 8 weeks with 60 middle-aged adults who had 
a diagnosis of type 2 diabetes mellites. Health status was mea-
sured using the Short-form 36 Questionnaire (SF-36), a self-ad-
ministered assessment measuring eight aspects of functional 
health. The subscales are divided into the physical component 
summary score (PCS) and mental component summary score 
(MCS). Results of the scoring showed significant improvement 
in both the PRT and AT groups with both physical and mental 
health benefits.  Furthermore, PRT may have some added bene-
fits since there were significant changes in more domains of the 
SF-36 than in the AT group. Although the benefits of both forms 
of physical activity are apparent, it is not necessarily certain that 
the same positive results would apply to a different population. 
Each population has many factors that can have an impact on 
health (Ng et al., 2011).  
In an additional study, the same questionnaire, SF-36, was 
completed by subjects which led sedentary lives and were di-
agnosed with type 2 diabetes. The purpose of this study was 
to determine if a 10-week moderate aerobic exercise regimen 
would affect the quality of life (QOL) as well as the physical 
health of these subjects. The survey was completed by a group 
of subjects who participated in the training, three days a week 
for 20-45 minutes. The survey was also completed by the group 
of control subjects who did not receive the training. Results 
of this study showed a decrease in percent body fat and an in-
crease in lactate threshold in the training group. However, there 
was no significant difference in the mental health component of 
the quality of life survey (Holton et al., 2003). 
A study determined if adults with or at risk for diabetes par-
ticipate in physical activity. A survey was collected by the Medical 
Expenditure Panel (a nationally representative survey of the 
U.S. population) regarding the physical activity of 23,283 adults. 
Additional information such as health conditions (diabetic vs. 
nondiabetic) and sociodemographic characteristics where self-re-
ported. Results of the survey showed that 58% of adults without 
diabetes were physically active versus 39% of adults with diabetes. 
The number of non-diabetic individuals who responded that they 
were physically active decreased as the amount of type 2 diabe-
tes risk factors increased. Income level, depression, severe obesity 
(BMI >40kg), and limitations in physical function were the strongest 
factors correlating with being physically active or not. The study 
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concluded that those who have type 2 diabetes or those who are 
at a higher risk for developing the disease do not participate in 
physical activity regularly. Thus, it is imperative to create efforts to 
target this population to increase the levels of their engagement 
in physical activity by reinforcing its value and ability to help curb 
rising diabetes and obesity epidemic (Morrato et al., 2003).   
As previously noted, most American adults who have type 2 di-
abetes or those who are at risk for developing the disease do not 
regularly engage in physical activity. A joint positional statement 
written by The American College of Sports Medicine and The 
American Diabetes Association concluded that self-efficacy (as-
sociated with the confidence in the ability to exercise) and social 
support are two of the most reliable predictors of greater levels 
of engagement in physical activity (Colberg et al., 2010). Family, 
friends, and health care professionals may be a source of support 
for these individuals. By taking the necessary precautions, individ-
uals with type 2 diabetes can maintain a safe exercise routine. An 
exercise program or leisure-time physical activity is critical for 
the overall health of those suffering from this disease. 
Conclusion
Many people assume that high-calorie diets, which are very prev-
alent in our society (due to fast food, etc.) is the main contribu-
tor to obesity and causes a higher risk for diabetes. The studies 
documented in this research paper highlight another key behav-
ioral factor which contributes to the high rate of this disease. 
The research has indicated that low physical activity and leading 
a sedentary life has a great effect on the risk of developing type 2 
diabetes. There is also strong evidence that leading an active and 
fit life has the potential to reduce mortality risk in individuals who 
already have this diagnosis. Over the past few years, our society 
has morphed into a technological hub in which the majority of 
our daily responsibilities can be taken care of with just a few 
clicks. Thus, it has become common for individuals to be physi-
cally inactive and lead sedentary lives. This phenomenon already 
starts at a young age. For example, our children no longer feel the 
need to play sports outdoors when they can play the video game 
version. It is, therefore, imperative to continue researching the 
effects of physical activity on diabetes risk to bring about global 
awareness and to halt this fatal epidemic.
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Abstract
Modern science takes at face value the fact that exercise is beneficial for man’s health. In recent years, medical health profession-
als have begun to harness exercise as a treatment for a broader range of maladies . Since various studies found increased exercise 
to correlate with higher levels of endorphins, most believed that the endorphins were directly responsible for what the vernacular 
dubbed “Runner’s High.” Scientists have sought to either augment or wholly disprove the endorphin hypothesis with further 
studies. Major Depressive Disorder, or MDD, is an affective condition affecting a significant portion of the general population. 
Aerobic exercise is increasingly being revealed to be an encouraging treatment for all types of depression and anxiety . The HPA 
Axis allows one to comfortably exercise without experiencing the extremely stressful symptoms that characterize psychological 
stress, such as depression, anxiety, fear, etc. Runners’ High is the “…happiness, elation…inner harmony, boundless energy, and…
reduction in pain sensation” that ensues following prolonged aerobic activity. Endorphins are the body’s naturally occurring opiates. 
The Neurogenesis Hypothesis states that “a decrease in the synthesis of new neurons in the adult hippocampus might be linked 
to major depressive disorder .” Further research implicates BDNF (Brain-Derived Neurotrophin Factor) in exercise-induced neuro-
genesis . The thought was that beta endorphins are what stimulate increased neurogenesis, in turn causing a decrease in MDD . 
β-endorphins are large molecules that are too bulky to pass through the BBB and therefore cannot be the cause any changes to 
occur within the brain . Researchers and scientists have thus turned their attention to endogenous endocannabinoids as the true 
source of analgesia, sedation, anxiolysis and reduced depression found in endurance exercisers . Chief ligand anandamide (AEA) 
engenders elevated levels of BDNF (Brain Derived Neurotrophic Factor) during exercise and return-to-baseline levels post-exer-
cise . Endocannabinoids modulate nociception by affecting the Periaqueductal Gray system (PAG) . Endogenous cannabinoids and 
exogenous cannabinoids (marijuana) act in similar fashions, leading to the addictive qualities of exercise . Compelling evidence has 
ascertained that endogenous endocannabinoids are the underlying cause of the many positive effects of aerobic activity .
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Introduction
Modern science takes as face value the fact that exercise is 
beneficial for man’s health. Hippocrates was known to say, 
“Even when all is known, the care of a man is not yet complete, 
because eating alone will not keep a man well; he must also 
take exercise...” While to a contemporary society this concept 
seems rather primitive and simplistic, it is a truth that forms 
the basis of modern health sciences. However, it has only been 
in recent years that medical health professionals have begun to 
harness exercise as a treatment for a broader range of maladies. 
Exercise is widely known to help keep one’s weight down, tone 
muscles and enhance physical fitness. Scientists are perpetually 
expanding their knowledge of exercise and what kind of effects 
it has on the brain and the body’s systems. An understanding 
of the neuronal activity, neurotransmitter actions and chemical 
releases that are the responses to varying degrees of exercise 
can be applied to treat disease and improve lives. One such 
application is exercise as a treatment for Major Depressive 
Disorder (MDD). MDD had previously been treated solely with 
antidepressants, but more recently is being dealt with using a 
combination of medication and exercise. Various case studies 
have undertaken to prove the relationship between exercise 
and positive changes in the MDD brain. Once the neuronal and 
chemical effects of exercise were established, it naturally led 
to the conclusion that depressive symptoms lessened due to a 
proliferation of certain positive hormones that were released 
into the brain in response to exercise. With further investiga-
tions, the popular conclusion was that the feel-good high asso-
ciated with exercise is caused by endorphins, opioid hormones 
that appear to increase in response to exercise. Since various 
studies found increased exercise to correlate with higher levels 
of endorphins, most believed that the endorphins were directly 
responsible for what the vernacular dubbed “Runner’s High.” 
Since then, scientists have sought to either augment or wholly 
disprove the endorphin hypothesis with further studies.
Methods
The search engines used include ProQuest, EbscoHost, and 
GoogleScholar. Tributary information was also obtained using 
Wikipedia, the New York Times and WebMD.
Discussion
Major Depressive Disorder, or MDD, is an affective condition 
affecting a significant portion of the general population. In 
America today, about 5% of all people will eventually be diag-
nosed with MDD. Quality of life with MDD is radically impaired, 
and basic life functions such as eating, sleeping and maintaining 
personal hygiene can be affected. It has been found that rough-
ly 10% of people diagnosed with MDD will probably commit 
suicide. This is all due to the overwhelming, pervasive feel-
ings of severe depression that characterize Major Depressive 
Disorder. Deficits in executive function are also consequences 
of MDD. Patients tested with a Stroop Task, Go/No Go Task, 
Task-Switching Paradigm and Flanker Tasks all scored low in 
reaction times, indicating deficits in executive function ability 
(Ernst, et al. 2006). Previously, MDD had been treated solely 
with antidepressant medications such as SSRIs (selective sero-
tonin reuptake inhibitors). The anti-depressant medication field 
is an ever-growing industry, despite limited success and many 
unwarranted side effects. For examples, anti-depressants stop 
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working after a while, since the body and brain become accus-
tomed to the drug and gain a tolerance for it. In such a case, 
the dose would have to continuously be raised in order to have 
any effect. Furthermore, if one abruptly stops taking the dosage 
of medication, withdrawal symptoms such as “dizziness, loss of 
coordination, fatigue, tingling, burning, blurred vision, insomnia, 
and vivid dreams” may incur.  Additionally, the patient may expe-
rience “nausea or diarrhea, flu-like symptoms, irritability, anxiety, 
and crying spells.” This tendency is called the “Discontinuation 
syndrome” and is obviously best to be avoided. Other nega-
tive side effects might include insomnia, diarrhea and stomach 
aches, headaches, joint and muscle pain, reduced blood clotting 
capacity due to lowered concentration of serotonin in plate-
lets and possible increased tendency towards violence and/or 
self-destructive behaviors. A Black Box warning was even issued 
in 2004 by the FDA against SSRIs, warning of the possible risk of 
“suicidal thoughts, hostility, and agitation in children, teens and 
young adults” (Harvard, 2019).
Between 30-35% of patients on medication do not even re-
spond to the antidepressant treatment at all. The unpleasant 
side effects considerably compromise the patients’ quality of 
life in many areas and make the medications undesirable as a 
primary treatment for depression. Furthermore, there is a high 
relapse rate found in patients treated with antidepressants, lead-
ing to a need for alternative and/or supplementary treatments 
(Blumenthal, et al. 1999).
Aerobic exercise is increasingly being revealed to be an en-
couraging treatment for all types of depression and anxiety 
(Heijnen, et al. 2016). A study was performed testing MDD 
symptoms in response to exercise. Participants were accepted 
for the study if they displayed depressive criteria as expressed 
in the DSM-IV and other symptoms such as “sleep disturbance, 
weight loss…psychomotor retardation or agitation, feelings of 
worthlessness or excessive guilt, impaired cognition…and re-
current thoughts of death.” They also had to receive a score of 
at leave 13 on the HAM-D test. The HAM-D is a clinical rating 
scale used to measure levels of depression. Scores of thirteen 
to eighteen is mildly depressed, above 18 is severely depressed. 
Each of the subjects of the study were assigned to one of three 
groups – exercise treatment, medication treatment, and a com-
bination of exercise and medication treatment. The assignment 
of groups was a randomized procedure to ensure that equally 
depressed participants were assigned across the groups. The 
exercise group met three times a week for 16 weeks, engaging 
in personalized exercise protocol according to their individual 
heart rate capability. The classes were overseen by a “trained 
exercise physiologist.” The medication group was administered 
the SSRI sertraline, specifically used due to its “documented 
efficacy and favorable side effect profile.” Dosages were admin-
istered by the staff psychiatrist at intermittent weeks. The com-
bination group concurrently received the same medication and 
exercise regimens described above. Results were generally pos-
itive. Firstly, patients who engaged in exercise showed improve-
ments in aerobic capability, with an 11% increase in the exercise 
group and a 9% increase in the combination group. Secondly, 
depressive symptoms improved equally across all three groups. 
Improvements on the HAM-D scores did not differ across 
groups, and neither did the scores based on DSM-IV depres-
sion criteria. “…The percentage of patients who were no lon-
ger classified as clinically depressed at the end of the 4-month 
treatment period did not differ across treatment groups.” The 
only difference found that they patients benefited more rapidly 
in the combination group than did the patients in the exercise 
or medication groups alone. This study demonstrated that ex-
ercise treatment as an intervention for depression is equally as 
effective as medication treatment (Blumenthal, et al. 1999).
Numerous other studies, all of which sought to prove the efficacy 
of exercise have tested people who suffer from depression across 
the spectrum. One set of studies has shown that participants, rang-
ing from young to elderly, who engage in daily exercise regimens 
are far less likely to develop MDD. Subsequent investigation further 
demonstrated that daily exercise improves depressive symptoms, 
even in people who have not been diagnosed with MDD. Exercise 
studies performed with healthy adults with no depressive symp-
toms also found positive results. These adults reported improved 
cognitive function, elevated mood and a general sense of well-being. 
One study tested how well exercise treated “moderate-to-severe” 
depression, concluding that the depression was highly improved. 
Another treated MDD patients with a combination of antidepres-
sant medication and exercise regimens. A control group received 
medication and “health education” lessons. The medication/exer-
cise group responded significantly better than the control group. 
Yet another tested a group of adults suffering from MDD, exercis-
ing with varying intensities of exercise. They found here that the 
most intense exercise group improved the most. A significant edge 
that exercise has over medication is that the effects of exercise may 
extend past the actual regimen, with the positive feelings enduring 
(in one study) up to almost two years past the experiment (Ernst, 
et al. 2006). This is in sharp contrast to antidepressant medication, 
of which the healing abilities curtail immediately with the end of 
dosage. This is why people on medication require concurrent ther-
apy so that they can manage their life even after their medication 
dosage is over. On the other hand, exercise is found to be even 
superior to therapy itself in many instances, with various “young 
and middle-aged adults” positing that aerobic exercise helped their 
depressive symptoms more than therapies like psychotherapy, CBT 
and occupational therapy (Blumenthal, et al. 1999). Aerobic exercise 
performed by patients with depression and anxiety may improve 
cognitive function. (Heijnen, et al. 2016) Patients who scored poorly 
on various task functions, such as Stroop and Flanker Tasks, scored 
significantly higher following 30 minutes of aerobic exercise (Ernst, 
et al. 2006). All of these studies have consistently found lower MDD 
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and anxiety levels in response to exercise training, in addition to 
higher psychosocial functioning, increased positive affect and ele-
vated mood (Blumenthal, et al. 1999).
The obvious question that troubles scientists and mental 
health specialists is why exercise has such a potent effect on the 
human psyche. While the physical action of aerobic exercise is 
known to cause weight loss and increased fitness due to burning 
of calories and fat and muscle toning, the reason behind the 
mental effects are not as simple to extrapolate. Exploring the 
neuroendocrine response that takes place in response to aero-
bic exercise may help to ascertain the underlying cause.
Exercise that activates the heart rate from its resting point 
and raises the maximum capacity of oxygen intake (VO2max) at 
least 60% can be classified as a physical stressor. In response to 
such a stressor, the hypothalamus secretes “corticotrophin-re-
leasing hormone, which travels…to the anterior pituitary to 
induce adrenocorticotropic hormone (ACTH) release” into the 
general circulation. Arrival of this hormone at the adrenal cor-
tex stimulates cortisol release into the bloodstream. Cortisol 
acts as an inhibitor and, through the use of medial prefrontal 
cortex (mPFC) receptors, inhibits “overexcitability of the amyg-
dala” that naturally occurs when a stressor arrives in the blood-
stream (Heijnen, et al. 2016). This stress response is known as 
the Hypothalamic-Pituitary-Adrenal (HPA) Axis, so named for 
the journey of hormones from the hypothalamus, through the 
anterior pituitary and into the adrenal cortex, causing relax-
ation from the body’s increased stress levels (Blumenthal, et al. 
1999). The elevated levels of cortisol can last up to 2 hours after 
the actual exercise action, and the amount of cortisol released 
is proportional to the amount of exercise. Equally important 
in the stress response is the inactivation of cortisol back into 
cortisone. This homeostatic cycle ensures that frequent exer-
cisers do not suffer from extreme cortisol levels that can lead 
to “hypertension, hyperglycemia, major depressive episode and 
anorexia nervosa” (Heijnen, et al. 2016). Thus, ACTH is a regula-
tory mechanism that acts as the body’s natural stress response. 
This allows one to comfortably exercise without experiencing 
the extremely stressful symptoms that characterize psycholog-
ical stress, such as depression, anxiety, fear, etc. (Angelopoulos, 
2001). However, while this neuroendocrine response accounts 
for the control of increased psychological stressors while exer-
cising, it could hardly account for the flood of “euphoria, anxi-
olysis (reduction of anxiety), sedation, and analgesia (relief from 
physical pain)” that characterize what we call Runner’s High 
(Reynolds, 2015).
Runner’s high is the reason that America has its plethora of 
addicted runners clocking miles in their sneakers every day. 
Every athlete can describe the “…happiness, elation…inner har-
mony, boundless energy, and…reduction in pain sensation” that 
ensues following prolonged aerobic activity (Dietrich, 2004). 
This so-described high is experienced frequently by endurance 
athletes, but really by anyone who exercises profusely for an 
extended amount of time. Scientists have struggled for decades 
with the reason behind runner’s high and many hypotheses have 
been debuted and disproven over time. For years the Endorphin 
Hypothesis was the most popular by scientists and the overall 
population, gaining strength through hearsay and seemingly im-
penetrable evidence.
Endorphins are the body’s naturally occurring opiates. When 
a person exercises, these chemicals are released in the brain, 
seeming to improve the athlete’s mood and promote endurance. 
While exercise is known to be a healthful practice to engage in 
for one’s physical health, it can cause degrees of discomfort or 
even pain. Therefore, it would make sense that in response to 
exercise, endogenous opiates with antinociceptive properties 
similar to morphine would be released (Reynolds, 2015). Any 
kind of intense endurance exercise can induce endorphin re-
lease, and it seems that the greater the exercise, more mood-al-
tering endorphins are proportionately released (Kolata, 2008). 
Endorphins are “cleaved from the preprohormone pro-opiome-
lanocortin (POMC)…a protein found in the pituitary gland and 
the brain” (Ernst, et al. 2006). The C-terminus of the POMC 
protein in turn gives rise to hormones such as opiate peptides. 
In one experiment, researchers used PET (positron emission 
tomography) scans to compare endorphin levels in the brains 
of athletes. Ten athletes did a two-hour run and were tested 
for opiate levels before and after the run. Additionally, the run-
ners took a psychological test pre and post-run, intended to 
measure their moods before, and in response to, the flood of 
endorphins. The researchers did find increased levels of endor-
phins attaching themselves to the limbic and prefrontal areas of 
the brain, zones typically associated with emotion. The athletes 
also reported higher mood and euphoria in a seemingly direct 
relation to higher endorphin levels in the brain (Kolata, 2008, 
Heijnen, et al. 2016). Technically, all this study proved was that 
there is indeed a flood of endorphins in the brain in response to 
exercise. While there seems to also be a correlation between 
the elevated opiate levels and mood, the proof was not – yet 
– impenetrable.
A study performed at the Iranian Academic Center for 
Education, Culture and Research (ACECER) attempted to as-
certain how endorphin levels are affected due to exercise. The 
researchers included subjects with fibromyalgia (FM) as well as 
healthy patients. The study was based on the assumption that ex-
ercise increases release of endogenous β-endorphins, and that 
β-endorphins lessen pain perception. Exercise has previously 
been used as a treatment for diseases such as FM, with a strong 
role in nociception and elevated pain threshold. Specifically in 
FM cases, however, the “analgesic effect” or lessening of pain 
perception seemed significantly dulled. According to the results 
of the study, this would seem to be due to the fact that FM pa-
tients produce less β-endorphins as they exercise and therefore 
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are less capable of blocking pain. All of the subjects first rested 
in a supine position in order to attain their basal heart rate, a 
range of 60 to 100 beats per minute. Blood from the anti-cubital 
vein was drawn at baseline and at the end of the exercise test 
in order to compare β-endorphins levels. The exercise test was 
a treadmill routine that continued as long as the subject was 
able, until the onset of “fatigue, pain, or physical exhaustion”. 
Every three minutes the incline of the treadmill as well as the 
speed increased according to specific intervals. As soon as 70% 
of the patients HRMax (maximum heart rate) was achieved, the 
subject was told to continue for 15 more minutes only, and 
their level of exercise intensity was recorded. The post exercise 
blood was drawn directly afterwards, when the heart rate was 
still at its maximum. The results were rather interesting. The 
mean exercise times for the FM and healthy groups revealed 
that it took a much shorter time for the FM subjects to achieve 
HRMax than the healthy group. The majority of subjects who 
were able to reach their HRMax at later stages of exercise were 
from the healthy group. Ninety three percent of the healthy 
group, as opposed to the mere 30% of FM subjects, reached 
HRMax during stage four of exercise. This indicated that FM 
patients were unable to exercise to the same extent that the 
healthy participants were. While the blood samples indicated 
that both groups had amounts of β-endorphins, the FM subjects 
has significantly lower levels in both their baseline blood and 
in the post-exercise blood. This means that while both groups 
experienced a rise in β-endorphins due to the exercise, the FM 
patients were unable to produce the same influx of β-endor-
phins as the healthy group. These blunted levels of β-endorphins 
may explain why FM patients are more immune to the analgesic 
effects of exercise that usually take over post-exercise. Usually, 
aerobic exercise stimulates elevated β-endorphins levels which 
in turn seem to stimulate decreased nociception, elevated 
mood and psychological stability. However, due to “failure of 
normal elevation of [endogenous] β-endorphins,” FM patients 
seem less able to produce the same analgesic effects. Therefore, 
they might be more prone to develop chronic allodynia (pain 
from a non-painful stimulation of the skin) and heightened noci-
ception with the absence of normal β-endorphins levels (Bidari, 
et al. 2016).
Scientists have explored how endorphin levels rise in re-
sponse to exercise. A study sought to verify the elevated levels 
of endorphins, with and without naloxone (opiate antagonist). 
It has already been proven than exercise with an intensity of 
75% of VO2max and 80% of HR (heart rate) causes an elevated 
release of beta endorphins into circulation. However, this study 
examined whether longer lengths of activity cause even further 
increased endorphin levels, and how long one must exercise to 
stimulate endorphin release. The study included “nine healthy, 
fit males.” In this double-blind experiment, some subjects were 
injected with naloxone, and some with a mere placebo. They 
all took a graded exercise test (GXT) to assess their physical 
capabilities and then performed exercise on treadmills, running 
until they were too exhausted to go on. Phlebotomy techniques 
were used to draw blood and measure beta endorphin levels. 
Levels of VO2max, HR (heart rate) and hematocrit (ratio of 
RBC volume in blood) were measured during 10 min, 20 min 
and 30 min intervals for both trials. No changes in Hct levels 
were found between trials.
β-endorphin concentration across the trials were recorded 
and trials showed significant differences. Before exercise, β-en-
dorphins levels were at roughly 40 ml; across 10, 20 and 30-min-
ute intervals, influxes of 80 to 90 ml of β-endorphins were re-
corded. Of note is that after the initial rise in β-endorphins, the 
volumes leveled off and stopped rising across time during exer-
cise - it stayed constant.  β-endorphin levels were significantly 
higher under naloxone administration. To summarize the results 
of the study, a significantly large increase in β-endorphin were 
found during and throughout exercise as compared to resting 
levels. They also found that the men injected with Naloxone ex-
perienced even higher levels of β-endorphins. Additionally, tests 
with low to moderate levels of exercise showed no changes 
at all in β-endorphin levels. Therefore, this suggests that it is 
only intense aerobic exercise that induces significant increases 
in β-endorphins. This elevation occurs rapidly from the onset 
of exercise and remains level through the duration. This test 
found much higher β-endorphin levels in the naloxone-injected 
participants as compared to the placebo participants. However, 
other experiments did not find much of a difference between 
naloxone test and placebo test. This is an obvious disparity that 
may be due to “differences in the exercise protocol, method of 
administration of the antagonist, and in the stereo-specificity of 
the antagonist used in the respective experimental protocols” 
(Angelopoulos, 2001).
Now the question stands, what is it that causes this dras-
tic β-endorphins rise during exercise? The researchers suggest 
that Naloxone attaches to the opioid receptor, blocking any 
other opiates and signaling the pituitary gland to release more 
β-endorphins. These β-endorphins do glucoregulation during 
exercise, “augmenting glucagon levels and attenuating insulin 
release.” Glucagon keeps blood glucose at high enough levels 
to allow the body to function normally (Glucagon, Diabetes.
Co). This is a positive feedback loop – more β-endorphin is re-
leased, it does more glucoregulation, and so more β-endorphin 
is released. This may be why endorphin levels were higher with 
Naloxone injections. 
ACTH also increases under stressful condition, just like β-en-
dorphins. ACTH is also secreted by the pituitary and regulates 
cortisol in the bloodstream. Just like the endorphins in this 
study, ACTH levels rise with an injection of Naloxone. Thus, it 
seems that both β-endorphins and ACTH are regulatory mech-
anisms, acting to ensure the body’s homeostasis despite outside 
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stressors. However, ACTH regulates the psychological stress 
response and endorphins normalize the physical response. 
This study demonstrated how and why β-endorphins levels 
were significantly elevated over the course of aerobic activity 
(Angelopoulos, 2001).
It is clear that aerobic exercise indeed causes an influx of 
β-endorphins to be released into blood circulation. The next step 
would be to secure as fact that it is indeed the flood of endorphin 
opiates that lowers depressive symptoms and induces a euphoric 
affect. The following study attempted to ascertain the possible 
link between aerobic exercise and the subjects’ emotional state. 
The study involved middle aged subjects engaging in physical ac-
tivity. First off, the subjects’ emotional states were evaluated using 
FaceReader. FaceReader is a facial analysis software that assesses 
emotional state based on 6 primary emotions - happy, sad, angry, 
disgusted, scared, and surprised. The subjects were also inter-
viewed personally to assess how they were feeling just then. After 
the facial analysis the researchers drew blood from the median 
cubital vein of each subject to have a baseline sample of blood 
plasma levels. The physical activity was measured using a veloer-
gometer load test. A veloergometer is similar to an elliptical exer-
cise bike, however it is equipped with specialized hardware capa-
ble of measuring physical prowess. This exercise regimen is called 
a load test, and it commenced for a half hour, with increasing 
load every three minutes.  After the load test, the pre-test proce-
dures – FaceReader, interview and phlebotomy – were repeated 
and analyzed. The pre and post blood measures were tested for 
plasma beta endorphin levels to see if there was an increase in 
endorphins in response to the exercise. If an increase was accom-
panied by a similar increase in mood, this would provide evidence 
that it is endorphins that cause the elevated mood associated 
with physical activity. The results showed an endorphin increase in 
only half of the subjects. However, in regard to positive affect, the 
data found a general increase across the subjects. A 20% increase 
in happiness was found and all except one showed a decrease in 
negative emotions. (One subject showed an increase in disgust 
due to unpleasant lab conditions) (Kundzina, et al. 2014). These 
findings definitively supported the hypothesis that extended aer-
obic exercise of at least 60% VO2 intensity is directly linked to 
increased positive affect and decreased depressive symptoms. It 
is of significance to note, however, that only half of the subjects 
showed a marked increase in circulating beta endorphin levels. 
Here we introduce a hypothesis that closely allies with the sub-
ject at hand. This is the Neurogenesis Hypothesis, which states 
that “a decrease in the synthesis of new neurons in the adult hip-
pocampus might be linked to major depressive disorder (MDD).” 
Anti-depressant medications such as SSRIs have been used for 
years as treatment for MDD. Anti-depressants act to stimulate 
synthesis of new neurons in the adult brain. Eventually, a link was 
drawn between the anti-depressants and neurogenesis, since the 
time it takes for medication to have an effect is the same span of 
time it takes for the newly synthesized neurons to gain function-
ality. Returning to our exercise hypothesis, an experiment with 
lab rats found a 2 to 3-fold increase in neurogenesis in rats who 
had “regular access to a running wheel when they are compared 
with control animals.” This discovery naturally led to the aware-
ness that exercise assuages depressive symptoms by inducing 
increased neurogenesis, the “growth of new neurons in the adult 
[mammalian] brain.” While it was once thought that neurogenesis 
is limited to the developmental stages of growth, it is now known 
that certain areas of the adult mammalian brain retain active pro-
genitor cells that are constantly synthesizing new neurons and glial 
cells. There are two major sites of adult neurogenesis, the dentate 
gyrus of the hippocampus and the subventricular zones adjacent 
to the lateral ventricles. Based on experiments performed with 
lab mice and rats, roughly 9,000 new neurons are synthesized 
daily in the dentate gyrus alone. Research indicates that these 
numbers are reflective of human neurogenesis as well (Ernst, et 
al. 2006).  One site of adult neurogenesis is the subventricular 
zone (SVZ) that is adjacent to the lateral ventricles of the brain. 
“Numerous proliferative precursor cells” line the walls of the 
ventricles that are composed of ependymal cells. The precursor 
cells are contained in this zone and eventually mature into new 
neurons and glial cells. The second site is the dentate gyrus (DG), 
located on the hippocampus in the brain. The hippocampus, a 
“bilateral limbic structure that plays a role in…learning and mem-
ory....” has two distinct areas – the Cornu Ammonis (CA) and the 
dentate gyrus. The CA has three subfields filled with pyramidal 
cells, multi polar neurons that act as primary excitation neurons 
in the brain. The dentate gyrus is connected to the CA and is 
“composed of small, round granule cells” that form a C shaped 
area. It is underneath these granule cells that active progenitor 
cells are housed and give rise to new neurons and glia, giving the 
area its name – the subgranular zone (SGZ) of the dentate gyrus. 
The two zones are closely adjacent to each other but develop 
differently. Active progenitor cells in the dentate gyrus give rise 
to daughter cells that migrate into the granule layer above. There, 
they develop and send out axons into the Cornu Ammonis region 
3 (CA3). Over the course of four to five weeks, these daughter 
cells mature and act like fully grown granule cells. The daughter 
cells in the subventricular zone give rise to daughter cells that 
migrate into the olfactory bulbs to act as local interneurons. Thus, 
there is adult neurogenesis occurring daily at a rapid rate in the 
healthy mammalian brain. The neurogenesis theory states that if 
this complex process should somehow be impaired and fewer 
neurons would be created, the result would be the expression 
of depressive symptoms. The introduction of anti-depressant 
medications would promote neurogenesis and get the brain back 
on track. The plot thickens with the discovery that exercise too, 
promotes neurogenesis in the hippocampus of the brain. This 
strongly links exercise as a reliable therapeutic intervention for 
treatment of MDD (Ernst, et al. 2006).
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Several research experiments have sought to augment the 
proof with concrete data. Firstly, MRI (magnetic resonance im-
aging) data have shown that hippocampal volume is severely 
compromised in the brains of depressed patients. This would 
give strength to the idea that it is reduced neurogenesis in the 
dentate gyrus that gives rise to depressive symptoms. Other 
studies showed that the corticosteroids released from the ad-
renal gland as part of the natural stress response (HPA Axis) 
negatively impact neurogenesis in the hippocampus, thus caus-
ing the “decreased hippocampal volume associated with MDD.” 
The stress response is thus amplified, sustaining a vicious cycle 
of continuous depression and stress response. It’s important to 
note that the decreased size of the hippocampus is not due to 
the degeneration of pre-existing neurons. Therefore, it would 
follow that fewer neurons are being created in the first place. 
Comparatively, researchers found increased hippocampal vol-
ume in direct relation to aerobic exercise. Lab rats that engaged 
in aerobic exercise consistently displayed large increases in hip-
pocampal volume due to subsequent supplementary neurogen-
esis. As compared to control mice and rats with no access to a 
running wheel, active mice displayed double the number of new 
neurons in the subgranular zone of the dentate gyrus of the 
hippocampus. Furthermore, it has been ascertained that treat-
ments for MDD, such as SSRIs (selective serotonin reuptake 
inhibitors) or electroconvulsive shock therapy, also cause an in-
crease in neurogenesis. This expresses a direct relationship be-
tween neurogenesis and lessening depressive symptoms. A third 
proof involves the timing. Newly generated neurons typically 
require four to five weeks to become fully functioning neurons. 
This is a “latency similar to the onset of therapeutic benefit 
for most…antidepressant medication[s].” This information also 
supports the idea that proper neurogenesis is integral to re-
ducing depressive symptoms. Research has even shown that in 
certain cases, aerobic exercise can foster the same therapeutic 
effects as cognitive therapy (Ernst, et al. 2006).
Further research implicates BDNF (Brain-Derived 
Neurotrophin Factor) in exercise-induced neurogenesis. BDNF 
promotes “neuronal survival and regeneration” in the adult 
brain. Aerobic exercise causes elevated levels of BDNF to be 
produced specifically in the CNS. This specificity indicated that 
BDNF plays a particularly central role, namely in the brain. One 
study found that exercise in mice led to increases in BDNF. They 
also noted that in a case with depressed lab animals, exercise led 
to an increase in both BDNF levels and hippocampal neurogen-
esis. On the other hand, it is known that it is neurogenesis that 
causes the anti-depressant effects of exercise; therefore, it was 
concluded that elevated levels of BDNF contribute to increased 
neurogenesis, thus playing an indirect role in lowering the de-
pressive symptoms. BDNF stimulates cell proliferation specif-
ically in the subgranular zone of the dentate gyrus, and also 
supports long-term survival of these new neurons. A positive 
cycle can thus be recognized: exercise increases BDNF, BDNF 
enhances neurogenesis and neuronal survival, causing increased 
positive affect, probably leading to further exercise to prolong 
the effect (Ernst, et al. 2006).
The obvious question is: why does exercise stimulate neuro-
genesis; what endogenous substance causes the brain to up the 
ante on neurogenesis when the body is engaged in aerobic ac-
tivity? This returns us to the endorphin hypothesis. The thought 
was that endorphins are what stimulate increased neurogenesis, 
in turn causing a decrease in MDD. Studies have found that not 
only do infusions of opiate peptides seem to cause an increase 
in neurogenesis in the dentate gyrus, but also that “opiate re-
ceptor antagonists” seem to cause a decrease in adult neuro-
genesis. Therefore, endorphins may have a role in the survival 
and/or formation of new neurons and glia (Ernst, et al. 2006).
The Endorphin Hypothesis seemed sound, and was sustained 
for decades in the medical arena and among lay athletes at 
large. However, significant holes in the hypothesis were sprung 
that threatened the authenticity of its claims. Among other 
problems, the most substantial issue was that of the Blood 
Brain Barrier (BBB). Blood Brain Barrier describes the pre-
cise “microvasculature of the central nervous system.” It is a 
semipermeable border separating the blood circulation from 
the brain and ECF (extracellular fluid of the CNS). This sys-
tem of tightly packed endothelial cells (in the capillary wall), 
astrocytes (covering the capillaries) and pericytes (embedded 
in the basement membrane of the capillaries) is able to control 
the movement of substances to and from the brain and blood 
circulation. Substances such as “molecules, ions, and cells” are 
screened heavily by the BBB to ensure that no harmful mi-
crobes or other destructive substances reach the brain. This 
system ensures proper neuronal function and protection of the 
brain and spinal cord against “toxins, pathogens, inflammation, 
injury, and disease” (Daneman, R, et al. 2015). Since the cells of 
the BBB are so tightly packed, certain molecules that are too 
large are unable to pass through to gain access to the Central 
Nervous System. An example of such large molecules are beta 
endorphins. They are too bulky to pass through the BBB and 
therefore cannot be the cause any changes to occur within the 
brain. So, while endorphins are indeed released during exer-
cise and may staunch peripheral muscle pain that results from 
exercise, they cannot be the source of any Runners’ High or 
diminished depressive affect (Reynolds, 2015, Fuss, et al. 2015, 
Dietrich, 2004). Other “methodological confounds” inherent in 
the endorphin hypothesis are as follows:
1. Firstly, the possibility of cross reactivity is very strong. Cross 
reactivity occurs when two antigens are very similar in 
their amino acid makeup and therefore an antibody raised 
against one antigen might also bear an affinity for the simi-
lar antigen. The antibody is “programmed” to find the first 
antigen but it also recognizes the second. Beta endorphins 
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bear almost identical amino acid sequences with adreno-
corticotropic hormone (ACTH) and other pro-opiomela-
nocortins. Therefore, any detecting antibody would possibly 
cross-react, making it difficult to detect which is which. 
(Proteintech, 2018) This is a serious confound for scien-
tific experiments involving the authentication of the beta 
endorphin hypothesis and possibly invalidates much of the 
proof presented from these experiments. The fact that en-
dorphins have similar structure specifically to ACTH is a 
further confound, since ACTH is also known to increase 
with endurance exercise.
2. Furthermore, when beta endorphins bind to a µ opioid recep-
tor, it activates the “endogenous opioid system” that further 
activates the “analgesic and euphoric properties” inherent in 
the opiate system. It is also known, however, that symptoms 
such as “severe respiratory depression, pinpoint pupils, and 
inhibition of gastrointestinal motility” are all characteristic of 
endogenous opioid activation (Dietrich, 2004). If it were beta 
endorphins that were activating the opioid system, these 
symptoms would also be present in runners and endurance 
athletes. Since they are not, we are forced to reevaluate what 
it is that truly causes Runners’ High. 
Endocannabinoids
Researchers and scientists have now turned their attention 
to endogenous endocannabinoids as the true source of an-
algesia, sedation, anxiolysis and reduced depression found in 
endurance exercisers (Dietrich, 2004, Heijnen, et al. 2016). 
More recent studies are focusing on endocannabinoids and 
what is it about them that makes exercise “mildly intoxicat-
ing” (Reynolds, 2015). Endogenous endocannabinoids are the 
body’s natural chemicals that improve mood and reduce noci-
ception. They are endogenous lipids that “engage cannabinoid 
receptors, producing analgesic and euphoric effects just like 
those of exogenous cannabinoids, namely marijuana (or can-
nabis - Δ-9-THC ((–)-trans-Δ9-tetrahydrocannabinol; THC) (Lu, 
et al. 2016, Reynolds, 2015). While we now know that opiate 
endorphins mediate analgesia on a peripheral level, we have 
seen that there are still analgesic effects that occur irrespective 
of a working opioid system. This supports the evidence that 
cannabinoid induced analgesia also takes place at a central level 
(Dietrich, 2004). Endocannabinoids are what tell the hypothal-
amus to induce the release of endorphins. Therefore, any an-
algesic effects that endorphins do have are actually mediated 
by endocannabinoids (Heijnen, et al. 2016). Unlike endorphins, 
endocannabinoids are small enough to cross the Blood Brain 
Barrier and bind to brain receptors, thus enabling them to in-
duce peripheral as well as central effects (Fuss, et al. 2015). An 
interesting feature of cannabinoid function is that way they are 
produced. Classic neurotransmitters are created ahead of time 
and stored in their respective synaptic vesicles for whenever 
they might be needed. Cannabinoids, on the other hand, are cre-
ated and released almost immediately on demand. When called 
upon, for example, by G protein coupled receptors or during 
depolarization, endocannabinoids will be “liberated in one or 
two rapid enzymatic steps and released into the extracellular 
space” to produce a rapid effect on the system (Lu, et al. 2016). 
There are two types of identified endocannabinoids, CB1 and 
CB2. CB1 can be found in the CNS, “densely concentrated” in 
the cerebral cortex, hippocampus, basal ganglia; amygdala, hypo-
thalamus and cerebellum (Dietrich, 2004). Most CB1 receptors 
are found on axon terminals and pre-terminal axon segments, 
not on the active zones (Lu, et al. 2016). This further elevat-
ed endocannabinoids over endorphins, for while endorphins 
cannot even cross over in to the brain, endocannabinoids are 
located in the places one would assume pain relievers and an-
algesics would be found. The hippocampus is a site for memory, 
as well as neurogenesis which reduces depression; the amygdala 
regulates the fear response; the hypothalamus is the “master 
gland” of the brain and orchestrates all incoming and outgoing 
activity. The cerebral cortex is a massive conglomeration with 
numerous functions that would be affected by endocannabi-
noids. The frontal lobe of the cortex cares for “higher executive 
functions” such as “emotional regulation, planning [and] reason-
ing…” The parietal lobe is responsible for sensory integration 
such as touch, temperature and pain perception. Thus, is makes 
sense that these areas would abound with CB1 receptors. CB2 
receptors are mainly located in the PNS, expressing themselves 
on immune cells, microglia and vascular elements to protect the 
CNS. (Lu, et al. 2016) There are also cb1 receptors on periph-
eral nerve terminals. For example, “pain sensing [small diame-
ter] C fibers, large diameter Aß and Aδ fibers… [and] dorsal 
root ganglia” (Dietrich, 2004). Therefore, we see that ECBs are 
synthesized both centrally and peripherally, unlike endorphins 
which hare only synthesized in the Peripheral Nervous System. 
The possibility of a third cB receptor is currently being inves-
tigated and may turn out to account for some of the Runners’ 
High effects.
Chief ligands of CB1 and CB2 receptors are anandamide 
(arachidonoyl ethanolamine) and 2-arachidonoyl glycerol (2-
AG) (Lu, et al. 2016). They are derived from fatty acid deriva-
tives. Anandamide is known to bind with cb1 receptors over 
cb2 receptors, indicating higher central activity over peripheral 
activity (Dietrich, 2004). Anandamide (AEA) is a “highly lipophil-
ic” fatty chemical and therefore can easily cross in to the brain 
proper (Heijnen, et al. 2016). This would implicate anandamide in 
activating analgesic effects in the brain (Dietrich, 2004). AEA in-
creased gradually when cortisol is released during the HPA Axis, 
demonstrating a role in regulation of stress and amygdalar over 
excitability (Heijnen, et al. 2016). Rats showed an increase in hip-
pocampal anandamide after running on a wheel for an extended 
period of time, indicating that anandamide plays a role in exercise 
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and homeostatic regulation (Fuss, et al. 2015). Additionally, anan-
damide acts as a vasodilator and produces hypotension, facilitat-
ing blood flow during exercise (Dietrich, 2004). 
Anandamide (AEA) also engenders elevated levels of BDNF 
(Brain Derived Neurotrophic Factor) during exercise and return 
to baseline levels post-exercise. As mentioned above, BDNF is 
part of the neurotrophin family and plays a strong role in ex-
ercise-induced neurogenesis. In addition to promoting positive 
affect due to neurogenesis, BDNF also “exerts beneficial effects 
on cognition through its ability to enhance neurogenesis, synap-
tic plasticity and long-term potentiation, the basis of learning.” 
Therefore, enhanced release of AEA due to exercise stimulates 
BDNF to stimulate heightened cognition and learning. Indeed, 
psychological stress and mood disorders have been found to re-
duce BDNF levels in the brains of rats and mice. Physical stress, 
or aerobic exercise, does just the opposite. A study among an 
elderly population showed that “moderate intensity walking” 
over a year served to intensify BDNF levels, further causing task 
switching functioning to remain constant. The control group of 
sedentary elderly showed a diametric decline in BDNF and 
in task switching as well (Heijnen, et al. 2016). Other studies 
have shown that aerobic activity “ranging from 20 to 90 min 
of 40–75% of maximal power output or 40–60% of VO2max 
or 75% of maximal heart rate” causes noticeable increases in 
BDNF levels (Heijnen, et al. 2016). Thus endocannabinoids play 
a role in cognition and mood as well.
Scientists noted that there were elevated levels of both en-
dorphins and endocannabinoids in the plasma of mice, post run 
(Reynolds, 2015). In one experiment, the cB receptors in mice 
were blocked, noticeably inhibiting the Runners’ High that is 
usually induced post run. The mice were anxious and sensitive 
to pain perception. Blocking the endorphin receptors had no 
effect and the mice experienced the calming and antinociceptive 
effects of runners’ high as usual (Fuss et al., 2015, Reynolds, 
2015). A similar study also involved lab mice running in a wheel. 
First off, increased running directly increased levels of endocan-
nabinoids, effectively inducing a reduction in anxiety and pain. 
Furthermore, ablation of the mice’s cb1 receptors completely 
inhibited the runners’ high effect, eliminating anxiolysis. When 
the mice were injected with blockers of their cB receptors, 
the analgesic effects were further inhibited (Fuss, et al. 2015). 
Yet another study with mice divided the mice into running and 
non-running groups. The running mice were at ease to spend 
more time in bright light areas, something anxious mice don’t 
do. This indicated that the running induced sedation. The mice 
were also tested for pain perception with a hot plate test. The 
runners did not jump in pain or lick their paws as much as 
normal, indicating that running induced antinociception, endow-
ing the mice with heightened “thermal pain sensitivity.” All of 
these studies found that reductions in anxiety and elevated se-
dation in mice are due to increased CB1 receptors in forebrain 
GABAergic neurons, while antinociception was caused by cb1 
and cb2 receptors in the PNS (Fuss, et al. 2015). This antinoci-
ceptive effect can even rival that of morphine (Dietrich, 2004). 
Another study engaged healthy male athletes running at 
“varying degrees of intensity” over a period of four days. Each 
running session induced a 70-80% raise in basal heart rate, and 
was performed at 50-90% of maximal intensity capacity. A sharp 
increase in cB1 receptors was found in the “frontal cortex, 
amygdala, hippocampus, and…hypothalamus” all known to be 
essential areas that regulate affective homeostasis (Heijnen, et 
al. 2016). A similar study involved male college athletes exercis-
ing on treadmills or stationary bikes at 70-80% maximal heart 
rate. After about an hour, drastically raised levels of anandamide 
were measured in their blood circulation (Dietrich, 2004). 
Another way that endocannabinoids modulate nociception 
is by affecting the Periaqueductal Gray system (PAG). The PAG 
serves an important role in modulating ascending pain transmis-
sion, fielding “afferents from nociceptive neurons in the spinal 
cord [and sending] projections to thalamic nuclei that process 
nociception.” In regard to descending pain inhibition, the PAG 
inhibits neurons in the dorsal horn of the spinal cord. The major 
functions of the midbrain periaqueductal gray (PAG) include 
suppressing pain, fear and anxiety, and promoting analgesia and 
cardiovascular control” (Bebehani, 1995). “Electrical stimulation 
of [both] the dorsal and lateral periaqueductal gray system” 
causes not only bindings to cb1 receptors but a subsequent re-
lease of anandamide into circulation. Additionally, an experiment 
revealed that “subcutaneous injection of the chemical irritant 
formalin” caused a direct infusion of the ligand anandamide into 
the periaqueductal gray. This implicates anandamide as a noci-
ceptive agent for central chemogenic pain (Dietrich, 2004). 
Upon observation, it can be noted that runners’ high is only 
found in response to endurance exercise, as opposed to exer-
cise in spurts. Sports such as “sprinting…weightlifting…track, 
soccer, football, tennis [and] basketball” doubtfully engage the 
endocannabinoid system since they do not involve long term 
exertion (Dietrich, 2004). Running, dancing or biking are ex-
amples of activities that would engage the ECB system and 
induce a runners’ high. As mentioned earlier, endorphins play 
a role in moderating only peripheral chemogenic pain in the 
muscles. In addition to the central effects of anandamide, we 
find that cannabinoids also act similarly to inhibit edema and 
muscle inflammation that might occur during intense exercise. 
This moderation is important for endurance athletes because 
muscle pain is a cause and effect of lactic acidosis, which in turn 
introduces symptoms like muscle ache, nausea and stomach 
pain (Dietrich, 2004). 
Endogenous cannabinoids and exogenous cannabinoids (mar-
ijuana) act in similar fashions. “The psychoactive constituent of 
marijuana, Δ-(9)-tetrahydrocannabinol (THC), exhibits high af-
finity for the CB1 receptor, which is densely expressed in brain 
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regions implicated in the control of emotion and cognition.” 
Therefore, just like marijuana, ECBs can induce sedation, analge-
sia, reduced anxiety, euphoria and even impaired spatial learning 
(Dietrich, 2004). This essentially means that prolonged exercise 
produces the same effects as marijuana. 
This leads into the addictive quality of endurance exercise. 
The endocannabinoid system is closely linked with the dopa-
minergic reward system of the brain. Dopamine is the brain’s 
pleasure hormone, and dopamine receptors D1 and D2 are 
modulated by endocannabinoids. The two main ECB ligands 
anandamide and 2-arachidonoylglycerol (2-AG) proliferate in 
dopaminergic pathways as a “retrograde feedback system” for 
GABA nerve terminals. There, they modulate dopamine trans-
mission (Bloomfield, et al. 2016). Additionally, cBs affect dopa-
mine activity by increasing firing rates in the medial forebrain 
bundle, ventral tegmentum and substantia nigra. In the same 
vein, withdrawing the cB presence would induce withdrawal 
symptoms similar to that characteristic of marijuana withdrawal. 
This is due to reduced firing of the pleasure hormone dopa-
mine. Therefore, endogenous as well as exogenous cannabinoids 
(CB1) are what cause the influx of dopamine release into cir-
culation, thus causing a feel-good high or a “Runners’ High.” Just 
like exogenous ECB cause drug addiction, so too endogenous 
ECBs engender an addiction to that which brings on the dopa-
minergic feelings, namely aerobic exercise. This explains exercise 
addiction; exercise causes elevated levels of ECBs, ECBs in turn 
cause increased firing of dopamine, inducing an addictive “high.” 
Indeed, it has been found that even just blocking dopamine 
receptors inhibits Runners’ High. Athletes who are forced to 
refrain from their routine endurance exercise (for example, in 
the case of an injury) report withdrawal symptoms not unlike 
those of drug withdrawal (Dietrich, 2004). 
Conclusion 
The analgesic, euphoric and anti-depressant effects that take 
hold in response to aerobic exercise have been a major source 
of contention among the medical, scientific and lay community 
for decades. The endorphin hypothesis certainly took center 
stage for quite a time as the source behind what the vernacular 
aptly termed “Runners’ High.” However, compelling evidence, 
experimental proofs and biological veracities have enabled sci-
entists to ascertain that endogenous endocannabinoids are the 
underlying cause of the many positive effects of aerobic activity. 
Included in these positive effects are: elevated ACTH to regulate 
the stress response, heightened BDNF production to promote 
neurogenesis and neural survival, analgesia, anxiolysis, decreased 
anxiety and depression, euphoria, enhanced cognition, and nu-
merous others. Endorphins do not cause Runners’ High; how-
ever, they do engender other positive effects during exercise. 
Exercise has been seen to induce Runners’ High in all ages and 
stages, be it depressed or emotionally healthy, young or elderly, 
and male or female. With this knowledge, the proof holds true 
that enhanced release of endogenous endocannabinoids due 
to aerobic activity reliably and consistently induces a Runners’ 
High, and thus decreases the depressive symptoms inherent in 
Major Depressive Disorder. 
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Polycystic ovary syndrome (PCOS) is recognized as the most common reproductive disorder in women. Obesity is believed to play 
a central role in the development of PCOS, as many women with this condition are reported to be overweight or obese. A strong 
correlational relationship exists between PCOS and obesity. This paper examines the relationship between PCOS and obesity in 
order to determine whether PCOS causes obesity as opposed to obesity causes metabolic changes that lead to PCOS.  Analysis was 
conducted by reviewing and comparing many studies related to the topic . Factors such as insulin resistance, hyperandrogenemia 
and body fat distribution were examined in obese and non-obese PCOS subjects.  Most studies included in this review could not 
conclusively determine whether PCOS contributed to obesity or vice versa.  The important points raised in the literature showed 
that obesity could be an important factor to predict PCOS.   In women who are predisposed to PCOS, the metabolic and hormonal 
issues that are present such as insulin resistance and hyperandrogenism, can lead to weight gain and eventually obesity. Obesity 
in turn can exacerbate the symptoms of PCOS such as further metabolic issues and reproductive abnormalities.
The Relationship Between PCOS and Obesity:  
Which Comes First?
Sara Leah Rosenberg
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Introduction
Polycystic ovary syndrome (PCOS) is a common metabolic and 
endocrine disorder   effecting 15- 20% of women of reproductive 
age. This disorder, originally known as Stein-Leventhal syndrome, 
was discovered in 1935. Its clinical features include obesity, hirsut-
ism, acne, infertility, and oligomenorrhea. PCOS is also attribut-
ed to several hormonal and metabolic disturbances, including 
increased androgen production and disordered gonadotropin 
secretion leading to menstrual irregularity, hirsutism, and infer-
tility. Aside from interfering with reproductive function, PCOS 
also disrupts the metabolism of women, affecting insulin action 
and β-cell function, increasing the risk for glucose intolerance and 
type 2 diabetes (Liu et al. 2017; Raisbeck 2009). 
The origin of PCOS remains unclear, but research has shown that 
one of the characteristics of this disorder is the excess produc-
tion of androgens in the ovaries (Alanbay et al. 2012). Androgen 
secretion is the result of abnormal response of the ovary to go-
nadotropins, insulin and insulin-like hormones such as insulin-like 
growth factor-1 (IGF-1), which enhances LH-stimulated andro-
gen secretion by theca cells. Although the condition is not life 
threatening, the lack of treatment could lead to more serious 
health issues in the future, such as increased risk of infertility, 
dysfunctional bleeding, endometrial carcinoma, obesity, type 2 di-
abetes mellitus, dyslipidemia, hypertension, and increased risk for 
cardiovascular diseases (Raisbeck 2009).
Among the risk factors associated with PCOS, overweight (body 
mass index (BMI) 25–29.9 kg/m2) and obesity (BMI ≥30 kg/m2) 
have been considered as major contributing factor to overall 
health concerns among women worldwide. Obesity has also 
been a determined as a contributing factor to reproductive health 
problems such as anovulation. As body weight increases, incidence 
of anovulation also increases significantly.  Another contributor to 
reproductive dysfunction is the accumulation of abdominal fat, 
indicating a higher risk associated with insulin resistance (IR). IR 
in obese women has been associated with anovulation and in-
creased androgen secretion (Kuchenbecker et al. 2011). 
Several studies relate obesity as a risk factor of PCOS (Reinehr 
et al. 2005; Soydinc et al. 2013). Some studies report that 
overweight and obesity incidence in females with PCOS is as 
high as 80%.The mechanisms by which obesity influences PCOS 
‘ pathophysiology and clinical expression are not fully under-
stood, but obesity is independently associated with IR (Rojas 
et al. 2014) and sex steroid imbalances that may lead to an in-
creased risk of menstrual irregularities and hyperandrogenemia, 
similar to PCOS symptoms (Pasquali and Gambineri 2006). On 
the other hand, others proposed that regardless of physical con-
dition PCOS could occur. PCOS may develop in women with a 
BMI in any range including both underweight and overweight 
women. (McEwen and Hartmann 2018). The consistent associ-
ation between PCOS and obesity suggests a biological basis for 
this observation. Obesity exacerbates many of the reproductive 
and metabolic abnormalities associated with PCOS. Considering 
the close association between PCOS and obesity, the question 
remains whether PCOS causes obesity or does obesity cause 
metabolic changes that lead to PCOS?
Method
A critical appraisal of the literature on the topic was conducted. 
A search for related studies was conducted using the access of 
Touro’s library in various databases, such as EBSCO, ProQuest, 
PubMed, MEDLINE, CINAHL, Cochrane Reviews, and Sage on-
line publications. Other information was sourced from Google 
Scholar. Keywords used to obtain the relevant documents in-
cluded PCOS, obesity, insulin resistance, reproductive health 
abnormalities and PCOS, metabolic anomalies and PCOS. In 
addition, a library search was also conducted for references in 




One of the main contributors to PCOS is insulin resistance (IR). 
Insulin is an important hormone produced by beta cells in the 
pancreas. It is responsible for the metabolism of glucose reduc-
tion of blood glucose levels by stimulating the glucose intake in 
insulin-sensitive tissue such as those found in the skeletal muscles. 
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IR is common and an early predictor of metabolic diseases. IR 
is the “inability of insulin to optimally stimulate the transport of 
glucose into the body’s cell” (McEwen and Hartmann 2018). 
Several studies investigated IR among women diagnosed with 
PCOS regardless of BMI. Fasting insulin levels in both lean and 
obese women diagnosed with PCOS were determined and com-
pared with control subjects. A total of 64 women with PCOS 
and 20 healthy subjects were evaluated using anthropometry, 
oral glucose tolerance tests, and insulin tolerance tests. Glucose 
levels were then measured using glucoseoxidase, whereas serum 
C-peptide and insulin levels were obtained using immunoradio-
metric assays. Insulin sensitivity and β-cell function were derived 
from fasting values of insulin and glucose or from oral glucose 
tolerance tests or insulin tolerance tests measurements. Results 
revealed that β-cell function is elevated in both lean and obese 
women with PCOS. In obese women suffering from PCOS, re-
duced values in fasting state-derived disposition index were 
found, whereas lean women suffering from PCOS were found 
to have increases in these variables when oral glucose tolerance 
tests were determined. The authors suggested that insulin hyper-
secretion may be an important mechanism in the pathogenesis 
of PCOS. Further, prevention of serious metabolic complications 
could be achieved with the early screening of impaired insulin 
action and secretion in women with PCOS (Vribikova et al. 2002).
Under normal conditions, the relationship between insulin 
secretion and sensitivity is constant to maintain normal glucose 
tolerance. If the sensitivity of insulin varies, the secretion of 
insulin also changes. Obese and lean females with PCOS have 
lower production of insulin sensitivity compared to the amount 
of insulin secreted in response to blood glucose levels than 
weight-matched healthy women (Dunaif 1999).
Another study investigated the association of IR to the in-
creased risk for cardiovascular disease among women with 
PCOS. They examined the effects of IR on myocardial microcir-
culation and peripheral artery function in patients with PCOS. 
A total of 55 women (28 with PCOS without IR, 18 with PCOS 
and IR, and 11 normal controls) participated in the study. All 
subjects were examined using high-resolution vascular ultra-
sound and real time myocardial contrast echocardiography 
(RTMCE).  Results indicated that women with PCOS and IR had 
depressed replenishment velocity and myocardial blood flow 
reserve, but no changes in endothelial dysfunction or intima–
media thickness. By contrast, women with PCOS but without IR 
were found to have isolated depression in replenishment veloc-
ity, suggesting that this condition could be an early indicator of 
myocardial flow abnormality (Aldrighi et al. 2015).
IR and hyperinsulinemia are exacerbated in obese individu-
als. The accumulation of excess intra-abdominal fat increases 
IR because of its sensitivity to lipolysis and releases more free 
fatty acids in the circulation and produces several cytokines 
(i.e. tumor necrosis factor-α [TNF-α], IL-6, leptin, resistin) that 
occur in IR (Carpentier 2008). Circulating free fatty acids can ac-
cumulate in non-adipose tissues, causing lipotoxicity and insulin 
resistance. In obesity, IR is also related to TNF-α that enhanced 
serine phosphorylation of IRS-1 and inhibits insulin receptor 
signaling (Hotamisligil et al. 1996). Furthermore, IR associated to 
obesity induces leptin resistance and reduced adiponectin levels, 
which are two factors that may reduce fatty acid oxidation and 
promote lipotoxicity (Carpentier 2008).
The mechanisms causing insulin resistance in PCOS have 
many similarities with those seen in relation to visceral adiposity 
(Kabir et al. 2005). Excess free fatty acids derived from lipolysis/
hydrolysis of acylglycerol in adipocytes accumulate in the hepatic 
portal veins, and this induces hepatic dysfunction. This condition 
contributes to elevated glucose secretion, stimulates pancreatic 
insulin secretion and glucose uptake in adipose tissue (Bergman 
et al. 2000). This specific insulin resistance, also known as hepatic 
insulin resistance, is only present in obese women with PCOS and 
not in healthy women of comparable body weight (Dunaif 1999). 
The results of these studies demonstrate only a correlational re-
lationship rather than a causal one between obesity and PCOS 
on glucose production, which may highlight an important factor 
of the pathogenesis of glucose intolerance.
Another approach was taken to determine the effects of insulin 
resistance on PCOS. Researchers investigated the relationship be-
tween neuropeptide Y (NPY) and insulin resistance. NPY enhanc-
es appetite and is structurally and immunologically similar to the 
pancreatic polypeptide, which has 36 amino acids. NPY is found in 
the central and peripheral nervous system. NPY controls nutrient 
intake and body weight. NPY also has an inhibitor effect on the 
hypothalamohypophyseal-ovarian axis. A total of 45 patients with 
PCOS and 44 healthy reproductive age individuals participated in 
the study. At early follicular phase in patients with PCOS, insulin, 
fasting blood sugar, follicle-stimulating hormone (FSH), luteinizing 
hormone (LH), prolactin, testosterone, dehydroepiandrosterone 
sulfate (DHEA-S), thyroid stimulating hormone (TSH), cortisol, 
estradiol, and NPY levels were determined. Meanwhile, insulin, 
fasting blood sugar, prolactin, DHEA-S, TSH, cortisol, and 17-OH 
progesterone levels were obtained from the control group. 
Fasting insulin levels and homeostatic model assessment for IR 
(HOMA-IR) were more elevated in obese patients with PCOS 
than in patients with normal weight and healthy controls. NPY 
levels were also higher in obese-overweight women with PCOS 
compared with the control and normal weight patients, but they 
were not statistically significant. NPY levels did not differ in pa-
tients with and without IR (Koseci et al. 2019). 
A study confirms the strong association between metabolic 
aberrations such as IR and PCOS. IR is clearly manifested among 
women with weight gain and who are genetically predisposed 
to develop PCOS. Conversely, weight reduction of women 
with PCOS reduces the negative impact of PCOS. Excluding 
obesity and fat mass, PCOS is related to metabolic aberrations 
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such as IR, dyslipidemia, and non-alcoholic fatty liver disease. 
Mechanisms attributed to the development of IR in PCOS have 
been established in previous studies. For example, the relation-
ship between visceral adipose tissue and IR has been proven 
in other studies.  Further investigation suggests that abdominal 
mass in women is proportional to the total fat mass regardless 
of PCOS status. This condition alone cannot completely ex-
plain the occurrence of IR in PCOS, however, fat distribution in 
women suggests an explanation as to why IR worsens as women 
with PCOS gain weight (Barber et al. 2016). 
Biochemical Indicators
Many studies have used biochemical indicators as an approach 
to better understanding PCOS. One examined the impact of 
hyperandrogenemia on IR.  Research has shown that impaired 
metabolism of glucose and IR is partially explained by high an-
drogen concentrations. Women with PCOS have both hyperan-
drogenemia and IR. By activating androgen receptors, testoster-
one caused IR in subcutaneous adipocytes. This impairs glucose 
metabolism due to defects in downstream protein phosphory-
lation, kinase-C protein, which usually mediates insulin’s impact 
on glucose transport (Corbould 2007).
In another study, the rationale for IR in PCOS patients was 
investigated. Adipocytes of women with PCOS had enhanced 
glycogen synthase kinase-3 (GSK3) action. Consequently, insu-
lin-stimulated glucose transport was impaired, and IR developed. 
Furthermore, overexpression of GSK3 promoted androgen bio-
synthesis through direct stimulation of P450c17 enzyme activity 
(Chang et al. 2008). Results from these two studies verify that 
continuous exposure to androgens impairs insulin action and 
contributes to the development of IR.
Androgens have an important role in body composition be-
cause they determine the location of fat stored in the body. 
Androgens influence adipocyte function and distribution by the 
inhibition of adipocyte differentiation, which modulates lipoly-
sis and lipogenesis (Dicker et al. 2004). In general, males have 
greater distribution of body fat in the upper portion of the 
body, whereas females accumulate fat in the posterior region of 
the body. Among women, distribution of adipose tissue differs 
between women with and without PCOS. Adipose tissues of 
women with PCOS have been found to be dispersed viscerally 
similar to that of males. For a given waist circumference, abdom-
inal subcutaneous fat in women has been found to be higher 
than that of men regardless of age (Kuk et al. 2005). 
To determine the possible developmental origins of PCOS, a 
model was constructed to trace the pathophysiology of PCOS 
involving excess androgens (including the signs and symptoms) 
at every stage of the disease. Androgen excess occurs in a vi-
cious perpetual cycle. The gene expression of excess androgens 
in utero results in high LH and insulin concentrations, enhanc-
ing the enzyme activities in theca cells and encouraging the 
progression of primordial to preantral and small antral follicles. 
These interactions elevate androgen levels. The process is com-
pleted and revived when a female with excess androgen procre-
ates and bears a female fetus, suggesting the genetic path of the 
syndrome (Homburg 2010). 
Body fat distribution was researched among females with and 
without PCOS. The subjects were matched for age and BMI. 
They also looked at the connection between concentrations 
of androgen, IR, and fat distribution. A total of 31 women with 
PCOS and 29 healthy subjects as controls participated in the 
study. Women with PCOS demonstrated higher fat mass value 
in the trunk and arms. Fat accumulation occurs during puberty 
in the hips, thighs, and buttocks and is preserved throughout 
women’s fertile stage.  However, there is more upper body fat 
distribution for females who have been diagnosed with meta-
bolic illnesses and PCOS. Excess androgens were ascribed to 
this disease. As a consequence of obesity, the impact of high 
androgens is increased due to lower concentrations of sex hor-
mone-binding globulin (SHBG) and greater concentrations of 
freely circulating bioactive androgens. Insulin increases testos-
terone’s impacts by suppressing SHBG. It functions as a co-go-
nadotropin and inhibits SHBG’s hepatic synthesis excluding sex 
steroid impacts that contribute to hyperandrogenism. Insulin 
stimulates the synthesis of ovarian androgen and decreases the 
concentrations of SHBG circulation due to the high concentra-
tions of complete serum and free testosterone. Consequently, 
there was more upper body fat distribution among females with 
PCOS. This research suggests that lowering the distribution and 
structure of fat may be useful in decreasing PCOS-related met-
abolic aberrations (Cosar 2008).
The relationship between abdominal and upper-body fat, 
glucose and lipid metabolism markers, and serum androgens 
in women with PCOS were investigated. The study includ-
ed 40 women aged 19-49 years with BMI 18.7 – 53.8 kg/m2. 
The participants had at least two of the following features of 
PCOS, namely, oligomenorrhoea or amenorrhea, clinical and/
or biochemical evidence of hyperandrogenemia, and polycystic 
ovaries in ultrasound imaging. All obese subjects had increased 
abdominal fat. A significant correlation was found between obe-
sity and serum fasting glucose and insulin levels. The same result 
was found in homeostatic model assessment index of IR. A posi-
tive correlation was observed between estimates of obesity and 
serum triglycerides and between obesity and blood pressure. 
Subsequently, the researchers confirmed direct positive cor-
relations between free androgen index, body weight and BMI 
(Kozakowski and Zgliczynski 2013). 
Others also recorded the elevated incidence of upper-body 
obesity as evidenced by enhanced waist circumference and 
waist-hip ratio compared with BMI-matched control females, 
confirming the same results. Studies using dual-energy x-ray ab-
sorptiometry have disclosed enhanced accumulation of core fat 
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in females with PCOS in accordance with these results (Douchi 
et al. 1995). Chronic exposure in females with PCOS to greater 
concentrations of testosterone may alter the distribution of 
body fat in these females. Studies of androgen administration 
in non-obese females to male transsexuals leading to increased 
visceral fat and adverse impact on insulin sensitivity provide 
support for this hypothesis (Elbers et al. 1997). In both obese 
and normal-weight females, exposure to androgens increases 
visceral fat (Rosenfield 1999). In rats, administering a single 
elevated dose of testosterone early in life contributes to the 
growth of insulin resistance and centralization as an adult of ad-
ipose tissue mass (Nilsson et al. 1998). Early androgen exposure 
may adversely affect future distribution of body fat with higher 
core fat accumulation.  Studies of isolated abdominal fat cells 
from females with PCOS have shown that there is a preferential 
abdominal accumulation of adipose tissue in both obese and 
non-obese females with PCOS compared to control females 
(Dunaif et al. 1992). In obese females with PCOS, femoral adipo-
cytes are fewer than reproductively ordinary females, consistent 
with a change to the distribution of upper-body fat in females 
with PCOS. Observation of the increased distribution of viscer-
al adipose tissue in PCOS can be ascribed to the impact of an-
drogens, their metabolism, and tissue-specific steroid receptor 
expression (Blouin 2009). Since this visceral fat is biologically 
active (Kuchenbecker et al. 2011), it most probably contributes 
to further metabolic and endocrine disorders in PCOS.
Women with upper-body obesity have PCOS symptoms such 
as reduced sensitivity to insulin and are at greater danger of car-
diac illness and diabetes (Vague 1956). It was observed that in 
females with upper-body obesity, the incidence of diabetes, hy-
pertension, and atherosclerosis was greater than in lower-body 
obesity. Furthermore, it has been noted that the incidence of 
upper body obesity rises in females after menopause and fe-
males with upper body obesity tend to have hyperandrogenic 
characteristics such as hirsutism.
PCOS is defined by anomalies in the hormone releasing go-
nadotropin (GnRH), a pulse generator that leads to a rise in the 
release of LH over the follicle stimulating hormone (FSH). These 
abnormalities are obesity-independent. Healthy obese females 
have no defects in levels of 24-hour LH and FSH. Excess insulin 
stimulates hypothalamic GnRH secretion up to a certain point, 
thus inducing gonadotropin secretion (especially LH) from pitu-
itary cells, which in turn stimulates the development of andro-
gen in the ovaries. When hyperinsulinemia is found, the pituitary 
is led to secrete big quantities of LH, which tends to boost the 
LH / FSH ratio. LH stimulates androgens synthesis in the ovaries, 
and an absence of FSH impairs the aromatization of androgens 
in granulosa cells to estrogens. These modifications cause the 
tiny ovarian follicles to grow and hinder the maturation needed 
for the development of the dominant follicle that then appears 
as polycystic ovaries (Dunaif 2003).
Obesity and PCOS
Although it is true that obesity is a risk factor, the disease has 
also been diagnosed in lean females, although reproductive is-
sues are generally discovered more frequently in obese females, 
regardless of PCOS.  Obese females were more probable to 
have irregular menstrual cycles and anovulatory infertility com-
pared to ordinary weight females. The risk of anovulatory infer-
tility rises by 24 kg / m2 at BMI and continues to increase as BMI 
rises. But even a slight proportion of decrease in body fat can 
restore these women’s menstrual cycles.
To understand which comes first, obesity or PCOS, studies 
have investigated this relationship in girls and adolescents. It was 
noted that girls with a high BMI in childhood had an increased 
risk of oligomenorrhea and a diagnosis of PCOS in young 
adulthood (age 24), yet the possibility that features of PCOS 
were already present in these girls cannot be excluded. The re-
searchers investigated if PCOS (or its features) in adolescents 
is predictive of later class III obesity. Despite not using pelvic 
ultrasonography, PCOS was diagnosed using the Rotterdam cri-
teria in 12 (40%) of 30 oligomenorrheic girls at age 14 years. 
Of these girls, 33% displayed class III obesity by 24 years of age 
versus 8.4% of girls without PCOS. Other predictors of class 
III obesity included low sex hormone binding globulin (SHBG), 
oligomenorrhea, high childhood insulin levels, increased cFT and 
MetS, all of which are recognized as PCOS phenotypes (Glueck 
et al. 2011). Meanwhile, others conducted a prospective study 
on 244 randomly selected postmenarchal girls from a large pop-
ulation-based birth cohort to investigate the influence of obe-
sity on the development of abnormal ovarian morphology. They 
found PCOS in 61.1% of the obese girls, but only in 32.1% of 
the normal- weight girls, suggesting that obesity is a contributing 
factor (Hickey et al. 2011). These studies illustrate that obesity 
and PCOS are correlative in their pathogenesis.
Additional trials explored the differences between obese and 
nonobese Croatian females with PCOS in clinical, hormonal and 
metabolic characteristics. The research included a total of 74 
obese and 208 nonobese females with PCOS. Obese females 
with PCOS were discovered to be at greater danger of develop-
ing oligomenorrhea, but at a lower risk of developing hirsutism 
and acne.  Furthermore, obese subjects were more likely to 
develop hyperandrogenemia, insulin resistance, hypercholester-
olemia, hypertriglyceridemia, and high serum CRP concentra-
tions than nonobese females. Among obese females with PCOS, 
metabolic problems were more probable to happen than their 
healthy counterparts (Baldani et al. 2013).
Especially in females with upper-body obesity, the discovery 
of enhanced androgen production in obese females was re-
vealed. Androgen clearance rates have also risen, however, the 
circulation of bioavailable androgens remains within the normal 
range. Similarly, due to hyperinsulinemia, SHBG concentrations 
are decreased in this state. SHBG concentrations in females 
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with or without PCOS are negatively associated with the cir-
culating insulin concentrations or with the degree of insulin 
resistance. Reducing insulin concentrations with diazoxide in 
obese PCOS females, a drug that only reduces insulin secretion 
without altering insulin sensitivity, has been discovered to in-
crease SHBG concentrations. This finding indicates that insulin 
may directly suppress the secretion of liver SHBG and com-
pensatory hyperinsulinemia as opposed to IR, explaining low 
concentrations of SHBG in obese females with PCOS. Due to 
reduced SHBG secretion induced by insulin, hyperandrogene-
mia is further exacerbated. Consequently, obesity-related hy-
perinsulinemia is a significant contributor to ovarian production 
of androgens in PCOS. By directly stimulating steroidogenesis 
in ovarian theca and granulosa cells, hyperinsulinemia may lead 
to hyperandrogenemia. Similar studies have been done on mice 
and have shown that liver and muscle cells display insulin resis-
tance during constant hyperinsulinemia, while insulin receptors 
remain sensitive in pituitary and ovarian cells, an adaptation that 
improves the secretion of pituitary hormones and ovarian an-
drogen production (Nestler, et al 1991). This observation was 
used as a model to describe the insulinemic contribution to the 
advanced androgen production to PCOS in obese women.
A systematic and meta-analytical review on existing literature 
was conducted to determine the prevalence of obesity among 
women diagnosed with PCOS. Moreover, the researchers in-
tended to determine whether ethnicity, geographic regions, 
and the diagnostic criteria of PCOS had confounding effects on 
this relationship.  A total of 106 studies conducted before 2010 
were included in the review. Among them, only 35 studies were 
included in the meta-analysis because the rest did not include a 
control group. They found that compared to non-obese women, 
obese women with PCOS were more likely to have poor clinical 
reproductive presentation. Evidence also suggested that PCOS 
contributed to obesity. Increased androgen levels in women re-
gardless of PCOS status were found to affect the appetite for 
high-fat and carbohydrate rich foods. However, other metabolic 
factors such as hyperinsulinemia, reduced postprandial thermo-
genesis, and basal metabolic rate and alterations contributed 
to weight gain in women with PCOS. However, the question 
remains whether PCOS contributed to obesity or vice versa. 
Some studies showed that women with PCOS had a greater 
tendency to accumulate fat in the upper body. This effect had 
also been found even in normal weight women.  Overall, it was 
concluded that women with PCOS were more likely to be over-
weight or obese compared to healthy counterparts. Caucasian 
with PCOS had greater risk for obesity than Asian women with 
PCOS (Lim et al. 2012).
Conclusion
In most health issues around the world, obesity is a signifi-
cant characteristic. Such observation does not exclude PCOS. 
However, most of the research in this review has not been able 
to determine conclusively whether PCOS contributed to obe-
sity or vice versa. However, the significant points raised in the 
literature showed that PCOS could be predicted by obesity as a 
significant factor. Overweight or obese females were at a high-
er risk of PCOS than ordinary weight females, but the weight 
problem does not exclude ordinary weight females from getting 
PCOS and its problems.
Researchers found that an elevated BMI among girls during 
childhood increases the risk of oligomenorrhea and a diagnosis 
of PCOS in young adulthood (age 24). They also investigated 
whether PCOS or its features were present in these adoles-
cents, which could predict later class III obesity during adult-
hood. Among 12 of 30 oligomenorrheic girls at age 14, 33% of 
the girls were predicted to have class III obesity in a decade 
compared to 8.4% without PCOS (Glueck et al. 2011). Another 
study found PCOS in 61.1% of the obese girls, but only in 32.1% 
of the normal- weight girls, suggesting that obesity is a contrib-
uting factor (Hickey et al. 2011). These studies illustrated that 
obesity and PCOS are correlative in their pathogenesis. 
By contrast, it was found that both lean and obese women 
with PCOS had elevated βF regardless of BMI. Lean PCOS sub-
jects had elevated DI values when OGTTs were determined. 
Aside from body weight, insulin hypersecretion could be an im-
portant mechanism in the pathogenesis of PCOS. Early screening 
of insulin action in women with PCOS regardless of BMI could 
prevent serious metabolic complications (Vribikova et al. 2002). 
Meanwhile, others found that both obese and lean women with 
PCOS have lower product of insulin sensitivity compared to the 
amount of insulin secreted in response to blood glucose levels 
than weight-matched healthy women (Dunaif 1999).
Nevertheless, being overweight or obese is a significant con-
tributory factor that aggravates the conditions of women with 
PCOS. IR among women with PCOS had been found to increase 
the risk of cardiovascular disease. Women with PCOS and IR 
demonstrated depressed replenishment velocity and MBFR, but 
no changes in endothelial dysfunction or IMT. However, women 
with PCOS but without IR were found to have isolated de-
pression in replenishment velocity, suggesting that this condi-
tion could be an early indicator of myocardial flow abnormality 
(Aldrighi et al. 2015).
Other studies indicated that only a correlational relationship 
(rather than a causal one) exists between obesity and PCOS on 
glucose production. It was noted that IR and hyperinsulinemia 
are intensified in obese individuals. Accumulation of excess in-
tra-abdominal fat increases IR because of its sensitivity to lipoly-
sis and releases more FFAs in circulation and produces several 
cytokines (i.e. tumor necrosis factor-α [TNF-α], IL-6, leptin, 
resistin) that occur in IR (Carpentier 2008). The mechanisms 
causing IR in PCOS have many similarities with those seen in 
relation to visceral adiposity (Kabir et al. 2005). A specific IR 
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also known as hepatic IR is only present in obese women with 
PCOS (Dunaif 1999). 
Researchers concluded that evidence in the literature suggested 
that PCOS contributed to obesity. Increased androgen levels in 
women regardless of PCOS status were found to affect the appe-
tite for high-fat and carbohydrate rich foods. However, other met-
abolic factors such as hyperinsulinemia, reduced postprandial ther-
mogenesis, and basal metabolic rate and alterations contributed to 
weight gain in women with PCOS. They also noted that women 
with PCOS were more likely to be overweight or obese compared 
to healthy counterparts. Caucasian with PCOS had greater risk for 
obesity than Asian women with PCOS (Lim et al. 2012).
The literature reviewed yielded significant information on 
PCOS. However, no conclusive evidence pointed to obesity 
as the main cause of PCOS or PCOS could cause weight gain. 
Biochemical and metabolic features that were impaired because 
of PCOS were suggested in these studies. Metabolic rate anom-
alies found in women with PCOS were more likely to cause 
their weight gain. Aside from weight gain, other PCOS features 
such as insulin hypersecretion, overproduction of androgens, 
reduced SHBG, relationship between IR and myocardial flow 
abnormality have been mentioned as contributing factors to 
more serious health issues among women with PCOS. 
PCOS is not an exclusive condition for females who are over-
weight or obese. Normal weight females also exhibited PCOS, 
especially females deemed to be PCOS candidates due to bio-
chemical and metabolic dysfunctions. Due to the confounding 
factors connected with body fat and PCOS, weight gain is feasi-
ble for these females. Nevertheless, it was discovered that more 
than half of the females with PCOS studied in this research 
were overweight or obese. To determine the connection be-
tween body mass and PCOS, a more comprehensive research 
should be performed.
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Abstract
Daptomycin is an important lipopeptide antibiotic used in the treatment of systematic and life-threatening infections of the skin 
and underlying tissue caused by Gram-positive bacteria . Calcium and phosphatidylglycerol (PG) must be present on the target cell 
membrane for daptomycin’s mechanism of action to proceed. Calcium and PG also promote oligomerization, a formation that has 
been assumed to aid in the bactericidal process . The purpose of the experiments conducted was to understand the basic biophys-
ical properties of membrane phospholipids as they exist in their pure and mixed monolayer forms . Furthermore, the experiments 
conducted attempted to discern how daptomycin penetrates the different lipids that were used . Data collected would be useful 
for future experiments that aim to understand the naturally occurring bacterial membranes and how daptomycin interacts with 
them. Using precise biophysical approaches, specifically monolayer studies involving a KSV NIMA-Langmuir Trough and Kibron 
Langmuir Trough, our lab conducted basic research which could prove to be useful in revealing daptomycin’s ambiguity. Preliminary 
results revealed differences in isotherms between phospholipids with anionic and zwitterionic head-groups . Further data collected 
revealed daptomycin’s degree of insertion in phospholipids with and without the presentation of calcium. Given the limitations 
of our retrospective studies, additional studies are needed to make definitive evaluations with these results. Because resistance 
to daptomycin is rising, it is particularly imperative to conduct further research to understand its unsolved mechanism of action . 
The Biophysical Study of the Efficacy of Various 
Phospholipid Membranes on Daptomycin
Chaya Shor and Tamar Itzkowitz
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Introduction
Daptomycin is a lipopeptide antibiotic used clinically against 
various Gram-positive bacterial infections. It is a naturally oc-
curring compound found in the soil saprotroph streptomyces 
roseosporus. Daptomycin was approved for clinical use in the 
United States in 2003 to treat complicated skin infections such 
as methicillin-resistant staphylococcus aureus, commonly known 
as MRSA. The molecule is larger and structurally more complex 
than most other antibiotics, with its mechanism of permeabiliza-
tion still not completely understood (Taylor et al. 2016). 
At present, it is believed that daptomycin works by disrupt-
ing Gram-positive cytoplasmic membrane function by creating 
oligomers in the outer membrane of the bacterial cell and then 
transferring them to the inner layer of the membrane. This caus-
es leakage of ions, such as potassium, which ultimately leads to 
loss of membrane potential that is fatal to the cell (Pogliano et 
al. 2012).
The most current research suggests that the antibiotic binds 
easily to cluster lipids (lipids with short, branched, and/or unsat-
urated fatty acyl chains). During the binding, the cell membrane 
structure alters significantly causing many peripheral membrane 
proteins, especially phospholipid synthase PlsX and lipid II syn-
thase MurG, to lose their ability to bind effectively (Muller et al. 
2016). This provokes rapid cell membrane depolarization and a 
potassium ion efflux, which effectively causes DNA, RNA, and 
protein synthesis cessation (Steenburgen et al. 2005).
Although the mechanism of action of daptomycin has yet to 
be elucidated, it was discovered that daptomycin is calcium de-
pendent (Zhang 2015, Ho et al. 2008). Additionally, binding and 
oligomerization are mediated by phosphatidylglycerol, or PG 
(Taylor et al. 2017). A lack of PG can result in bacterial resistance. 
Phosphatidylglycerol (PG) is anionic at a neutral pH. Because 
daptomycin is negatively charged, its insertion into an anionic 
material would be inhibited. However, it has been shown that 
calcium will facilitate the interaction of daptomycin within anionic 
membranes by acting as a middleman, or electrochemical bridge, 
to assist binding of oligomers of daptomycin to the membrane 
(Zhang 2015, Ho et al. 2008, Taylor et al. 2017). 
Cardiolipin (CL) is a membrane lipid associated with bacterial 
resistance to the antibiotic. The reason for this is that CL confines 
daptomycin to the outer membrane leaflet, thus preventing the 
drug from penetrating the inner membrane leaflet and hindering 
pore formation. It was also discovered in previous studies that 
CL reduces the number of oligomer subunits by approximately 
half. Subsequently, bacteria may become more resistant to dapto-
mycin by increasing the content of CL in their cell membranes. 
However, inhibition of pore formation may not suffice to prevent 
bactericidal action. This is because daptomycin may damage bac-
teria by more than one mechanism, which has yet to be proven 
(Zhang 2014).
Focus in the laboratory enhanced our understanding of dap-
tomycin and how it interacts with various lipids. A phospholipid 
layer arranges itself so that its polar, hydrophilic head group co-
operates with the water. The fatty acid hydrocarbon tails act in a 
hydrophobic manner by resisting the water and directing them-
selves toward the nonpolar air. Daptomycin is amphipathic, which 
means it contains both polar and nonpolar parts. When injected, 
it can either interact with the water or the membrane. This cer-
tainly aids the antibiotic in integrating effectively and quickly with 
a bacterium because it does not require a carrier to enter the 
cell. Studies show that Daptomycin is effective in as little as one 
hour and this can be attributed to its quick insertion into the cell 
(Steenburgen et al. 2005).
It would be necessary to research how many molecules of dap-
tomycin interact with the water, and how many molecules interact 
with the membrane. If the antibiotic does, in fact, insert into the 
membrane, an increase in surface pressure would be expected due 
to a more compact and crowded surface. Based on pressure, it can 
be determined how effectively daptomycin inserted.
The lipids used in our laboratory were sought to mimic the 
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bacterial cell membrane. The primary subphases used in our studies 
and in other studies as well were Ultrapure water and buffer. The 
buffer was used as a comparative subphase commonly exposed to 
bacteria and blood in the human body. pH, in both subphases, are 
similar enough to suggest that no inconsistency will result, even 
with the slight differentiation between a pH of 7 for the water and 
7.4 for the buffer. Langmuir monolayer studies provided us with the 
information necessary to determine the nature of the lipids and 
how daptomycin interacts with the various lipids. 
Langmuir monolayer studies provide useful information other 
than just surface pressure. Despite the 2-D nature of the mono-
layer, the molecules in monolayers exist in states that are analo-
gous to that of the 3-D nature of liquids, solids, or gases. Just as 
changing the pressure of a gas can change its phase, changing the 
surface pressure of monolayer can do so as well. Surface pres-
sure is a measure of the various forces between the molecules 
of a monolayer. As pressure is often plotted against volume at a 
constant temperature, so too surface pressure is plotted against 
the mean molecular area. The mean molecular area is the aver-
age free space each molecule in a monolayer must occupy. It can 
be viewed as the analog of volume- just as surface pressure is 
the analog of pressure. As the molecules get closer, increased in-
teractions change the surface pressure. A surface pressure-area 
isotherm gives information about a monolayer such as its phase 
and degree of interaction between the molecules. When the mol-
ecules in a Langmuir monolayer are spread very far apart, they 
exert little force on one another. This, conceptually, is similar to 
that of a gaseous state. In the gas phase, surface pressure is almost 
undetectable. The behavior of the gaseous phase is treated as a 
parallel to the ideal gas law, where PV=nRT. As the monolayer is 
condensed, the molecules can enter a transition into the liquid 
state. There are two stages in the liquid phase- the liquid-expand-
ed phase (LE phase) and the liquid-condensed phase (LC phase). 
In the LE phase, the π-A isotherm displays some curvature and 
liftoff from π=0. As compression progresses, the molecules enter 
a coexistent LE-LC phase, where the LE and LC phases are at 
equilibrium with each other, displayed by a somewhat horizontal 
line. The LC phase is typically marked by a steep slope, when the 
molecules are compressed even further. Increased interaction be-
tween the tails occur, thereby causing a more “solid-like” phase to 
transpire. Further compression of the monolayer can result in an 
actual solid-like phase. However, further compression is extreme-
ly difficult and the molecules strongly interact with each other 
until they reach the final phase where they collapse. The place of 
collapse informs us of the extent of pressure the molecule can 
withstand (Zhang 2014).
Materials and Methods
All experiments took place on a Langmuir Trough, which con-
sisted of movable barriers. The Langmuir trough is filled with a 
liquid called the subphase, typically water or buffer. The lipids 
were deposited on the surface dropwise. This dropwise tech-
nique is called “spreading” and involves a certain degree of man-
ual skill (Zhang 2014). Movable barriers compress and expand 
over the spread monolayer, altering the density of the molecules 
on the surface. This change in density resulted in changes in the 
surface pressure, which was detected and evaluated.
To ensure that the machine would consistently hold pressure, 
the barriers were tested and then assigned to lie in a specific 
orientation during every experiment. The softwares used along 
with our MicroTrough were the complementary KSV NIMA and 
Kibron softwares (Figures 1A and 1B). Ultrapure, distilled, and 
R1 water were used for both cleaning (the machines and the 
probe) and for the subphase. Ultrapure water and R1 were ob-
tained through the Millipore Direct-Q 3 with UV Ultrapure. The 
KSV NIMA Langmuir trough was disassembled and thoroughly 
cleaned with R1 water, ethanol, and rinsed off with R1 once 
more before and after every run. The probe was rinsed with 
R1, ethanol, and R1, as well. Once water or buffer was added to 
the trough, the machine was calibrated by zeroing the balance. 
The probe was raised out of the subphase to verify accurate 
reading, after which it was inserted back into the subphase. The 
surface was aspirated to remove any foreign substances. The 
Kibron Langmuir trough followed a similar protocol, however, 
Figure 1A. KSV NIMA Langmuir Trough used in our laboratory for 
the experiments conducted .
Figure 1B. Kibron Langmuir Trough used in our laboratory for the 
experiments conducted .
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the probe was sterilized via a bunsen burner.
In addition to the standard trough used to carry out the 
procedures in the laboratory, a modified trough was used, as 
well. This trough contained a reduced and depressed area upon 
which the subphase could reside. It included a small cavity that 
was useful for insertion of daptomycin into the subphase. The 
cleaning measures did not differ from the standard procedures. 
Buffer or water served as the subphase and was applied to the 
trough. A mini stirrer was positioned within the indented area 
in order to stir the subphase. Lipid was meticulously applied to 
the surface until a surface pressure of 5 mN/m or 10 mN/m was 
achieved. Following that, 16 µl of 10 mM daptomycin was inject-
ed into the subphase, using a Stuart Pipette. Once stabilization 
of surface pressure was attained, 5 µl of 1.6 M calcium buffer 
solution was injected into the subphase using a Stuart Pipette 
with a changed tip.
Daptomycin was acquired from Teva Pharmaceutical. The buf-
fer that was used was a concentration of 100 mM NaCl and 
10 mM Hepes, reaching a pH of roughly 7.4. To accomplish this, 
2.383 grams of Hepes and 5.844 grams of NaCl were measured 
out. They were then combined to dissolve until the neck of a 1L 
volumetric flask filled with Ultrapure water. The solution was 
then placed in a 1L beaker and evaluated with an electronic 
pH meter. Via a Pasteur pipette, the pH was adjusted by adding 
NaOH and HCl, respectively.
All lipids used were obtained in pure form from Avanti Polar 
Lipids Inc. The lipids were prepared by dissolving 10 mg of lipid 
in a 10 mL flask containing 3:1 chloroform methanol, resulting 
in 1:1 mg/mL of lipid. All pipettes and other volume measuring 
materials were tested for precision and accuracy. 
Hamilton syringes were used to apply the lipid solution. 
Chloroform was used to clean the syringes which were cleaned 
consecutively approximately 5-10 times. For the KSV NIMA, 
lipid solution was distributed by using a 50 µL syringe which was 
filled with 15 µL of lipid. To distribute solution to the Kibron, 
we used a smaller syringe filled to 8 µL. While administering 
the lipid solution, the individual applying it would be cautious 
to do so quickly and with minimal contamination (i.e. breathing, 
sneezing, and coughing). This is crucial because the machine can-
not distinguish between molecules of the lipid and molecules of 
the contaminant. Start was delayed by 10 minutes to allow for 
the lipid to spread.
The experiments focused primarily on lipids such as choles-
terol, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 
1,2- dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmi-
toyl-sn-glycero-3- phospho-(1’-rac-glycerol) (DPPG), 1,2- dimyris-
toyl-sn-glycero-3-phosphocholine (DMPC), and 1,2-dimyristoyl-sn-
glycero-3-phospho-(1’-rac-glycerol) (sodium salt) (DMPG).
Our preliminary experiments sought to calculate the surface 
pressure (π) over Å2/molecule for pure cholesterol, pure POPC, 
pure DPPC, pure DMPC, pure DPPG, 50% cholesterol/50% 
DPPC, 50% cholesterol/50% DMPC, and 50% cholesterol/50% 
DPPG. Our research then shifted its focus toward DMPG and 
its interaction with the daptomycin. 
Results/Discussion:
Cholesterol Monolayer
Figure 4 shows the surface pressure-area (π-A) isotherm 
obtained for a pure cholesterol monolayer. The curvature of 
Figure 3A . Cholesterol .
Figure 3B. POPC.
Figure 3C . DPPC .
Figure 3D . DMPC .
Figure 3E . DPPG .
Figure 3F . DMPG .
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the isotherm indicates that cholesterol molecules remained in 
a gaseous state upon compression until they sharply enter a 
more condensed phase as the compression proceeded. 
Following evaluation of our results, it was noticed that a 
somewhat steep rise in surface pressure occurred at 45.5 Å2/
molecule. Collapse occurred at 44 mN/m. The relative domain 
of cholesterol is quite minimal, attributing to the smaller values 
of Å2/molecule.
POPC Monolayer
Figure 5 shows the surface pressure-area (π-A) isotherm 
obtained for a pure POPC monolayer. Under experimental 
conditions, POPC exists in a liquid-expanded (LE) phase during 
compression. Further compression would cause the POPC to 
exist in a liquid-condensed (LC) phase (Faye et al. 2013). The 
isotherm revealed a rise in surface pressure at around 107.5 
Å2/molecule, with a steady and smooth curve until a collapse at 
around 44 mN/m.
Figure 5 exhibits the curve of a typical unsaturated molecule. 
POPC contains a double bond (Figure 3B), rendering it unsatu-
rated. Since unsaturation hinders effective packing of molecules, 
the isotherm displays a smooth and continuous curve, lacking 
phase changes.
DPPC Monolayer
Figures 6 illustrates the surface pressure-area (π-A) isotherm 
obtained for a pure DPPC monolayer. Five distinct regions, cor-
responding to different phases, were seen in the isotherm in a 
varying study (Takeshita et al. 2017). These phases have been 
assigned as gaseous, LE, the coexistence of LE and LC phases, 
and the collapsed phases. The isotherm can be interpreted as 
follows: in the gaseous phase, the molecules are random and 
disordered, thereby giving rise to insignificant surface pressure. 
Once in the LE phase, the molecules are more condensed than 
they are in the gaseous phase, yet they are still considered 
disordered. In the LC phase, the molecules are more ordered 
and densely aligned than they are in the LE phase, causing them 
to adopt a somewhat crystalline configuration (Takeshita et al. 
2017). Finally, a kink in the isotherm suggests that the monolayer 
collapsed.
Due to the saturated nature of DPPC (Figure 3C), the tails 
can pack efficiently against one another, causing a phase change 
to take place. The isotherm begins with minimal to no surface 
pressure, which is indicative of the fact that the molecules are 
in the gaseous phase. The DPPC then entered the LE phase at 
around 96 Å2/molecule, where the molecules rearranged them-
selves in a more disordered fashion. Moving onward, it is difficult 
to determine where exactly the molecules entered the LE-LC 
phase, although perhaps it occurred from 56-72 Å2/molecule. 
Nonetheless, that area of the curve is not distinct enough to be 
certain that the coexisting phase happened then. It seems that the 
LC phase, i.e. the area where the slope steepened, occurred at 70 
Å2/molecule. Finally, the monolayer collapsed at around 55 mN/m.
DPPG Monolayer
Figures 7 displays the surface pressure-area (π-A) isotherm 
obtained for a pure DPPG monolayer. According to other stud-
ies, a “knee” is present at around 75 Å2, until a plateau forms. 
Above this plateau, a steep rise in surface pressure occurs upon 
decreasing area. There is an apparent coexistence of the LE 
phase and LC phase. These observations agree with the typical 
anionic nature of DPPG (Figure 3E). Although it should be noted 
that the exact position of these transition phases can vary based 
on compression rates, subphase conditions, or temperature, as 
with every experiment (Kim et al. 2012).
Figure 4. Surface pressure (π, mN/m) vs. area per molecule (MMA) 
isotherm of cholesterol monolayer on water obtained in our lab .
Figure 5. Surface pressure (π, mN/m) vs. area per molecule (MMA) 
isotherm of POPC monolayer on water obtained in our lab.
Figure 6. Surface pressure (π, mN/m) vs. area per molecule (MMA) 
isotherm of DPPC monolayer on water obtained in our lab .
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Figure 7 displays an increase in surface pressure at 75 Å2/
molecule. It is difficult to tell where the coexisting LE-LC phase 
resides. Still, the slight elevation from 48-56 Å2/molecule may 
be attributed to that. The area past 48 Å2/molecule represents 
the LC phase.
In another study conducted in our laboratory, 1 M dapto-
mycin solution was tested without lipid. No reaction occurred. 
Then, an additional solution of daptomycin with 4 µL DPPG and 
2 µL of calcium was prepared. In this experiment, the (π-A) iso-
therm increased immediately and dramatically, illustrating that 
daptomycin requires PG and calcium ions to work effectively.
DMPC Monolayer
Figure 8 establishes the surface pressure-area (π-A) isotherm 
obtained for a pure DMPC monolayer. As illustrated by the iso-
therm, the DMPC monolayer exhibits a smooth and continuous 
curve due to its shorter acyl chain (Figure 3D), characterized 
by a steady and constant liquid phase for the lipid, lacking phase 
changes. The results obtained in our lab follow this pattern of 
DMPC’s molecular nature of interaction, with an even curve 
beginning to rise at 105 Å2/molecule and a collapse at around 
47 mN/m.
Cholesterol-DPPC (1:1) Monolayer
Figure 9 showcases the surface pressure-area (π-A) isotherm 
obtained for a DPPC:Cholesterol (1:1) monolayer (red curve), 
relative to pure cholesterol (green curve) and pure DPPC (blue 
curve) monolayer isotherms. Due to the cohesive forces be-
tween cholesterol (Figure 3A) and saturated DPPC (Figure 3C) 
(Ohe et al. 2007), the isotherm values are lower than those 
expected by the rule of additivity (Cruz Gomes da Silva et al. 
2017), however the values are only insignificantly lower. The rule 
of additivity informs us of the area that would be occupied if 
the lipids were to be mixed ideally. The interaction between 
the smooth hydrophobic part of cholesterol and DPPC is due 
to van der Waals forces (Sabatini et al. 2008). Nonetheless, due 
to DPPC’s saturated and rigid acyl chain, it is difficult for bulky 
cholesterol to penetrate, thus interfering with the molecular 
packing and causing DPPC:Cholesterol to occupy less area per 
molecule at constant pressure, but not significantly.
Additionally, it can be perceived from the results obtained 
that the collapse pressure for pure cholesterol lies at around 40 
mN/m, while pure DPPC lies at 52 mN/m, and DPPC:Cholesterol 
lies at 50 mN/m. Pure DPPC creates the most stable monolayer 
since it is able to withstand the highest surface pressure, as indi-
cated by the higher collapse pressure value. DPPC:Cholesterol 
withstood pressure at a value that lies slightly lower than pure 
DPPC, due to destabilization of the film via cholesterol.
Lastly, the phase change observed in the DPPC:Cholesterol 
monolayer at 48-72 Å2/molecule, has a broader range than the 
phase change observed in the pure DPPC monolayer, occur-
ring at 56-72 Å2/molecule. This is because cholesterol serves 
as a contaminant or impurity, which broadens the phase change 
upon compression.
Cholesterol-DMPC (1:1) Monolayer
Figure 10 displays the surface pressure-area (π-A) isotherm 
obtained for a DMPC:Cholesterol (1:1) monolayer (green curve), 
relative to pure cholesterol (red curve) and pure DMPC (blue 
curve) monolayer isotherms. There must be cohesive van der 
Waals forces present since the isotherm for DMPC:Cholesterol 
illustrates that the DMPC:Cholesterol occupies less area per 
molecule at constant pressure, thereby exhibiting lower surface 
area values than those expected by the rule of additivity. Despite 
the fact that bulky cholesterol interferes with the saturated 
Figure 7. Surface pressure (π, mN/m) vs. area per molecule (MMA) 
isotherm of DPPG monolayer on water obtained in our lab .
Figure 8. Surface pressure (π, mN/m) vs. area per molecule (MMA) 
isotherm of DMPC monolayer on water obtained in our lab .
Figure 9. Surface pressure (π, mN/m) vs. area per molecule (MMA) 
isotherm of DPPC:Cholesterol (1:1) monolayer on water obtained in 
our lab .
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DMPC acyl chain (Figure 3D), the chain is nevertheless shorter 
than DPPC’s chain. Thus, between DPPC and DMPC, effective 
packing of cholesterol is more likely in DMPC.
Additionally, it can be observed from the results obtained that 
the collapse pressure for pure cholesterol lies around 40 mN/m, 
while pure DMPC lies at 48 mN/m, and DMPC:Cholesterol 
lies at 45 mN/m. Pure DMPC creates the most stable mono-
layer since it is able to withstand the highest surface pres-
sure, as indicated by the higher collapse pressure value. Like 
DPPC:Cholesterol, DMPC:Cholesterol withstood pressure at a 
value that lies slightly lower than pure DMPC, due to destabili-
zation of the film via cholesterol.
Cholesterol-DPPG (1:1) Monolayer
Figure 11 displays the surface pressure-area (π-A) isotherm 
obtained for a DPPG:Cholesterol (1:1) monolayer (green 
curve) relative to pure cholesterol (blue curve) and pure DPPG 
(red curve) monolayer isotherms. DPPG and cholesterol in the 
1:1 mixture are repelling one another, as the DPPG:Cholesterol 
occupies more area per molecule, thereby displaying higher sur-
face area values than those expected by the rule of additivity. 
This repulsion is perhaps due to the negative charge present on 
DPPG and due to its longer acyl chain (Figure 3E).
Furthermore, it can be observed from the results obtained 
that the collapse pressure for pure cholesterol lies at around 40 
mN/m, while pure DPPG lies at 55 mN/m, and DPPG:Cholesterol 
lies at 52 mN/m. Pure DPPG creates the most stable mono-
layer since it is able to withstand the highest surface pres-
sure, as indicated by the higher collapse pressure value. Like 
DPPC:Cholesterol and DMPC:Cholesterol, DPPG:Cholesterol 
withstood pressure at a value slightly lower than pure DPPG, 
due to destabilization of the film via cholesterol.
Lastly, the phase change observed in the DPPG:Cholesterol 
monolayer at 45-58 Å2/molecule, has a more broad range than 
the phase change observed in the pure DPPG monolayer, occur-
ring at 48-56 Å2/molecule. This is because cholesterol serves as 
a contaminant or impurity, which broadens the phase change 
upon compression.
DMPG Monolayer Injected with Daptomycin
Daptomycin was put to the test, as portrayed in Figure 12. For 
the experiment, DMPG was injected at that start with a steady 
surface pressure achieved. At around 400 seconds, daptomycin was 
injected and surface pressure increased to 12 mN/m until levelled 
out. At 835 seconds, calcium solution was injected and surface 
pressure increased to 20 mN/m. 
Based on our results, it appears that daptomycin penetrated the 
DMPG at 400 seconds, indicated by an increase in surface pressure, 
even without the presence of calcium. As discussed, daptomycin 
is calcium dependent. We would need to continue exploring this 
wondrous enigma as to why or how daptomycin inserted into the 
membrane even when calcium was not yet present.
Conclusion and Future Studies:
The extent to which daptomycin inserts itself into the mem-
brane was observed. How this correlates to effectiveness may 
be the object of further research subsequent to the findings of 
the experiments performed. For example, if daptomycin does 
not penetrate the membrane at all, then a new experiment 
may be suggested to show that the lack of insertion may have 
been the cause of ineptitude. On the other hand, if the drug 
inserts well, then an experiment may be pursued to determine 
Figure 10. Surface pressure (π, mN/m) vs. area per molecule 
(MMA) isotherm of DMPC:Cholesterol (1:1) monolayer on water 
obtained in our lab .
Figure 11. Surface pressure (π, mN/m) vs. area per molecule 
(MMA) isotherm of DPPG:Cholesterol (1:1) monolayer on water 
obtained in our lab .
Figure 12. Results of surface pressure (π, mN/m) vs. time (s) inter-
action of daptomycin with DMPG on subphase of water obtained 
in our lab . DMPG applied, then daptomycin injected, followed by 
insertion of calcium solution .
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if successful insertion may be the cause of effectiveness.
Moreover, using the Gibbs Adsorption Isotherm for daptomy-
cin in water, we can determine the concentration of daptomycin 
in contact with the surface, which in turn alters the surface 
tension. Additional experiments would have to be conducted to 
determine such a phenomenon.
Lastly, in keeping with daptomycin’s ability to treat MRSA, 
some mutant strains of MRSA were found to be resistant to 
daptomycin. As such, analogs of daptomycin may be studied to 
determine if they might find a way to insert into MRSA with al-
tered surface proteins, since those would be considered mutant.
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Arthritis is a debilitating disease where joint inflammation occurs.  There are different types of arthritis, such as Osteoarthritis and 
Rheumatoid Arthritis.  Osteoarthritis is the destruction of the articular cartilage that usually comes with age, whereas Rheumatoid 
Arthritis is a chronic autoimmune disease .  They both have symptoms which include reduced range of motion, pain and swelling . 
There are various treatments to alleviate the pain and reduce the inflammation of arthritis.  Among them are medication, physical 
therapy, surgery and a whole food, plant-based diet .  The whole food, plant-based diet yields the best results and is the most 
effective and practical . 
Is a Whole Food, Plant-Based Diet the Most Effective 
Treatment of Arthritis?
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Introduction
Arthritis is a disease characterized by joint inflammation that 
causes discomfort and eventually intense pain along with stiff-
ness of the joints.  Other symptoms include reduced range of 
motion, muscle weakness, redness, and swelling.  These symp-
toms can come and go at different intensities.  Arthritis is also 
characterized as a musculoskeletal disorder (Carter & Rizzo 
2007).  Arthritis is twice as common in women than in men; 
however, men and children of all ages can experience it as well 
(Lourdudoss et al. 2018).  Though there are various kinds of 
treatments that can alleviate the pain of arthritis, many say that 
arthritis cannot be cured.  It is a chronic disease that causes 
pain, but that one can live a lifetime with.  Between the years 
2013 and 2015, approximately 54.4 million adults had arthritis, 
of which 23.7 million adults were limited in activity.  Arthritis 
affects approximately a sixth of the American population today 
and is predicted “to affect 78.4 million people by 2040” (Barbour 
et al. 2017) (Juyoung et al. 2018).
There are many types of arthritis, some that occur in many 
joints at once or other types that are isolated in one joint. 
Arthritis can be found in the ankles, fingers, wrists, back, jaw, 
and neck.  Different causes give rise to different types of ar-
thritis.  Osteoarthritis and Rheumatoid Arthritis are two of the 
most common types. The most rampant musculoskeletal dis-
ease amongst the elderly is Osteoarthritis (Hinman et al. 2007). 
Osteoarthritis
Osteoarthritis is when the articular cartilage begins to with-
er away and eventually disintegrates.  The articular cartilage 
allows for painless joint movement through load distribution 
and reduces friction between the bones.  In Osteoarthritis, the 
bones rub against each other which can cause extreme pain. 
For example, a person with Osteoarthritis of the knee will have 
difficulty walking and climbing the stairs.  Researchers believe 
that the cartilage destruction has a chemical and mechanical 
cause; however, the direct mechanism is unknown.  Mechanical 
factors that can increase the risk of Osteoarthritis are obe-
sity, heavy lifting, abnormal loading of joints from trauma, and 
joint instability (Beasley 2012).  Osteoarthritis is asymmetrical, 
meaning that if one experiences pain in a joint on one side of 
the body, this does not mean that they experience it in the 
same joint on the other side.  The pain is most intense in the 
evening and night hours and is a cool pain rather than hot. 
Along with Osteoarthritis comes crepitus which is a grinding, 
clicking, or popping movement of the joint accompanied by a 
sound (Witulski et al. 2014).  Osteoarthritis is most commonly 
found in elderly people, due to the wear and tear of many years 
of living.  It has a relatively slow onset that worsens with age 
(Azumasa & Misako 2017). 
Rheumatoid Arthritis
Rheumatoid Arthritis is different in that it’s a chronic autoim-
mune disease.  The body attacks itself causing inflammation 
of the joints, which overtime erodes the bones.  Normally, 
joints have synovial fluid which provides lubrication.  In 
Rheumatoid Arthritis the synovial fluid becomes less viscous, 
causing further cartilage damage because of the reduced joint 
lubrication (Beasley 2012).  In contrast to Osteoarthritis, 
Rheumatoid Arthritis most often occurs symmetrically, mean-
ing that if one has arthritis in the left shoulder, they usually 
also have it in the right shoulder as well.  Further, the sites 
of Rheumatoid Arthritis are warm, and sufferers experience 
the most pain during the morning hours.  The flare ups of 
Rheumatoid Arthritis are random unlike the constant pain of 
Osteoarthritis.  The symptoms of Rheumatoid Arthritis can 
get better, only to worsen again. Rheumatoid arthritis can be 
found in people of all different ages. 
Methods
The Touro College Online Library allowed access to Ebsco and 
Proquest which were the two databases used to find the proper 
scholarly articles needed.  Analysis of these studies helped de-
velop the answer to whether or not a whole food, plant-based 
diet is the most effective treatment of arthritis. 
Discussion 
Treatments of Arthritis
Popular treatments of arthritis include medication, physical 
therapy and sometimes surgery.    Another less popular but 
interesting approach is a whole food, plant-based diet.  Studies 
have shown that a whole food, plant-based diet can alleviate the 
pain and possibly cure arthritis.  This paper will try to answer 
the question: is a whole food, plant-based diet actually the most 
effective treatment of arthritis?
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Medication
Although various medications are anti-rheumatic, they come 
along with many possible negative side effects as well.  Names 
of different arthritis medications are Leflunomide, Sulfasalazine, 
Methotrexate, Etanercept, Adalimumab, Anakinra, Canakinumab, 
Abatacept, Infliximab, Rituximab, and Tocilizumab.  Leflunomide 
and Sulfasalazine can be taken orally.  Methotrexate can be 
taken orally or given as an injection.  Etanercept, Adalimumab, 
Anakinra, and Canakinumab all only come in an injection form. 
Abatacept, Infliximab, Rituximab, and Tocilizumab can only be 
given intravenously.  Some of the common side effects are in-
cluded below (Table 1). While medication may alleviate the pain 
of arthritis, the patient may have to deal with other annoying 
and sometimes painful side effects (Brinkman et al. 2017).  
Another downside of taking medication is the cost, which can 
be very high without insurance. For example, Etanercept costs 
around one thousand dollars per weekly injection (Brinkman 
et al. 2017).
Common Medications Used to Treat Arthritis 
and Their Side Effects
Medication Common Side Effects
Leflunomide Headache, diarrhea, upset stomach, cold symptoms
Sulfasalazine Headache, diarrhea, upset stomach, cold symptoms
Methotrexate Headache, upset stomach, mouth sores, nausea
Etanercept Headache, upset stomach, sinus infection, common 
cold, itchy or allergic rash, redness or soreness 
where needle enters skin 
Anakinra Headache, upset stomach, sinus infection, common 
cold, itchy or allergic rash, redness or soreness 
where needle enters skin
Adalimumab Headache, upset stomach, sinus infection, common 
cold, itchy or allergic rash, redness or soreness 
where needle enters skin
Canakinumab Headache, upset stomach, sinus infection, common 
cold, itchy or allergic rash, redness or soreness 
where needle enters skin
Abatacept Headache, upset stomach, common cold, sinus or 
throat infection 
Rituximab Headache, upset stomach, common cold, sinus or 
throat infection
Infliximab Headache, upset stomach, common cold, sinus or 
throat infection
Tocilizumab Headache, upset stomach, common cold, sinus or 
throat infection
Table 1 . Medications retrieved from www.cincinnatichildrens.org 
Arthritis Medication Choice Cards
Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
These drugs are preferred to treat arthritis over acetaminophen, 
aspirin and mild opiates.   Many people often take aspirin for 
arthritic pain and although it mitigates the pain, they get gastro-
intestinal toxicity from it.  This gastrointestinal toxicity inhibits 
NSAIDs and thus the preferred medical treatment cannot be 
used (Lisse et al. 2003).
Disease Modifying Anti Rheumatic Drug
Another approach to healing Rheumatoid Arthritis is a modern 
type of drug known as a disease modifying anti rheumatic drug. 
This type of drug suppresses the immune system to inhibit the 
body from attacking itself and causing joint inflammation.  It was 
designed to get rid of pain and tenderness of the joints and 
improve joint function long term.  Yet, this was true for only 
10-50% of patients treated with this drug.  Many Rheumatoid 
Arthritis patients still suffer intense pain (Winkvist et al. 2018). 
Because of this result, disease modifying anti rheumatic drugs 
do not sound promising.
Physical Therapy
A study was done where the physical therapists did exercises 
with the arthritis patients.  At the end of the treatment period 
they saw improvement in grip strength.  Physical activity im-
proved the functional status of arthritis patients.  Some thera-
pists use a paraffin wax bath for distal joints to reduce pain.  The 
moist heat of the wax soothes the joints and makes the exercise 
of physical therapy less painful (Shinde & Varadharajulu 2017). 
This study is not an accurate assessment of a good treatment 
for arthritis.  The study was flawed in that their subjects ranged 
from ages twenty to fifty-five.  While the physical activity may 
improve the symptoms of younger and middle-aged people, it 
probably would not have the same effect on the elderly.  Elderly 
bodies are often fragile and worn out.  It is harder for old peo-
ple to recover from diseases.  This study does not effectively 
prove that physical therapy is the most effective treatment for 
arthritis across the board. 
Hydrotherapy
In addition to traditional physical therapy, hydrotherapy, physical 
therapy done in an aquatic environment, is another treatment 
for arthritis. During hydrotherapy, physical therapists treat pa-
tients through exercises in heated pools.  There are multiple 
benefits of hydrotherapy that standard physical therapy does 
not have.   Firstly, “buoyancy reduces loading across joints af-
fected by pain and allows the performance of functional closed-
chain exercises that otherwise may be too difficult on land.” 
Another benefit is that the water movement and pressure can 
be used as resistance which makes the exercises more effective. 
Furthermore, pain relief, swelling reduction, and ease of move-
ment increase due to the warmth and pressure of the water. 
The warm water leads to muscle relaxation, enhancing move-




Electrotherapy is another effective form of physical therapy: 
“Electrotherapy consists of the application of electrothera-
peutic procedures (ionization and ultrasound) to the affected 
regions, with an analgesic, anti-inflammatory and decontractur-
ing indication” (Tosa et al. 2016). It uses electrical energy as 
a medical treatment and reduces inflammation and decreases 
pain. Electrotherapy is amongst the most frequently used physi-
cal therapy treatments of Rheumatoid Arthritis.  
Analysis of Physical Therapy
Different kinds of physical therapy can be helpful in treating 
arthritis; however, physical therapy is often not so practical. 
Physical therapy is costly and Medicare may limit access or cov-
erage of services like these.  Thus, elderly patients with arthritis 
are less likely to receive physical therapy (Carter & Rizzo 2007). 
Hydrotherapy is costly and pools are not always accessible in 
every community.  Hence, hydrotherapy is not available for all 
arthritic patients. Additionally, although hydrotherapy somewhat 
reduced the pain in Osteoarthritis patients, studies have shown 
that after six weeks of treatment the pain relief was minimal. 
Hydrotherapy only reduced pain, stiffness and hip strength 
slightly. Therefore, it appears that hydrotherapy is not the most 
effective treatment of arthritis (Hinman et al. 2007). 
Joint Replacement Surgery 
Joint replacement is another approach to healing arthritis, yet 
this option is a last resort for most people.  People get joint 
replacements once the articular cartilage is almost completely 
destroyed and they are in a debilitating state.  A preventative 
cure is more preferred (Clinton et al. 2015). 
Whole Food, Plant-Based Diet
Whereas all the treatments mentioned thus far were costly, an 
effective approach called the whole food, plant-based diet is in-
expensive.  Besides for being affordable, this method of treating 
arthritis is also doable, practical, and easy.  Anyone can do it; it 
does not require higher education.  A study was done where 
patients with arthritis kept a whole food, plant-based diet and 
eliminated meat and dairy foods for six weeks.  Researchers 
observed that the patients’ Rheumatoid Arthritis symptoms de-
creased while the patients were off of meats and dairies.  The 
whole food, plant-based diet has been shown to improve the 
pain and other symptoms of Osteoarthritis patients as well. 
After only the first two weeks of this six-week study research-
ers saw clinical results.  This demonstrates the diet’s effective-
ness in lessening the pain, and the pain got less and less as time 
went on.  After being on a whole food, plant-based diet, people 
had increased levels of alpha and beta carotene, lycopene, lutein, 
vitamin C and vitamin E in their sera.  These are all beneficial 
and healthy antioxidants or vitamins.  According to the USDA 
pyramid, a human should ingest solid and liquid animal protein 
daily, such as meats and dairies.  This is not in accordance with 
the whole food, plant-based diet (Clinton et al. 2015).  
Arachidonic Acids and Omega-3 Fatty Acids
Arachidonic acids are precursors to proinflammatory eicosa-
noids and prostaglandins and are found in cell phospholipids. 
Prostaglandins are hormones that are created during chemical 
reactions due to an injury or disease and they can increase in-
flammation. An eicosanoid is a signaling molecule that can in-
crease inflammation as well.  More than 80% of ingested arachi-
donic acids are used to produce eicosanoids (Adam et al. 2003). 
Animal products are high in arachidonic acids whereas a whole 
food, plant-based diet is low in arachidonic acids.  By keeping 
to a diet low in arachidonic acids, inflammation in patients with 
Rheumatoid Arthritis can decrease (Clinton et al. 2015). 
Studies show that Omega-3 fatty acids reduce arthritic pain. 
Omega-3 fatty acids from fish oil stop the formation of cyto-
kines and eicosanoids.  This is because they compete with the 
Omega-6 fatty acids for a spot in the cell phospholipids and 
for the binding sites of cyclooxygenase and lipoxygenase.  Since 
the eicosanoids cause inflammation, eating Omega-3 fatty acids 
reduces inflammation, reducing arthritic pain (Adam et al. 2003). 
In a study, Omega-3 fatty acid levels were highest in the 
serum of whole food, plant-based dieters.  Omnivores and fish 
eaters had less Omega-3 fatty acids.  Alpha-linoleic acid is found 
in legumes, vegetables and soy.  When alpha-linoleic acid is me-
tabolized, it produces anti-inflammatory prostaglandins.  These 
anti-inflammatory prostaglandins help reduce arthritic symp-
toms (Clinton et al. 2015).
There was a study done over the span of eight months, in 
which the subjects were divided into two groups.  One group 
was put on an anti-inflammatory diet and the other on a west-
ern diet.  There was a positive correlation between arachidonic 
acid consumption and the percent of arachidonic acids in eryth-
rocyte lipids. Those on an anti-inflammatory diet (AID), where 
they ate a minimal amount of animal products, had a lower per-
cent of arachidonic acids in their blood than those on a western 
diet (WD) (Adam et al. 2003). 
Populations with high fish consumption include the Alaskan 
Natives, Greenland Eskimos, and Japanese living in villages 
where fishing is constant (Zheng et al. 2012).  In these areas, 
the percent of arachidonic acids in plasma phospholipids was 
approximately 2%, whereas in industrialized countries it was 
approximately 16% (Adam et al. 2003).  Rheumatoid Arthritis is 
not nearly as prevalent in populations with high fish consump-
tion as it is in industrialized countries due to the Omega-3 fatty 
acids in fish.  
In the eight-month study mentioned above, in addition to the 
diet they were instructed to follow, some subjects in each group 
received placebo or verum pills and some fish oil capsules. 
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Those in the anti-inflammatory diet group who received the 
placebo had a 14% decrease in tender and swollen joints collec-
tively.  Those in the anti-inflammatory diet group who received 
fish oil had a 28% decrease in tender joints and a 34% decrease 
in swollen joints.  Those in the western diet group who received 
fish oil had an 11% decrease in tender joints and a 22% decrease 
in swollen joints.  Overall, the anti-inflammatory diet with a fish 
oil capsule decreased the tenderness and swelling of joints 
more than the western diet with a fish oil capsule.  It is also 
clear that the fish oil which is rich in Omega-3, had an effect and 
decreased the tenderness and swelling of the joints more than 
the placebo did (Adam et al. 2003). 
Two different capsules were administered to patients that 
were not real fish oil.  The placebo was corn oil and the verum 
was menhaden oil.  Even without fish oil, which has a greater ef-
fect than the other oils, the anti-inflammatory diet is significantly 
more effective in reducing symptoms of arthritis than the west-
ern diet is.  This is a good study, adequately proving how a diet low 
in arachidonic acids and including fish oil supplements can greatly 
alleviate pain, improve arthritic symptoms and reduce production 
of eicosanoids and cytokines (Adam et al. 2003).
Another study compared two groups.  One group kept to an 
ordinary, omnivorous diet, while the other kept to a whole food, 
plant-based diet.  The results were that the whole food, plant-
based diet caused the swelling of the joints to decrease, less pain 
and increased functional status.  Compared to the omnivorous 
diet, the whole food, plant-based diet was more effective in pain 
reduction (Clinton et al. 2015).  
As an added bonus, a whole food, plant-based diet can result 
in weight loss and blood pressure reduction (Silberman et al. 
2010).  Excess weight can add abnormal mechanical stress on 
the knee joint; obesity makes arthritis worse (Cianflocco 2011). 
As a result of weight loss, the mechanical load on arthritic joints 
decreases, alleviating the pain caused by arthritis (Messier et al. 
2005).  Knee Osteoarthritis symptoms can greatly improve even 
from small weight losses (Bartlett et al. 2004).  For someone 
with arthritis in the knee, “for every pound of weight lost, there 
is a four-pound reduction in mechanical load exerted on the 
knee during daily activities” (Clinton et al. 2015).
Due to articular cartilage disintegration there is a loss of 
space between the femur and tibia in this Osteoarthritis patient. 
The bone rubbing against bone can cause extreme pain to this 
patient.  The more weight the patient has to carry around on 
that knee, the more the bones will rub and the more pain there 
will be (Cianflocco 2011).  For this reason, it is worth attempt-
ing to lose weight through a whole food, plant-based diet. 
It is a common misconception that a diet without animal 
protein causes malnutrition.  A whole food, plant-based diet 
provides enough protein, fats, vitamins, minerals and calories 
(Clinton et al. 2015). 
Conclusion
After analyzing the different treatment options to alleviate the 
pain of and possibly cure arthritis, it is apparent that the whole 
food, plant-based diet has the most promising results.  One on 
this diet must not eat any animal proteins in order to maintain a 
low level of arachidonic acids to prevent or reduce inflammation. 
Along with this diet, dieters should take fish oil capsules for bet-
ter results.  Fish oil contains Omega-3 fatty acids which further 
reduce inflammation and prove beneficial to those with arthritis. 
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Symptoms of acute Infectious Mononucleosis (IM), which develops after Epstein-Barr virus (EBV) in half the cases, is strikingly like 
those of Hodgkin’s Lymphoma (HL). This, combined with the findings that many patients with HL had a history of EBV and/or IM, 
triggered an interest in scientists to learn if the two were biochemically related. Many studies in this field unanimously concluded 
that the development of IM after EBV infection presented a higher risk of developing HL. However, whether this relationship is 
coincidental or pathological remains a matter of controversy until this day . In the last decade, there has been a lot of research and 
advances in this field. Various studies have looked at the correlation of EBV and HL considering age factors, genetic predispositions, 
and immunity and susceptibility dynamics. Researchers discovered that development of HL after EBV was most prevalent in 
young adults and old patients, pointing to immune system function, or lack thereof . It was also found to be more common in men, 
suggesting that this may be a sex-related disease. Specific genes activated or mutated in both EBV and HL have proposed that 
the development of HL after EBV/IM may be genetically regulated. By tracing geminal centre B cell replication patterns, EBV gene 
expression, and lytic cycle proteins, different mechanisms for the pathogenesis of HL from EBV were proposed. Various studies 
made use of statistics and patients’ medical records to make assumptions. Other methods employed in these studies included 
probe hybridization to extract DNA and RNA samples from tumor specimens, flow cytometry and polymerase chain reactions 
(PCR) to identify genetic sequences, and immunohistochemistry to study antigens specific to EBV and related diseases.
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Introduction
Is there a correlation between Epstein - Barr virus and Hodgkin’s 
Lymphoma? If so, what is the nature of this relationship? The 
objective of this paper is to briefly discuss some studies which 
initially led health professionals to believe that Hodgkin’s lym-
phoma (HL) is caused by EBV. Then, possible causes and mech-
anisms which may lead the viral disease to transform infected 
cells to malignant tumors will be expounded upon.
The lymphatic system is an important regulatory mecha-
nism involved in the immune response of the body. It is com-
prised of lymphatic channels which conduct the lymphatic fluid 
throughout the body and converge regionally to form discreet 
lymph nodes (Freeman and Matto, 2018). The function of the 
lymph node is to evaluate and initiate an immune response 
when necessary. It functions as an antigen filter consisting of 
a multi-layered sinus that successively exposes B-cell lympho-
cytes and T-cell lymphocytes to an afferent extracellular fluid 
(Evans, 1974). B and T lymphocytes are subtypes of white blood 
cells that contribute to the immune system. For example, by 
secreting antibodies, the B cells thus play a central role in im-
munity. In addition, T cells exhibit cell-mediated immunity. In 
the course of an immune response, where foreign proteins 
are recognized and attacked, the immune cell line undergoes 
multiplication, thereby causing the lymph node to increase in 
size. Generalized or localized lymphadenopathy, an abnormality 
in the size or consistency of lymph nodes, is the most common 
feature in lymphoproliferative disorders. These disorders refer 
to potentially fatal conditions in which lymphocytes are pro-
duced in excessive quantities. Included in this broad category of 
disorders, are Epstein-Barr Virus, Infectious Mononucleosis, and 
Hodgkin’s Lymphoma. 
EBV is a tumorigenic double stranded DNA herpesvirus that 
commonly develops in the first decade of life of an individual. 
It infects more than 90% of the human population worldwide 
(Yang, et. al., 2015). EBV consists of the EBV-1 and EBV-2 sub-
types, with EBV-1 being more prevalent in western societies. 
An immune response consisting of natural killer (NK) cells and 
EBV-specific cytotoxic CD8+ T lymphocytes controls the pri-
mary infection and reactivation that occurs in all EBV-positive 
individuals. While EBV is often found in B cells in its latent ep-
isomal form, lifelong persistence of EBV in infected individuals 
involves occasional reactivation to the lytic state, resulting in 
lyses of infected cells and the release of virus particles which 
triggers acute infection (Babcock, et. al., 1998). 
Primary EBV infections in children are usually asymptomatic 
yet can result in infectious mononucleosis (IM) development in 
50% of adolescent patients (Jenson, 1996). It was not until 1968 
that EBV was first associated with IM, followed by further re-
search which ultimately confirmed that EBV was a causative agent 
of IM. Most of the symptoms of infectious mononucleosis are at-
tributed to the proliferation and activation of T cells in response 
to infection. It is characterized by abnormally high numbers of 
circulating CD8+ T cells and B cells. Among its many symptoms, 
lymphadenopathy and lymphocytosis – abnormal numbers 
of lymphocytes in the circulating blood (Sawari, et. al., 2016) - 
acutely resemble HL. In fact, IM is occasionally misdiagnosed as 
Hodgkin’s Lymphoma due to the similarity in their symptoms and 
small biopsy specimens in the Waldeyer’s ring (WR), which may 
be difficult to differentiate (Delecluse, et. al., 2007). This similarity, 
among other factors had led researchers to suspect that one dis-
ease may derive from the alteration of the other.
According to the World Health Organization (WHO), 
Hodgkin’s lymphoma is a disorder characterized by an abnor-
mality in the lymph node’s architecture (Tzankov and Dirnhofer, 
2006). HL, also commonly known as Hodgkin Disease (HD), en-
compasses four histological subtypes, with 40% of sclero-nod-
ular type and 80% of mixed cellularity type carrying the EBV 
virus (Delecluse, et. al., 2007).  It is comprised of characteristic 
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neoplastic cells known as Hodgkin’s Reed-Sternberg (HRS) cells. 
These interspersed cells only constitute approximately 2% of 
the total tumor mass while the rest of the tumor consists of T 
cells, B cells, eosinophils, macrophages, granulocytes, and others 
(Yang, et. al., 2015). The classic Hodgkin Reed–Sternberg cells 
are large cells with two or more round nuclei. The mononuclear 
form is referred to as the Hodgkin cell (Ok, et. al., 2015). HRS 
cells communicate with other cells via cell contact dependent 
interactions, including proliferative and anti-apoptotic signals 
favoring tumor cell survival and expansion. EBV is most com-
monly associated mixed-cellularity subtype, the most common 
type of classical Hodgkin disease. 
Using data from discharge records of patients hospitalized for 
Hodgkin’s Lymphoma and/or Infectious Mononucleosis, studies 
were performed by compiling the prevalence of the disorder 
relating to age and gender. Tracking the medical history of these 
patients allowed for the determination of how many patients 
with HL have a past history of EBV/IM. B and T lymphocytes in 
blood of patients with Hodgkin’s disease, infectious mononucle-
osis, and normal controls were collected and compared. Due 
to the rarity of EBV-infected B cells in healthy virus carriers, it 
is complicated to analyze them directly (Caldwell, et. al., 1998). 
To resolve this issue, Thorley-Lawson developed a method in 
which human B cells are separated via flow cytometry, which 
works by suspending cells in a fluid and passing them through 
an electronic detector. Then, using polymerase chain reaction 
(PCR), cells are analyzed for the presence of EBV infection. 
Additionally, using, viral DNA and RNA segments from tumor 
specimens were extracted and studied via southern blot hy-
bridization with probes specific for parts of the EBV genome. 
Reverse transcriptase of RNA can also be used to identify the 
genetic sequence of specific genes (Khan, et. al., 1996). Epstein-
Barr virus’ early RNA transcripts were detected in tumor tis-
sues, via fluorescein-labeled oligonucleotides complementary to 
the RNA sequence. The fragments were then visualized under a 
microscope by tetramethyl rhodamine isothiocyanate (TRITC), 
a bright orange-fluorescent dye. Other studies have applied 
immunohistochemistry techniques, the detection of antigens in 
cells of a tissue by introducing antibodies binding specifically to 
these proteins. Finally, experiments with transgenic mice were 
useful for studying genes. Control and experimental groups of 
mice were infected with either wild type (WT) or knockout 
(KO) genes to see how they affect the course of the disease. 
Discussion
It is generally held that a lymph node is considered enlarged when 
it is larger than 1 cm, however, this can vary depending on the loca-
tion of the node and the age of the patient (Cheng and O’Connor, 
2017). Patients with a diagnosis of EBV, IM, and HD presenting with 
lymphadenopathy, were studied. The goal was to determine if and 
how these diseases are correlated. Different propositions as to 
the nature of their relationship have been reviewed.  
Using data from the Oxford Record Linkage Study (ORLS), 
a cohort of 2797 patients admitted to the hospital with an 
International Classification of Diseases (ICD) code for infec-
tious mononucleosis on the discharge record were studied. 
Patients studied were mostly ages <20-30 at the time of admis-
sion. Admission was substantially more common in males than 
in females. Those with a diagnosis of cancer either before or at 
the same time as admission for IM were excluded. Tracking the 
medical records of these patients showed an increased risk for 
the development of HD with a relatively short follow up period 
ranging from 1-7 years post discharge (Goldacre, et. al., 2008). 
A similar study looked at 233 cases of HL in children recorded 
between 1957 and 2001. Reliable data concerning the onset of 
symptoms was available in 172 cases, and in 31 of these patients, 
EBV status was unknown. Of the 141 tumors, 69 (48.9%) were 
EBV-positive (Reiman, et. al., 2003). In another unrelated cohort 
study on young adults, it was indicated that individuals who had 
a history of IM were three times more likely to develop HL 
(Jarrett, 2003). The incubation period of infectious mononucle-
osis after EBV was observed to be between 32 and 49 days. 
(Balfour, et. al., 2015). The follow up period between EBV and HL 
varied with different genders, ethnic groups, and age.
Both IM and HL typically develops in adolescence and early 
adult life. In fact, the development of IM after EBV is now con-
sidered to be a risk factor for Hodgkin’s disease. However, the 
nature of this association remains unclear. Examining blood 
samples from patients with HD, showed EBV latency in B cells. 
However, it must be noted that not all subtypes of HL harbor 
EBV to the same degree. Some data suggests that the incidence 
of EBV-positive HL may be age-related. The observed age-in-
cidence pattern suggests that risk of HD is increased among 
younger people, with a peak in incidence at 25 to 30 years and a 
second rise after the age of 45 (Khanna, et. al. 1995). An increase 
in the severity of infection in young patients leads to the devel-
opment of cancer. In one study, a similar pattern was recorded 
among aging patients suggesting that the immunologic status of 
the patient plays a crucial role in the subsequent development 
of pathologies (Mueller, 1987). Dr. Evans proposed that perhaps 
HD represent the host’s response to an EBV infection that is 
delayed until adolescence/early adulthood (1974). Another plau-
sible explanation would be that HD develops as a secondary 
response in patients with genetic susceptibility, low immunity, 
or a combination of both. 
A study was done in which a samples of B and T lymphocytes 
in patients with HD, IM, and a normal control were analyzed. They 
then compared the results of each group to the others. In over-
all counts, the number of T lymphocytes significantly exceeded 
that of B cells. However, while in infectious mononucleosis the 
count of T-lymphocytes was elevated, there was a slight reduction 
in Hodgkin’s Disease. It was also observed that in patients with 
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HD there was an increase in the number of DNA synthesizing 
lymphocytes was found when compared to normal controls. The 
ability of the disease to persist despite potential immune respons-
es against it indicates that the virus has invented pathways to 
evade the immune system. Also, untreated patients differed from 
their treated peers in their absolute lymphocyte counts; treated 
patients presented with a lower number of DNA-synthesizing 
blood lymphocytes. Cells observed in the blood of patients with 
Hodgkin’s disease and infectious mononucleosis were indistin-
guishable. Based on these findings, it was inferred that trans-
formed lymphocytes represent normal lymphocytes that have 
undergone a proliferative response signaled by tumor surface 
antigens or viral infections (Huber et. al.1975).
EBV-associated lymphoproliferative disorders (LPDs) are 
life-threatening diseases commonly found in those with a com-
promised immune system, especially children. T-cell dysfunction 
can cause development of mature B-cell lymphoma by impairing 
immune function. Additionally, a partial lytic infection plays a role 
in EBV-induced B-cell tumors. Although the main targets of EBV 
are B cells, EBV may also infect other cells, such as T cells and 
epithelial cells (Rickinson and Kieff, 2001). 
Once infected, EBV persists in rare peripheral blood lympho-
cytes for the rest of the host’s life, usually as a harmless passenger 
residing in B cells (Ohashi, et. al., 2012). Since there is limited viral 
protein expression in the latent form, EBV reduces the number 
of viral proteins that permit the recognition of infected cells by 
cytotoxic T cells. During its reactivation, which takes place during 
the lytic life cycle, memory B cells are activated and differentiate 
into plasma cells. People who have EBV can transmit the disease 
through oral secretions because the virus replicates in cells in 
the oropharynx. Generally, the number of infected lymphocytes is 
stable over time. However, in rare instances, infection of epithelial 
cells by EBV in vitro results in active replication, and consequently, 
lysis of the cell which spreads the virus to other cells (Cohen, 
2000). Although the primary site of virus replication is in the 
pharyngeal epithelium, circulating B lymphocytes can become in-
fected too, thereby generalizing the infection. In B cells, persistent 
infection can transform the cell, which may result in the develop-
ment of malignant lymphomas, especially Hodgkin lymphoma. Like 
all herpes viruses, EBV has latent and productive (lytic) phases in 
its life cycle (Niedobitek, et. al., 2001). Therefore, EBV establishes 
a life-long infection in individuals which is generally harmless un-
less the host–virus balance is upset. The latent genes which keep 
the virus in the host’s B lymphocytes induce immortalization and 
oncogenic potential too. EBV differs from other herpes viruses 
though in its capacity to transform B cells. Latent infection of B 
cells by EBV in vitro can result in a transformation to lympho-
blastoid cells, thereby leading to immortalization of the cells. In 
fact, the International Agency for Research on Cancer classified 
EBV as a group 1 carcinogen.
In more recent years, studies of tissue cultures of Epstein-Barr 
virus growth in peripheral blood lymphocytes has shed some 
light on the molecular events associated with B cell growth 
transformation and virus replication (Ohashi, et. al., 2012). Studies 
have shown that the main type of EBV-associated B-cell lym-
phoma — that is, Hodgkin lymphoma— seems to derive from 
germinal-Centre B cells, a structure found in lymphoid tissues 
that is composed of proliferating B cells. This indicates that EBV-
infected germinal-Centre B cells are at the greatest risk for ma-
lignant transformation (Küppers, 2003). After B cells are infected, 
virus–receptor interaction induces activation of the infected cells 
which enter the mitotic cycle, leading to lymphoblastoid cell lines 
(LCLs). LCL has the phenotype of an activated B-blast, expressing 
activation, adhesion, and anti-apoptosis proteins. Since lympho-
blasts resemble activated B cells both in their phenotype and 
molecular features, the virus is thought to push infected naive B 
cells into the memory state by switching the cell from the growth 
program to the default program. Normally, the latently infected 
memory cells shut down the viral expression entering the latent 
state. However, when the latently infected memory cells divide, 
they express the EBNA-1 protein causing the viral DNA to rep-
licate. Ultimately, the latent virus is reactivated and proliferates, 
spreading to other hosts. It is therefore derived that the virus can 
remain latent in the memory cells for long periods of time with-
out causing any harm to the host. A risk arises if memory cells 
are accidentally triggered into expressing the growth program 
(Thorley-Lawson and Gross, 2004).
In germinal centre B cells, a more restricted EBV gene ex-
pression pattern is detected in which only EBNA1, LMP1 and 
LMP2A proteins are expressed (Bancock, et. al., 2000). Also, 
in the germinal centre expansion causes the number of EBV-
infected B cells to increase. These germinal centre B cells then 
differentiate into memory B cells, which are the long-term la-
tent form of EBV (Babcock, et. al., 1998). In EBV-associated HL, 
viral genomes were found in their monoclonal form, indicating 
that infection of the tumor cells occurred prior to their un-
restrained replication (Kapatai and Murray, 2007). Therefore, it 
can be concluded that EBV infects mostly germinal-centre and/
or memory B cells, and some naive B cells before they begin to 
replicate and proliferate (Kurth, 2000). HRS cells are believed 
to derive from germinal-centre B cells that evaded apoptosis by 
restricting their own gene expression and by receiving survival 
signals through stimulation of CD40 (Kanzler, et. al., 1996). EBV-
positive malignant cells provide proliferative and anti-apoptotic 
signals, assisting in survival and growth of the tumor (Kapatai 
and Murray, 2007). It remains unclear however, under which 
conditions EBV+ B cells enter germinal centres and how the 
EBV-gene expression in these cells is regulated, leading to the 
development of Hodgkin’s Lymphoma.
The EBV genome consists of a linear DNA molecule that en-
codes nearly 100 viral proteins. During the lytic state, these pro-
teins regulate the expression of viral genes causing viral DNA to 
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replicate. After infecting B cells, the linear EBV genome becomes 
circular, forming an episome. In these cells, the episome can rep-
licate independently of the host cell, regulated by the cell as 
part of the normal mechanism of memory B-cell homeostasis, 
thereby establishing a latent infection (Sarwari, et. al., 2016). The 
EBV viral genome is encased within a nucleocapsid surrounded 
by the viral envelope. Entry of EBV into B cells is initiated when 
the envelope glycoprotein, gp350, binds to the viral receptor 
on the surface of the B-cell called the CD21 molecule (Kojima, 
et. al., 2010). Infection of B lymphocytes with EBV results in 
persistent latent infection and immortalization of the cells to 
perpetual proliferation. 
Studies done using flow cytometry and PCR in biopsy speci-
mens demonstrated reactive B lymphocytes (Kojima, et. al., 2010). 
Based on these studies, it was observed that EBV infects naive B 
cells. This was derived from the fact that these are the only cells 
that were observed expressing all the latent EBV genes. The naïve 
EBV-infected B cells then undergo an expansion phase, thereby 
making use of normal B-cell differentiation pathways to establish 
a lifelong persistence in the B-cells. When tracking the primary 
infection of naive or memory B cells, Latent Membrane Protein 
1 (LMP1) and Latent Membrane Protein 2A (LMP2A) were both 
detected which suggests that they provide the signals for anti-
gen-independent replication in the germinal centre (Macsween 
and Crawford, 2003). In most HD cases the neoplastic cells are 
derived from B-cells as indicated by a sequence analysis of the im-
munoglobulin V region genes revealing mutations. In some cases, 
nonfunctional genes have been detected by stop codons in their 
sequence. Another study concluded that the site of persistence of 
EBV within the body must be the resting memory B cells based 
on the observation that “shedding of EBV from the oropharynx is 
abolished in patients treated with acyclovir whereas the number 
of EBV infected B cells in the circulation remains the same as 
before treatment” (Cohen, 2000) . 
In one important study, biopsy specimens of Hodgkin’s tumors 
revealed a 40-50% proportion of EBV positive tumors (Hjalgrim, 
et. al., 2003). Using southern blot hybridization viral RNAs (re-
ferred to as EBERs) and DNA fragments of EBV were detected 
in 20-25% of specimens. Likewise, patients with Hodgkin’s disease 
were often found to have higher titers of antibody to EBV pro-
teins before or with the onset of lymphoma, suggesting a correla-
tion between the two. Immunohistochemistry was performed on 
biopsy specimens from patients with HD. Using the immunop-
eroxidase technique, LMP-1-antibody was applied to the tumor 
section. Epstein-Barr virus early RNA transcripts (EBERs) were 
detected in tumor tissues via fluorescein-labeled oligonucleotides 
complementary to EBER (Alexander, et. al., 2000). The fragment 
was visualized under a microscope by tetramethyl rhodamine iso-
thiocyanate (TRITC), a bright orange-fluorescent dye. 
One study went so far as to suggest that EBV infection is 
actually the beginning of tumor development. EBV infection 
permanently induces B-cell activation, ultimately leading to un-
controllable cell division. EBV-positive HRS cells exhibit a type of 
virus latency and express different combinations of EBV nuclear 
and latent membrane proteins. In the first type, only EBNA-1 and 
EBER are expressed, while in the second, EBNA-1, LMP-1, LMP-2, 
and EBER are expressed. In the third pattern, all the latency genes 
are expressed. An additional pattern of latency was found in B 
cells obtained from the peripheral blood of patients with a past 
infection of EBV, in which only EBER and LMP-2, and in some cases, 
EBNA-1 have been detected (Mandage, et. al., 2017). Epstein-Barr 
virus nuclear antigen 1 (EBNA1) is a protein-encoding gene that is 
expressed in all EBV malignancies. EBV latent membrane protein 
1 (LMP1) is a gene which induces cellular activation and prolifer-
ation while inhibiting apoptosis through expression of the B-cell 
activation markers, CD23 and CD40 (Kapatai and Murray, 2007). 
EBV latent membrane protein 2 (LMP2A) expression enhances 
cell survival and inhibits normal B cell transduction. LMP2A does 
this by mimicking an activated B cell receptor (BCR), replacing 
the signals that are normally supplied to the B cells and suppress-
es cell immunity (Caldwell, et. al., 1998). Expression of LMP-2 in 
transgenic mice allowed B cells to survive even in the absence of 
normal B-cell–receptor signaling. It was also noticed that during 
primary infection, many EBV-positive cells appear to express all 
latent genes associated with viral-driven lymphoproliferative dis-
eases. (Steven, 1997).
BLF1 is a lytic cycle protein found to be involved at both initial 
and late stages of viral infection. It is involved in DNA replication, 
repair, and ultimately, immune avoidance. A recent study on EBV 
BPLF1-knockout mice demonstrated that the BPLF1-knockout 
mice were approximately 90% less likely to be infectious than 
wild-type (WT) mice. Without the BPLF1 there was a reduction 
in transformed human B cells. Overall, humanized mice infected 
with BPLF1-knockout virus survived longer than mice infected 
with the WT virus. Additionally, tumors were formed in 100% of 
mice infected with WT EBV but in only 25% of mice infected 
with BPLF1-KO virus (Whitehurst, et. al., 2015). These findings 
suggest that BRLF1 is required for activation of lytic replication 
and expression. Additionally, ten million cells were injected with 
either WT or BPLF1-knockout virus and after labeling with B- cell 
antibody, the total percentage of B-cells in each group was deter-
mined using flow cytometry. There was rarely B-cell outgrowth 
in cells infected with delta BPLF1 virus, suggesting that BPLF1 is 
necessary for immortalization of B-cells. This provides evidence 
that BPLF1 plays a role in B-cell transformation, and therefore 
contributes to EBV’s oncogenic role in cells. As of now, the mech-
anism by which BPLF1 inhibits these processes is still unknown.
Another EBV lytic gene expressed during infection of B cells 
is BALF1. This gene is known for its anti-apoptotic properties 
leading to B cell transformations. BARF1 is a secreted protein 
that blocks Colony Stimulating Factor 1 (CSF-1) signaling, func-
tioning as a trap to block the action of the cytokine. This helps 
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the virus evade the host’s immune system during acute EBV 
infection or reactivation of virus from latently infected cells 
(Ohashi, et. al., 2012).
Since the Epstein-Barr virus is associated with an increas-
ing number of diseases, including infectious mononucleosis 
and Hodgkin’s disease in both immunocompetent and immu-
nocompromised individuals (Yang, et. al., 2015), some research 
suggests that this correlation may be due to genetic factors.  The 
SH2D1A gene provides instructions for the synthesis of a pro-
tein called signaling lymphocyte activation molecule associated 
protein (SAP). SAP interacts with other proteins to activate 
signaling pathways that are involved in the control of immune 
cells. These cells are important in that they help control immune 
reactions and signal apoptosis. The SH2D1A gene is expressed 
primarily in T and NK cells as well as in some B-cells (Parolini, 
et. al., 2002).  Therefore, a defective gene causes an alteration 
of these lymphocytes which most likely results in the inability 
to control EBV infected cells. To test the possibility of SH2D1A 
gene involvement in the pathogenesis of Hodgkin’s disease, a 
SH2D1A gene analysis was studied in patients with a history 
of EBV and EBV- related diseases like Hodgkin’s lymphoma. A 
group of healthy patients was also analyzed to serve as the 
control group. Results showed an alteration in the 5′ region of 
the SH2D1A gene in the majority of patients with a diagnosis 
of mononucleosis, of which 25% went on to develop malignant 
B cell lymphomas.  This indicates that there may be a genetic 
correlation between EBV and HL.  
The SH2D1A gene is located on the X-chromosome, which 
may contribute to the fact that males are more prone to de-
velop Hodgkin’s Lymphoma after EBV (Robinson, 1976). Unlike 
females, males do not have another X chromosome to counter-
act the mutated gene. In one study 23 patients with HD, con-
sisting primarily of males, had their X-chromosomes analyzed. 
Analysis by reverse transcriptase polymerase chain reaction 
(RT-PCR) found EBV genome or protein in 16 of 23 tumor sam-
ples. The risk of contracting Hodgkin’s disease was found to be 
significantly increased in males who had a positive reaction to 
the Paul-Bunnell test, a heterophile antibody test that screens 
for IM.  (Rosdahl, et. al., 1974). Notably, anti-EBNA-1 antibody 
levels showed 43% heritability. 
In a study on transgenic mice, EBNA1 and LMP1 proved to play 
a key role in lymphoma development. EBNA1 is essential during 
cell division ensuring equal partitioning of a cell, while contribut-
ing to immortalization of cells by allowing for the maintenance of 
newly synthesized plasmids. The central part of EBNA1 consists 
of Gly-Ala repeats, which are believed to block the processing of 
proteins by proteasomes. This functions in inhibiting immune rec-
ognition and apoptosis of infected cells because viral proteins are 
normally broken down by proteasomes to peptides for recogni-
tion by cytotoxic T cells (Kojima, et. al., 2010). In turn, the infected 
cells that accumulate have oncogenic potential. During recovery 
from the acute phase, CD8+ T cells return to normal levels and 
antibodies develop against EBV nuclear antigen-1 (Balfour, et. al., 
2015). LMP-1 mimics CD40 and activates the nuclear factor-kap-
pa B, promoting cellular proliferation (Ok, et. al., 2015). LMP-1 
also induces BCL-2 and cyclin-dependent kinase 2, activating cell 
replication and inhibiting cell death. 
Conclusion 
Although an association has been identified, the pathogenetic 
role of EBV in these diseases is still unclear (Flavell, et. al., 2000). 
Likewise, the exact factors responsible for cancer development 
remains a matter of debate. Researchers are limited in their 
investigation of the relationship between viral infection and the 
development of cancer due to the lack of small animal mod-
els that can accurately reproduce the biology of EBV.  Yet over 
the past few years, some important advances have been made 
in understanding the biology of EBV and its role in the devel-
opment of EBV-associated lymphomas. The observation that a 
significant proportion of cases of HL contain the Epstein–Barr 
virus genome strongly suggests that the virus contributes to the 
development of the lymphoma. Significant progress has been 
made in understanding the functions of EBV-encoded genes in 
B cells (Sarwari, et. al., 2016) and viral protein functions. Several 
key issues remain to be clarified. 
Additionally, whereas EBV infection in tumors has been firmly 
established by several independent research groups, its associ-
ation remains controversial. Many still believe that it is by coin-
cidence, mainly due to the fact that the origin of Hodgkin’s can 
be regarded as heterogeneous because only half of the cases 
are known to be associated with EBV (Tamayose, et. al., 2004). 
Others maintain that Hodgkin lymphoma is a multi-factorial 
disease which depends on both biological and environmental 
factors and therefore, a specific causative agent cannot be pin-
pointed (Huang, et. al., 2012). 
There is no current approved treatment for EBV. Ongoing re-
search is currently trying to develop vaccines to prevent or treat 
these conditions. This is a difficult task due to a lack of an animal 
model to study the pathogenesis of the disease. It is further com-
plicated by the fact that the number of virus-infected cells in the 
body would amplify and establish latency before immune mech-
anisms develop. A future approach would be to synthetize ther-
apeutic vaccines designed to generate specific immune attacks 
for the latent virus. Adoptive immunotherapy and EBV-specific 
pharmacologic therapies offer promise for future treatment. 
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Abstract
Inflammatory Bowel Disease encompasses two diseases, Crohn’s Disease and Ulcerative Colitis.  During the last 70 years the 
evolving of diet in the industrialized countries has led to the utilization of foods that have been processed rather than those in 
their more natural original state .  This increase in the processing of foods has been correlated with the more recent occurrence 
of metabolic diseases such as Inflammatory Bowel Disease.  Patients suffering from this problem exhibit lesser amounts of an-
ti-inflammatory bacteria such as Roseburia and Faecalibacterium and increased amounts of pro-inflammatory bacteria Escheria 
and Fusobacterium.  Since diet directly alters the composition of the gut biome, this review aims to define the role of diet in the 
pathogenesis and management of Inflammatory Bowel Disease.
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Introduction 
What is Inflammatory Bowel Disease?
Inflammatory Bowel Disease (IBD) encompasses two diseases, 
Crohn’s Disease (CD) and Ulcerative Colitis (UC). CD is char-
acterized by inflammation of the digestive tract anywhere from 
mouth to anus. In CD inflammation may reach through many 
layers of the walls of the gastrointestinal tract causing severe 
tissue damage. However, UC occurs when there is an inflamma-
tion of the colon and the rectum. In UC, the inflammation only 
affects the innermost layer of the lining of the colon. There are 
many symptoms for CD and UC. Some of the more common 
ones include diarrhea, abdominal pain, cramping, blood in stool, 
reduced appetite, unintended weight loss and severe bowel con-
striction (Conners, et al., 2017). Many times, inflammation is so 
severe that the intestinal tissue is damaged beyond repair. In the 
event of such inflammation the damaged tissue is removed via 
colectomy. IBD tends to affect individuals of all ages. However, 
IBD is most commonly found in individuals at a young age, inter-
fering with education, work ability, social interaction and basic 
quality of life. Therefore, researchers feel compelled to find res-
olutions for this disease (Lovasz, et.al., 2013).
How the Diet has Changed
Over the centuries the western diet has changed incredibly. In 
the traditional diet, food was produced and consumed shortly 
after harvest. In contrast, much of today’s food supply is pro-
cessed, modified, and transported over great distances before 
being ingested. In recent years, the western diet has been dom-
inated by an increased consumption of refined sugars, omega-6 
polyunsaturated fats and fast food, in addition to a deficiency 
in fruits, vegetables and fiber. The western diet is prevalent in 
industrial countries such as the United States, Canada, Western 
Europe, Australia, and New Zealand, and has been spreading 
and reaching newly developing countries as well (Lovasz, et.al., 
2013). This change in diet has led to the worldwide development 
of many metabolic diseases, such as IBD. (Ng, 2013) (Moschen, 
2012). Recent studies indicate that the incidence rate of IBD in 
developing industrial countries has been increasing in the past 
50 years. This increase suggests that IBD may be triggered by an 
environmental factor (Martinez & Chang, 2013). Although many 
studies have been done, there is still no definite pathogenic 
pathway nor cure for this disease.
Recent research suggests that diet is the key environmen-
tal risk factor in IBD pathogenesis. IBD is an intestinal disease 
and is associated with a dysbiosis in the gut microbiota, the 
microbe population found in the intestine (Reddavide, et al., 
2018).  In general, IBD patients have been found to have lower 
amounts of anti-inflammatory bacteria such as Roseburia and 
Faecalibacterium and have increased amounts of pro-inflamma-
tory bacteria Escheria and Fusobacterium (Aleksandrova, et.al., 
2017). Many studies have shown that one’s diet directly alters 
microbe composition, making diet a pivotal risk factor of IBD. 
Moreover, changes to the traditional diet of newly industrialized 
countries can be linked to the increasing incidence of IBD. The 
purpose of this review is to define the role of diet in the patho-
genesis and management of IBD.
Methods
Critical analysis of peer reviewed articles and clinical research 
papers were used to write this review paper. Articles were ob-
tained from the Touro College online library in order to deter-
mine the relationship between diet and IBD.
Discussion: 
IBD and Gut Microbes
The gut microbiome is an ecosystem, often referred to as a 
Super Organ (Dolan, 2017). The microbes live in a symbiont 
relationship with the host, performing beneficial tasks such as 
nutrient production, development and maturation, regulation 
of immune system and preventing the growth of harmful mi-
croorganisms (Aleksandrova, et.al. 2017). Dysbiosis, which is an 
alteration to the gut flora, can cause disruption to these vital 
tasks. Several studies show that IBD is correlated with altered 
composition of gut microbes in the intestines. 
Interestingly, Studies have shown, that there is an age-related 
variation of IBD onset with three distinct stages. Early onset is 
less than 10 years of age, with a peak onset at 15-30 years old, and 
late onset cases occur at 60 years old. These changes correspond 
to the change in the microbiome’s stability and diversity. Early 
life is associated with a microbiome of minimal complexity and 
stability and can be affected by diet change, illness and puberty. 
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As individuals reach adulthood, the microbiome stabilizes and 
shows improved resilience, but the composition may be altered. 
Correspondingly, decreased stability is often observed in the el-
derly (Kostic, et.al., 2013). Considering this, the microbe compo-
sition and stability in the gut is a key factor in IBD progression.
One role of the microbiota is to maintain a healthy mucosa 
by the production of anti-inflammatory interleukins. This is the 
production of SCFA- short chain fatty acids such as butyrate, 
succinate, lactate, phenols, thiols, and indoles (Reddavide, et al., 
2018). These SCFA act as energy for colonocytes which protect 
against inflammatory responses (Frank, 2007). Patients suffer-
ing from IBD have reduced levels of beneficial SCFA producers 
Bacteroidetes, Lachnuspiraceace, and Ruminococcaceae (Martinez & 
Chang, 2013). An Additional study shows that IBD patients show 
reduced levels of several other SCFA producing bacteria such as 
Calibacterium praunsnizti and Roseburia (Dolan, 2017). This shows 
a direct link between dysbiosis and IBD. 
Another task of the gut microbiome is to maintain the mucus 
layer of the colon and the small intestine. If the mucus layer is in-
tact the gut flora will not directly interact with the epithelial cells 
and inflammation will not occur. However, there is an adherent 
invasive strain of E . coli that is found in abundance in IBD patients 
compared with controls. These invasive bacteria can potentially 
invade epithelial tissue and induce granuloma formation during 
inflammation.  A second group of invasive bacteria Fusobacteria 
is found in abundance in the colon mucosa of IBD patients. 
Fusobacterium varium have been found to cause colon mucosa 
erosion, indicating the possibility of the influence of Fusobacterium 
varium on the pathogenesis of IBD (Kostic, et. al. , 2013). 
Bile Acid signaling is another point where host, microbe and 
even dietary factors all come together. Bile acids assist in diges-
tion and emulsification of fats to be absorbed in the intestines. 
These bile acids are made in the liver from cholesterol. After 
undergoing conjugation to glycine or taurine, the bile acids are 
released in to the digestive tract. In the intestines, deconjuga-
tion of bile acids occurs through Bile Salt hydroxylase (BSH) 
enzymes, making the bile acids functional. These BSH enzymes 
are made exclusively by bacteria, making the bile acid composi-
tion in the intestine dependent on the microbiota composition. 
The two products of bile acid metabolism act as ligands for 
FXR (Farnesoid X receptor) and TGR5 (G protein-coupled bile 
acid receptor 1), which act as signals for anti-inflammatory and 
barrier function. It was found that IBD patients have increased 
levels of conjugated bile acids compared to the control group, 
making these patients prone to inflammation. Furthermore, 
when bile acids are increased in the gut, it can promote growth 
of pathobionts such as Bilophila Wadsworth, which is known to 
induce inflammation (Dolan, 2017). 
On the other hand, many microbes perform protective tasks 
when enriched in the host. Bacteroides and Clostridium species 
have been shown to cause expansion of T-cells and reduce 
inflammation. Additionally, many bacteria can reduce intestinal 
inflammation by regulating nuclear factor (NF)κB activation. 
Faecalibacterium praunsnizti has anti-inflammatory properties 
and is underrepresented in patients with IBD. Many species, such 
as Bifidobacterium, Lactobacillus and Faecalibacterium, protect the 
host from mucosal inflammation by down regulating inflamma-
tory cytokines or stimulating IL-10 anti-inflammatory cytokines 
(Kostic, et. al., 2013). Lastly, intestines rich in Bacteroidetes are 
shown to initiate host responses that protect the host from 
lethal infectious colitis (Brown, et. al., 2012).  
Due to this connection between IBD and dysbiosis, there 
are many current treatments for IBD that are directed at the 
microbiota. Many antibiotics such as ciprofloxacin, metronida-
zole, the combination of both rifaximin and anti-tuberculous 
regimens are used to treat IBD (Nitzan, et.al., 2016). Normally 
antibiotics may cause thinning of the mucus layer, weakening the 
barrier function, leading to increased gut infections. Additionally, 
antibiotics tend to cause an increase in E. coli composition in 
the gut, which is a distinctive feature in intestinal inflammation. 
However, studies show that brief exposure to antibiotics causes 
slight changes to the microbiota in IBD patients that provides 
relief from symptoms. Alternatively, repeated exposure of the 
same antibiotic causes persistent changes to the microbiota 
leading to infection (Kostic, et.al., 2013).  Due to this contro-
versy of antibiotics, in the last few years methods to repopu-
late the gut with healthy beneficial microbes has been gaining 
popularity as a potential treatment for IBD. Evidence shows 
that Fecal Microbiota Transplantation (FMT) can be effective in 
replenishing a healthy microbiota. FMT, also known as a stool 
transplant, is the transplantation of gut microbes from the stool 
of a healthy individual into the recipient. There has been a high 
success rate for FMT in many other metabolic diseases such 
as relapsing C. difficile infection. Therefore, researchers are con-
sidering FMT for other gastrointestinal illnesses such as IBD. 
Additional studies are needed to determine the outcome of 
FMT on IBD patients (Kostic, et.al., 2013). 
It is now clear that IBD is inherently linked with dysbiosis. 
There are many factors that can cause dysbiosis such as genet-
ics, immune function, and diet. Genetic susceptibility is the most 
obvious factor. IBD patients carrying a mutation in a NOD2 
related gene, have increased numbers of mucosa adherent bac-
teria, as well as significant alterations in bacterial composition 
(Kostic, et. al., 2013). Studies have shown that CD is common in 
the Ashkenazi Jewish population. Many studies were done using 
large families of Ashkenazi Jews to determine a genetic vari-
ant cause to CD.  One study found the haplotype 268SJW1 on 
chromosome 16 to contribute to the risk of CD in Ashkenazi 
Jews (Sugimura, 2003). Although genetic susceptibility cannot be 
ignored, due to the increasing incidence rates of IBD, research-
ers believe that environmental factors are the core triggers.
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Dietary Factors effecting the Microbiome
Diet is suspected to be the prime contributor to the patho-
genesis of IBD. Dietary composition has been proven to be 
associated with intestinal inflammation by directly or indirect-
ly modifying the gut microbiome (Reddavide, et al., 2018). So, 
current research is aimed at examining how diet changes the 
microbiome and how these changes affect the host, in order 
to determine foods that can cause or prevent inflammation 
(Kostic, et.al., 2013).
In a study done, subjects were put on a western-style diet for 
one month and showed a 71% increase in plasma endotoxins. 
The western diet is characterized by a high fat diet and therefore 
may cause endotoxemia by causing changes in the intestinal bar-
rier function or microbiota composition (Pendyala, et.al., 2012). 
Another study showed that mice fed a high fat diet were associated 
with endotoxemia and systemic inflammation. These mice showed 
lowered amounts of Bifidobacterium spp, indicating that this species 
of bacteria have anti-inflammatory properties (Cani, 2007).
Variations in long term diet patterns change the ratios of 
Bacteroides, Prevetolla, and Firmicutes. However, modifications in 
short term diets have no significant influence. It has been deter-
mined that enriched protein and animal fat diets, common in the 
western diet, favored Bacteroides. Diets rich in carbohydrates, 
such as in agrarian societies, favored Prevetolla (Wu, 2011). 
Switching to a high fat diet causes a decrease in Bacteroides and 
an increase of Firmicutes and Proteobacteria (Hildebrandt, 2009). 
It has been proven that protein rich diets increase enzymes that 
produce toxic metabolites which trigger inflammatory response 
(Brown, DeCoffe, et.al., 2012). 
Another microbe often associated with IBD inflammation 
is Bilophila Wadsworth, a sulfite producing bacteria. In a recent 
study when mice were fed a milk fat enriched diet, it led to 
a series of reactions that ultimately led to an abundance of 
Bilophila Wadsworth. Although there is no precise mechanism for 
how it causes inflammation, there are many hypotheses (Frank, 
2007). Furthermore, an interesting study concluded that refined 
dietary glucose intake can change microbe composition and in-
crease intestinal inflammation (Whitehead, 2011).  A strict Vegan 
or Vegetarian diet led to a significant reduction in Bacteroides 
spp, Bifidobacterium spp, and the Enterobactericeae which helps 
manage inflammation of IBD (Enck, 2011). 
A further connection between diet, microbes, and host in-
flammation has been discovered through studies of the intes-
tinal function of the aryl hydrocarbon receptor (AhR). AhR is 
a nuclear receptor that activates certain metabolic genes. AhR 
also plays a key role in adaptive immunity through the regula-
tion of T-cell activity. IBD patients have a decreased expression 
of AhR which may cause pro-inflammatory immune activation 
conditions. It has been discovered that certain gut microbes can 
produce AhR agonists. IBD patients contain less amounts of the 
microbes necessary to produce these agonists. An important 
dietary source of AhR ligands are found in cruciferous vegeta-
bles such as cauliflower, broccoli, brussels sprouts and bok choy. 
This may explain why these vegetables have a protective effect 
on IBD risk (Dolan, 2017). 
One major role of the microbiota is to act as an immune sys-
tem of the host. The gut flora protects the host from pathogens 
by maintaining the integrity of the intestinal mucosa. Dysbiosis 
can cause a disruption in the intestinal mucosa and allow access 
for pathogens which can lead to reactions which cause inflamma-
tion and eventually tissue damage. Many studies were conducted 
to determine the influence of micro and macro nutrients on im-
munity. Many micronutrients are essential for immunonutrition 
such as vitamins A, C, D, E, folic acid, zinc, and iron (Reddavide, et 
al., 2018). Deficiencies in vitamins A and D may reduce function 
of natural killer cells, while supplemental zinc and vitamin C 
can increase their activity. Vitamin D is important in intestinal 
function for it is known to suppress microbial invasion into the 
epithelium. 82% of IBD patients have been found to have vitamin 
D deficiencies which have been linked to a weakened epithelial 
barrier. Although studies have been done to determine the ef-
fects of vitamin D supplements on IBD patients, more research 
is needed. Furthermore, Iron deficiencies have been associated 
with faulty T cell response and weakened cytokine production. 
However, iron supplements have been shown to have a negative 
effect on IBD patients by increasing an individual’s susceptibili-
ty to infections. It is evident that micronutrients can affect the 
immune system thereby causing dysbiosis and the onset of IBD 
(Aleksandrova, et.al., 2017). More research is needed to recog-
nize optimal nutrient levels and therapeutic options.
These findings support the fact that the microbiota is di-
rectly related to food quality. Diet influences the composition 
of the microbiota and thereby controls IBD pathogenesis. The 
current diet is significantly different than the diet of previous 
generations when the prevalence of IBD was not as widespread. 
Countless experiments were performed to see the effects of 
diet on IBD. Dietary factors can have a negative effect on IBD 
and increase inflammation, or they can have a protective or even 
healing effect on patients with IBD.
Dietary Risk Factors of IBD
Refined and processed carbohydrates are risk factors for IBD, 
but complex carbohydrates, such as fruits, vegetables, or fibers 
can help manage IBD. A diet high in animal protein was cor-
related with a 3.3-fold increased risk in IBD (Reddavide, et al., 
2018). Individuals that consumed milk products including milk, 
yogurt and cheese, had a lower chance of developing IBD. This 
suggests that dairy intake has no risk effect on IBD and may 
even have a protective effect (Malavia, 2017). Many studies were 
done on the effects of fat intake on IBD. Although it is known 
that a typical high fat western diet has a negative effect on IBD, 
it is unclear which specific fats cause that.  One study showed 
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that an increase in poly-unsaturated fatty acids was positively 
associated with IBD (Parekh, 2015). Another study concluded 
that long term intake of trans-unsaturated fatty acids is associ-
ated with a trend towards IBD. Evidence shows that excessive 
consumption of omega-6 poly-unsaturated fatty acids increases 
the risk of IBD, while consumption of omega-3 poly unsaturated 
fatty acids is associated with a decrease in one’s risk for the 
onset of the disease (Brown, et. al., 2012). 
Dietary Management in IBD
Interestingly, research has shown that the Mediterranean Diet, due 
to its unique balance of fat, is directly correlated with decreased 
inflammation. The Mediterranean Diet (MD) is characterized by 
fruits and vegetables rich in fiber, vitamins, and antioxidants, whole 
grains, and nuts, as well as olive oil and oily fish that are high in 
poly and mono unsaturated fatty acids. Each item in the diet pro-
vides benefits to patients with IBD (Serra-Majem, 2009).
Legumes, a major part of the MD, contain soluble fibers that 
do not aggravate the gut microbes. Furthermore, legumes tend 
to have a prebiotic action and promote the growth of beneficial 
SCFA producing microbes which protect the gut mucosa. Fruits 
and vegetables have a naturally high fiber content and therefore 
using a juicer to extract the essential vitamins and minerals 
showed best results when treating IBD patients. Recent studies 
claim that olive oil has ani-inflammatory effects. This is due to the 
synergic action of its oleic acid with other antioxidant molecules. 
Grains that were proven to have the most beneficial effect were 
unmodified grains. These grains have low immunogenic impact 
and do not cause inflammation in the gut mucosa. Bluefish, which 
is popular in the MD, is shown to have anti-inflammatory effects 
due to its omega-3 fats EPA and DHA (Reddavide, et al., 2018). 
An alternative diet that has shown promise in IBD manage-
ment is the Specific Carbohydrate Diet (SCD). This diet works 
with the hypothesis that patients with IBD can not break down 
disaccharides and amylopectin. Large amounts of disaccharides 
can lead to an over growth of microbes and cause IBD relat-
ed symptoms. Therefore, the SCD is a strict monosaccharides 
diet excluding disaccharides and most polysaccharides. The diet 
includes vegetables with a high amylose to amylopectin ratio. 
The real potential for this diet is in the maintenance of IBD 
patients in remission to help maintain a healthy gut microbiome 
(Reddavide, et al., 2018). A similar diet the FODMAP – Low 
Fermentable oligosaccharide disaccharide monosaccharide and 
polyols diet also showed significant improvement of symptoms 
in patients with IBD (Dolan, 2017). Although these findings 
clearly define the effects of diet on IBD, the role of diet does 
not stop there. 
Dietary Factors and Epigenetics
New emerging evidence points to epigenetics as a major com-
ponent of IBD pathogenesis. Epigenetics is the study of heritable 
changes in gene expression that do not involve changes in the 
actual DNA sequence. This leads to a change in phenotype with-
out a change in genotype. Epigenetic modifications, such as his-
tone modifications, influence DNA accessibility and chromatin 
structure, thereby effecting the regulation of gene expression. 
The body uses epigenetic modifications as natural ways to con-
trol gene expression as needed throughout one’s life. However, 
epigenetic changes can also be induced by external factors in-
cluding age, the environment, lifestyle, and disease state. Dietary 
factors have been shown to contribute to IBD in an indirect 
manner via epigenetics (Reddavide, et al., 2018). 
Over time, researchers have discovered new methylation 
patterns emerging for IBD. Many therapeutic studies were done 
to try to counteract this methylation using drugs and other 
processes. However, researchers found it difficult to pinpoint 
the methylation in specific tissue and to predict drug response 
in clinical trials so other strategies were considered. Dietary 
factors have been known to alter epigenetics which can influ-
ence an immune response that can potentially offset inflam-
mation. Therefore, scientists looked at dietary components 
for a solution to IBD methylation patterns. It was discovered 
that secondary plant metabolites, such as polyphenols, have 
been demonstrated to inhibit DNA methyltransferase activity. 
Furthermore, gut microbiome has been shown to alter host 
histone acetylation and methylation in human colon tissues. 
Interestingly, SCFA, which is generally produced from microbial 
fermentation of fibers, is shown to be important in epigenetic 
regulation of inflammatory responses. It was determined that 
a lack of SCFA can disturb chromatin effects. This deficiency of 
SCFA can be a result of a diet low in fiber or a decrease in ben-
eficial SCFA producing bacteria. As mentioned previously, IBD 
patients have been found to have low amounts of Bacteroidetes, 
Lachnuspiraceace, Ruminococcaceae, Calibacterium praunsnizti, and 
Roseburia, SCFA producing bacteria, making IBD patients sus-
ceptible to epigenetic changes which can lead to inflammation. 
(Reddavide, et al., 2018).
Other Environmental Factors
Although diet has been presumed to be the primary trigger for 
IBD, there are many other environmental factors that can prompt 
IBD symptoms. Smoking, and stress are such factors that have 
also been shown to influence IBD pathogenesis. Interestingly, 
Smoking has been found to be negatively associated with UC 
but positively associated with CD. Patients who did smoke 
only developed UC after they ceased smoking. Additionally, 
male UC patients who smoked during disease progression, re-
ported reduced symptoms and had lower hospitalization rates 
compared to non-smokers. Increased colectomy rates were 
seen in non-smokers and ex-smokers than in current smok-
ers. Also, reduced rates of relapse were seen in patients who 
began smoking after the onset of UC. On the other hand, many 
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studies show an increased risk of CD in smokers compared to 
non-smokers. There is a 34% increased relapse rate for CD in 
smokers. Furthermore, severe lesions at the anatomic sight have 
developed more in smokers than non or ex-smokers in CD 
patients (Thomas, et.al., 2000).  
There are many theories for the possible mechanism of the 
influence smoking has on IBD. Firstly, due to the interrelationship 
of gut microbes and immunity, researchers studied how smok-
ing influences the immune system. Studies show that changes in 
T cells, such as increased levels of suppressor OKT8+ cells and 
a decreased ratio of OKT4+ to OKT8+ cells have been seen 
in heavy smokers. Remarkably, these changes revert to normal 
range once a patient terminates smoking. The low levels of IgA’s 
in the saliva and intestinal secretion of smokers dictates an addi-
tional immune effect. The IgA antibody is a vital component of se-
cretions that lubricate the mucosal surfaces which act as the first 
line of defense in the immune system. Therefore, patients who 
smoke will already have a weakened immune system. Another 
possible mechanism involves the inflammatory pathway. Nicotine, 
a substance found in most cigars and cigarettes, is known to 
effect cytokine production in the body, specifically by reducing 
pro-inflammatory cytokines. Also, certain eicosanoids, which are 
correlated with inflammation, are seen in decreased amounts in 
smokers. This may be the cause to the negative effect of smoking 
on UC patients. Nevertheless, smokers show lower levels of two 
interleukins, IL-1β and IL-8, which help regulate inflammatory 
response. Lastly, smoking may also influence IBD via intestinal 
mobility. One major symptom of IBD is issues with bowel move-
ment and defecation. It has been found that nicotine can affect 
the intestinal motility at many sites. Nicotine relaxes the smooth 
muscles of the intestine and therefore reduces contractile activity 
during bowel movement (Bhatti, 1997). These mechanisms por-
tray the direct influence that smoking may have on IBD. 
Another environmental factor that researchers have discov-
ered to be effective in the pathogenesis of IBD, is stress related 
influences. In earlier years IBD was classified as a psychosomatic 
disorder. Although this classification had been long disproved, it 
does represent the deep relationship between stress and IBD. 
In general, stress acts as a threat to an organism’s homeostasis. 
Therefore, the body will exert mechanisms to maintain equi-
librium in the face of any stress. There are two interconnected 
pathways in the body that govern stress related responses; the 
HPA axis - hypothalamic pituitary adrenal axis and the ANS - au-
tonomic nervous system. The pathway of the HPA axis begins 
when stress stimulates the release of corticotropin releasing 
hormone from the hypothalamus. This causes the release of ad-
renocorticotropic hormone from the anterior pituitary gland 
which then stimulates the secretion of cortisol from the adre-
nal cortex. Cortisol then travels throughout the blood stream 
causing changes all around the body to help deal with stress. The 
pathway of the ANS involves the stress induced activation of 
pontomedullary nuclei, which control autonomic responses. As 
a response to stress, adrenaline and noradrenaline are released 
from the adrenal medulla via the stimulation of the sympathetic 
nervous system. Furthermore, The HPA axis and ANS are key 
modulators of the rich nerve supply of the gut, the ENS – enteric 
nervous system. The ENS is composed of 100 million neurons 
that regulate functions of the gastrointestinal tract. The term 
“Brain-Gut Axis” refers to this complex network of neurons of 
the HPA axis, ANS, and ENS (Mawdsley, 2005). 
The actual pathway of the Brain-gut axis response to stress is 
complex. Various interconnected activities occur in both the gut 
and around the body in response to stress that can lead to inflam-
mation. Specifically, in the gut, in response to stress, inflammatory 
cytokines, SCFA, and microbial products can alter the ANS and in 
turn lead to the secretion of cortisol and adrenaline. Also, under 
stress, the gut microbiota and mast cells can release various 
chemicals such as histamine or serotonin which are known to 
impair the intestinal secretion and intestinal mucosa, which can 
lead to inflammation. There are many stressors that can affect the 
intestinal mucosa’s permeability, making a host predisposed for 
infections and inflammation (Brzozowski, 2016).
Due to this intimate correlation between the nervous system 
and the gut, it is obvious that stress can influence the patho-
genesis of IBD. Chronic heightened stress has been determined 
to have an important role in predicting the relapse of IBD in 
patients in remission (Mawdsley, 2005). Also, mice that were 
induced with depression demonstrated an increase in inflam-
mation which was modulated by an increase in pro-inflamma-
tory cytokines secreted by macrophages (Brzozowski, 2016). 
Although researchers have not determined an absolute direct 
pathway for the control of stress on inflammation, there are 
many suggestions. Many propose that patients with IBD have 
altered HPA axis functioning, which may explain the relation 
of stress to IBD symptoms. Interestingly, cortisol, which is 
released under stress, is known to have anti-inflammatory ef-
fects. However, in patients with UC, levels of cortisol showed 
no correlation to the levels of inflammatory cytokines. On the 
other hand, others hypothesized that due to the high levels of 
inflammatory cytokines in the blood of active IBD patients, the 
response of the HPA axis and thereby the response of cortisol 
may be dampened. Likewise, stress is known to impact gastro-
intestinal motility, and water and ion secretion. While these are 
non-inflammatory effects, they may contribute to the non-in-
flammatory symptoms of IBD patients (Mawdsley, 2005). The 
above mechanisms demonstrate the correlation between stress 
and IBD, making psychological factors a key influence in the 
pathogenesis of IBD. 
Conclusion
The intestinal microbiota performs vital jobs in host metabo-
lism making its composition vital to the host’s health. Dysbiosis, 
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which is found in IBD, can be caused by several different factors. 
While genetics and other environmental factors cannot be ig-
nored, an altered microbiota resulting from diet-induced dysbi-
osis may also be a factor that contributes to the inappropriate 
inflammatory responses that occur. As our understanding of the 
microbiota continues to grow, promoting microbes to prevent 
or control inflammatory-mediated diseases through diet may 
represent an exciting therapeutic avenue.
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Abstract
Anorexia Nervosa (AN) is a psychiatric disorder characterized by significantly low body weight and over-evaluation of weight and 
shape in self-identity . The complex etiology of Anorexia Nervosa renders many current treatments ineffective, thereby prolonging 
the course of the illness . Among the many psychological and behavioral features of AN, cognitive features like obsessiveness, 
rigidity, and perfectionism are often described. Patients hold firm beliefs about an ideal body weight and find it difficult to alter 
their thinking patterns. Recent studies have identified a pathway to understanding this disorder through characterization of it’s 
cognitive features . With this research, advances have been made in identifying cognitive processes that likely mediate symptom 
expression in AN . This paper will describe the cognitive rigidity observed in patients with AN and will include a discussion of ther-
apeutic approaches to target this feature . 
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Introduction
Anorexia Nervosa (AN) is an eating disorder characterized by 
restricted food intake and inability to maintain an appropriate 
body weight. Individuals with AN engage in extreme weight 
control behaviors, such as caloric restriction and compulsive 
exercise.  According to the National Institute of Mental Health 
(2017), AN has an estimated prevalence of 0.6% in adults and 
has the highest mortality rate of any psychiatric disorder. The 
onset on AN typically occurs during adolescence and can per-
sist into adulthood, increasing the risk of mortality. Research 
has demonstrated that risk of mortality is higher for patients 
with a comorbid psychiatric condition, such as depression and 
substance abuse disorder (Jordan et al., 2003). One study found 
that substance use disorders, particularly alcohol use disorder, 
was associated with increased mortality in individuals with AN 
(Kask et al., 2016). Furthermore, a meta-analysis of 36 stud-
ies showed that the weighted annual mortality for AN was 10 
deaths per thousand people (Arcelus et al., 2011). The incidence 
proportion for AN (10 death per thousand people) is higher 
than the one for other eating disorders, like Bulimia Nervosa (3 
deaths per thousand people).
Diagnostic criteria for AN include: 1. Restriction of energy in-
take leading to significantly low body weight 2. Intense fear of 
weight gain or persistent behavior that interferes with weight 
gain 3. Disturbance in the way in which ones’ body weight or 
shape is perceived (American Psychiatric Association, 2013). The 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 
includes severity specifiers for AN based on current body mass 
index (BMI). The level of severity can reflect clinical symptom ex-
pression and degree of functional disability in patients with AN. 
The etiology of AN is complex; many factors contribute to the 
development and maintenance of the disorder. Predisposing ge-
netic and personality factors can render an individual susceptible, 
while environmental and social factors can trigger the onset of 
the disorder at a vulnerable time. Aside from individual person-
ality factors, previous research has found that cognitive factors 
play a role in the development and maintenance of the disorder. 
Specifically, cognitive deficits in working memory, mental flexibili-
ty, and set-shifting have been observed in patients with AN.
This paper will examine the neurocognitive deficits found in 
patients with Anorexia Nervosa, particularly cognitive rigidity and 
set-shifting. Etiology, maintenance, and therapeutic approaches for 
the disorder will be discussed, with a focus on specific treatments 
targeted at decreasing rigidity in patients with AN. 
Methods
This review was conducted using databases like PubMed and 
ProQuest, through the Touro College library system. Peer-
reviewed articles were also retrieved using Google Scholar and 
Semantic Scholar.
Discussion
Much of the research on AN has been conducted with patients 
undergoing treatment. Study samples often exclude those in-
dividuals who are not actively engaged in outpatient or resi-
dential treatment. However, many individuals with AN do not 
seek treatment due to perceived stigma (Dimitropoulos et al., 
2016). As a result, they are not included in study samples and 
the data obtained may not fully represent the general popula-
tion. Therefore, this literature review is largely limited to studies 
that have used clinical samples to obtain data.
Neurocognitive Deficits found in AN
Numerous studies have identified neurocognitive impairments 
in patients with AN (Phillipou et al., 2015, Chan et al., 2013). 
Neurocognition encompasses processes, such as planning, at-
tention, visuospatial function, working memory, and concept 
formation.  A broad range of neurocognitive functions have 
been found to be compromised in patients with AN, particularly 
cognitive flexibility and set-shifting. Cognitive flexibility refers to 
the capacity to adapt cognitive processing strategies in the face 
of new and unexpected conditions in the environment. In pa-
tients with AN, this ability is compromised and thus contributes 
to the behavioral symptomatology of the disorder.
Personality Traits in AN
Personality traits associated with AN include perfectionistic 
tendencies, introversion, and rigidity. These traits impact the 
way patients with AN perceive and react to people and their 
environments. Patients with AN have been described as having 
high harm avoidance and persistence, and low novelty seeking. 
These dimensions correspond with behaviors exhibited by 
those with AN, such as avoidance of weight gain and determi-
nation to reach a low body weight. Additionally, patients with 
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AN often endorse a rigid cognitive style and are unable to alter 
their cognitions related to eating behavior. They exhibit inflexi-
ble behaviors such as counting calories, compulsively exercising, 
and preoccupation with rigid rituals.
Possible Causes of Cognitive Rigidity in AN
A considerable amount of research supports the familial nature 
of neurocognitive deficits in AN. One study found that when 
compared to healthy controls, mothers of patients with AN 
displayed a more rigid thinking style on a neuropsychological 
measure of cognitive rigidity (Lang et al., 2016). Neurocognitive 
impairments have also been noted in healthy siblings of patients 
with AN, suggesting that these disturbances are not solely the 
result of the illness (Hason et al., 2011). Rather, these individuals 
may have biologically-based predispositions to respond to their 
environments in particular ways. Another study found that pa-
tients with AN had poor cognitive flexibility irrespective of the 
duration of their illness, highlighting the trait nature of cognitive 
rigidity in patients with AN (Tchanturia et al., 2011).
From a neurocognitive perspective, a rigid cognitive style 
stems from a lack of mental flexibility. Mental flexibility is the 
ability to think about multiple concepts simultaneously and to 
transition from thinking about one concept to another. Mental 
inflexibility can result in rigid thinking patterns, such as dichot-
omous thinking (black-and-white thinking) and inability to alter 
cognitions and behaviors. Individuals with rigid cognitive style 
are unable to change beliefs or behaviors that are ineffective in 
helping them achieve their goals. There are several processes 
that are compromised in individuals with cognitive rigidity; one 
example is set-shifting ability. Individuals with impaired set-shift-
ing ability cannot efficiently adapt to new situations in response 
to changing environmental demands. Similarly, individuals with 
AN have been found to perform poorly on tests of mental flex-
ibility in relation to healthy controls. For example, one study 
found that compared to healthy controls, patients with AN 
showed fewer fluctuations in their patterns of response in a test 
of perceptual judgement, even when their answers were incor-
rect (Tchanturia et al., 2001). In other words, patients with AN 
did not attempt to change their incorrect response patterns as 
frequently as healthy controls.
Assessment of Cognitive Rigidity in Patients with AN
One commonly used neuropsychological measure of cognitive 
rigidity is the Wisconsin Card Sorting Test (WCST). The WCST 
assesses set-shifting ability which is the ability to move back and 
forth between tasks, operations, or mental sets in response to 
changing goals or environmental demands. In this test, an individ-
ual must classify items according to one of four rules, while re-
ceiving feedback only when the rule that was used is correct. The 
classification rule changes every ten cards; therefore, once the 
participant has figured out the rule, the rule may quickly change. 
This task measures how well individuals can adapt to the changing 
rules and if they are able to change their behavior accordingly. 
In one study, researchers hypothesized that patients with AN 
will have lower set-shifting scores on the WCST when com-
pared to healthy controls. In their study, the AN group consisted 
of 24 adolescent females, and the control group consisted of 37 
healthy adolescent females with no prior history of eating dis-
orders. The adolescents in the AN group had lower set-shifting 
scores than the healthy controls (McAnarney et al., 2011). In 
a similar study, the WCST was used to measure of set-shift-
ing ability in two groups: one had patients with AN and one 
was healthy controls. All participants were female and ranged 
in age from 18 and 55 years. Results of the study indicated that 
patients with AN performed poorly in relation to the healthy 
controls (Tchanturia et al., 2012). Another study demonstrated 
that children and adolescents share a similar cognitive profile 
with adults with AN, providing support to the idea that these 
cognitive deficits may be underlying traits in all patients with 
AN (Lang et al., 2015). However, in contrast to this finding, a 
meta-analysis found that problems with set-shifting that are ob-
served in adults with AN were not as prevalent in children with 
AN (Lang et al., 2014). This observation suggests that set-shift-
ing inability may directly result from long-term starvation and is 
related to duration of the illness.
Neural Basis for Cognitive Rigidity in AN 
In addition to causes like heritability, research has pointed to 
neurological differences between patients with AN and healthy 
controls. These differences in brain structure may be responsi-
ble for features of cognitive rigidity. Prior research has estab-
lished the role of the prefrontal cortex in executive function 
and cognitive control.  Specifically, one prefrontal subregion, the 
anterior cingulate cortex, mediates complex cognitive functions 
such as affect regulation, cognitive control, and decision making 
(Stevens et al., 2011).  Cognitive control is required during neu-
ropsychological tests that measure cognitive flexibility, such as 
the WCST. During this test, individuals must change their behav-
ior if previously successful responses fail to yield reinforcement. 
Researchers used animal models to determine the role of the 
anterior cingulate cortex in cognitive control. After creating le-
sions in the anterior cingulate cortex of rats, they found that 
the rats had difficulty adjusting cognitive control, demonstrating 
that hypoactivity in this brain region can interfere with cognitive 
function (Newman et al., 2015).
Similarly, in a literature review on cognitive rigidity in AN, 
researchers suggested that the hippocampi and anterior cingu-
late showed a reduced thickness in gray matter in individuals 
with AN; therefore, processes associated with these structures, 
like working memory and set-shifting, have been impaired in 
AN patients (Kucharska et al., 2019) Likewise, another study 
found that during a test of set-shifting, patients with AN showed 
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hypoactivity in the dorsal anterior cingulate cortex (Zastro 
et al., 2009). This finding suggests that patients with AN have 
reduced motivation and initiative to complete tasks in a non-
routine way. 
The Effect of Cognitive Rigidity on Treatment 
Outcomes
A rigid cognitive style can influence treatment outcomes for 
patients with AN. Patients commonly have rigid rules about 
how many calories they can consume and the restricted range 
of foods they can consume (Tchanturia et al., 2001). This rigid 
thinking style can prevent behavioral change and can negatively 
affect treatment outcomes. Behavioral therapies intended to 
change perceptions of eating behavior can be ineffective for 
patients with a rigid and inflexible thinking pattern. Therefore, 
treatments aimed at decreasing cognitive rigidity can help pro-
mote new and adaptive thinking patterns in patients with AN. 
Recent translational research has begun to focus on character-
izing the cognitive features of AN and adapting existing treat-
ments accordingly. 
Therapeutic Approaches Aimed at Decreasing 
CognitiveRigidity in AN
Cognitive remediation therapy (CRT) is a method designed to 
improve neurocognitive abilities, such as cognitive flexibility, 
set-shifting, and attention. This form of therapy can lead to im-
proved psychosocial functioning in individuals who have cogni-
tive distortions. CRT consists of a set of mental exercises aimed 
at improving cognitive strategies and increasing holistic thinking. 
CRT was initially developed for patients with brain injuries and 
has more recently been adapted for patients with AN. It aims to 
address two primary features found in patients with AN: a lack 
of cognitive flexibility, and a preoccupation with details. Unlike 
traditional treatments for AN, CRT does not directly address 
behaviors related to eating disorders. Rather, CRT interventions 
for AN address these deficits by focusing on the patients’ pro-
cess of thinking, rather than on the content of their thoughts, 
thus helping patients develop a metacognitive awareness of 
their own thinking style. 
A study on the efficacy of CRT in improving cognitive func-
tion has demonstrated that cognitive flexibility improved sig-
nificantly after a ten-week CRT training (Kucharska et al., 2019). 
Furthermore, one study noted clinical changes following ten CRT 
sessions, notably, patients became more aware of their own cog-
nitive deficits and were able to apply alternative strategies that 
were demonstrated during the CRT sessions (Wood et al., 2011). 
Conclusion
Anorexia Nervosa is a complex illness with both behavioral and 
cognitive features. One of the main cognitive deficits found in 
AN is cognitive rigidity, or an inability to think about multiple 
perspectives simultaneously and to change one’s view on an 
issue. Several studies have suggested that this deficit is herita-
ble and is found in healthy siblings and parents of AN patients. 
Other studies have shown that level of cognitive rigidity is cor-
related to duration of illness, suggesting that this deficit may be 
a result of long-term starvation. Cognitive rigidity contributes 
to the maintenance of AN by making it difficult for patients 
to alter their cognitive distortions surrounding the disorder. 
Treatments that address secondary symptoms of the disorder, 
such as weight loss and food avoidance, can be ineffective if the 
underlying cognitive features of the disorder are not properly 
addressed. A considerable body of research has demonstrated 
that cognitive remediation therapy is effective in increasing cog-
nitive flexibility in patients with AN. This form of treatment can 
allow patients to see their behaviors as maladaptive and can 
help promote behavioral change.
References
American Psychiatric Association. (2013). Diagnostic and 
statistical manual of mental disorders (5th ed.).
Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality 
Rates in Patients With Anorexia Nervosa. Archives of General 
Psychiatry, 68, 724-731.
Chan, T., Ahn, W.-Y., Bates, J. E., Busemeyer, J. R., Guillaume, S., 
Regrave, G. W., & Courtet, P. (2013). Differential impairments 
underlying decision making in anorexia nervosa and bulimia 
nervosa: A cognitive modeling analysis. International Journal of 
Eating Disorders, 47(2), 157-167.
Dimitropoulos, G., Freeman, V. E., Muskat, S., Domingo, A., & 
McCallum, L. (2016). “You don’t have anorexia, you just want to 
look like a celebrity”: perceived stigma in individuals with anorexia 
nervosa (Vol. 25). Journal of Mental Health.
Hason Rozenstein, M., Latzer, Y., Stein, D., & Eviatar, Z. (2011). 
Neuropsychological psychopathology measures in women with 
eating disorders, their healthy sisters, and nonrelated healthy 
controls. Comprehensive Psychiatry, 52(6), 587-595.
Jordan, J., Joyce, P. R., Carter, F. A., Horn, J., McIntosh, V. V., Luty, S. 
E., & ... Bulik, C. M. (2003). Anxiety and psychoactive substance 
use disorder comorbidity in anorexia nervosa or depression. 
International Journal of Eating Disorders, 34(2), 211-219.
Kask, J., Ekselius, L., Brandt, L., Kollia, N., Ekbom, A., & 
Papadopoulos, F. (2016). Mortality in Women With Anorexia 
Nervosa: The Role of Comorbid Psychiatric Disorders. 
Psychosomatic Medicine, 78(8), 910-919.
Kucharska, K., Kułakowska, D., Starzomska, M., Rybakowski, F., 
& Biernacka, K. (2019). The improvement in neurocognitive 
functioning in anorexia nervosa adolescents throughout the 
integrative model of psychotherapy including cognitive remedi-
ation therapy. BMC Psychiatry, 19(15).
Lang, K., Lloyd, S., Khondoker, M., Simic, M., Treasure, J., & 
70
Miriam Sheynblyum
Tchanturia , K. (2015). Do children and Adolescents with 
Anorexia Nervosa Display an Inefficient Cognitive Processing 
Style? PLOS One, 10(7).
Lang, K., Stahl, D., Espie, J., Treasure, J., & Tchanturia, K. (2014). 
Set Shifting in Children and Adolescentswith Anorexia 
Nervosa: An Exploratory Systematic Review and Meta-Analysis. 
International Journal of Eating Disorders, 47(4), 394-399.
Lang, K., Treasure, J., & Tchanturia, K. (2016). Is inefficient 
cognitive processing in anorexia nervosa a familial trait? A 
neuropsychological pilot study of mothers of offspring with 
a diagnosis of anorexia nervosa. The World Journal of Biological 
Psychiatry, 17(4), 258-265.
McAnarney, E. R., Zarcone, J., Singh, P., Michels, J., Welsh, S., 
Litteer, T., & Klein, .. J. (2011). Restrictive Anorexia Nervosa and 
Set-Shifting in Adolescents: A Biobehavioral Interface. Journal of 
Adolescent Health, 49(1), 99-101.
National Institute of Mental Health. (2017). Eating Disorders. 
Retrieved August 21, 2019 from https://www .nimh .nih .gov/health/
statistics/eating-disorders .shtml.
Newman, L. A., Creer, D. J., & McGaughy, J. A. (2015). Cognitive 
control and the anterior cingulate cortex: how conflicting 
stimuli affect attentional control in the rat. Journal of Physiology 
Paris, 109(1-3), 95-103.
Phillipou, A., Gurvich, C., Castle, D., Abel, L., & Rossell, S. L. 
(2015). Comprehensive neurocognitive assessment of patients 
with anorexia nervosa. World Journal of Psychiatry, 5, 404-411.
Stevens, F. L., Hurley, R. A., & Taber, K. H. (2011). Anterior 
Cingulate Cortex: Unique Role in Cognition and Emotion. 
The Journal of Neuropsychiatry and Clinical Neurosciences, 23(2), 
121-125.
Tchanturia, K., Davies, H., Roberts, M., Harrison, A., Nakazato, 
M., Schmidt, U., & ... Morris, R. (2012, January). Poor Cognitive 
Flexibility in Eating Disorders: Examining the Evidence using 
the Wisconsin Card Sorting Task. PLOS One, 7(1).
Tchanturia, K., Harrison, A., Davies, H., Roberts, M., Oldershaw, 
A., & Nakazato, M. .. (2011). Cognitive Flexibility and Clinical 
Severity in Eating Disorders. PLOS One, 6(6).
Tchanturia, K., Serpell, L., Troop, N., & Treasure, J. (2001). 
Perceptual illusions in eating disorders: rigid and fluctuating 
styles. Journal of Behavior Therapyand Experimental Psychiatry, 
32(3), 107-115.
Wood, L., Al-Khairulla, H., & Lask, B. (2011). Group cognitive 
remediation therapy for adolescents with anorexia nervosa. 
Clinical Child Psychology and Psychiatry, 16(2), 225-231.
Zastro, A., Kaiser, S., Stippich, C., Walther, S., Herzog, W., 
Tchanturia, K., & ... Friederich, H.-C. (2009). Neural Correlates 
of Impaired Cognitive-Behavioral Flexibility in Anorexia 
Nervosa. The American Journal of Psychiatry, 166(5), 608-616.

